10-Q
--12-31False0001785056Q1http://fasb.org/srt/2024#ChiefExecutiveOfficerMemberP0YP0YP0YP0YP0YP0Y0001785056srt:MinimumMember2025-01-012025-03-310001785056trnr:ClmbrIncMembersrt:ScenarioPreviouslyReportedMember2024-02-020001785056trnr:StockOptionsToPurchaseCommonStockMember2025-01-012025-03-310001785056trnr:SeriesAConvertiblePreferredStockOneMember2024-03-292024-03-290001785056trnr:AccountingStandardsUpdate20540Member2023-08-220001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-02-280001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2025-01-012025-03-310001785056trnr:OtherRelatedPartyConvertibleNotesMember2025-03-310001785056trnr:CommonStockWarrantsJanuaryOneTwoThousandTwentyFiveMember2025-03-310001785056us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleNotesPayableMember2025-03-310001785056trnr:CommonStockWarrantsBestEffortsPreFundedMember2025-03-310001785056us-gaap:FairValueInputsLevel3Membertrnr:EmbeddedDerivatiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:MarchTwoThousandTwentyFiveWarrantsMember2024-01-012024-12-310001785056trnr:CommonStockWarrantsWoodwayMember2025-01-012025-03-310001785056us-gaap:CommonStockMember2025-02-282025-02-280001785056us-gaap:CommonStockMember2024-02-012024-02-010001785056trnr:SeriesBConvertiblePreferredStockMember2024-03-310001785056trnr:MatureAtFebruaryEighteenTwoThousandTwentyOneMembertrnr:OtherRelatedPartyConvertibleNotesMember2024-12-310001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveWarrantsMember2025-01-012025-03-310001785056us-gaap:WarrantMember2023-12-310001785056trnr:CommonStockWarrantsRegisteredDirectPlacementAgentMember2025-03-310001785056trnr:InternalUseSoftwareMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveClassBIncrementalWarrantsMember2025-01-280001785056us-gaap:CostOfGoodsTotalMembersrt:MinimumMembertrnr:VendorThreeMemberus-gaap:SupplierConcentrationRiskMember2025-01-012025-03-310001785056us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashAndCashEquivalentsMember2024-12-310001785056us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsBestEffortsPlacementAgentMember2025-01-012025-03-310001785056trnr:LoanModificationAgreementMember2024-04-240001785056us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-02-042025-02-040001785056us-gaap:RelatedPartyMembertrnr:PrincipalStockholderPromissoryNotesMember2025-03-310001785056trnr:SeriesCConvertiblePreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-11-300001785056trnr:PrincipalStockholderPromissoryNotesMember2025-01-290001785056us-gaap:CommonStockMember2024-01-012024-03-310001785056us-gaap:SalesRevenueNetMemberus-gaap:CashAndCashEquivalentsMembersrt:MinimumMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001785056us-gaap:RelatedPartyMembertrnr:PrincipalStockholderPromissoryNotesMember2024-12-310001785056trnr:MarchTwoThousandTwentyFiveDerivativeMember2025-01-012025-03-310001785056trnr:PromissoryNotesMember2025-03-052025-03-050001785056us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001785056trnr:FORMEMembercountry:US2025-01-012025-03-3100017850562024-03-072024-03-070001785056trnr:RegisteredDirectPlacementAgentWarrantsMember2024-01-012024-03-310001785056us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:PromissoryNotesMember2024-11-300001785056trnr:January2025ConvertibleNoteDerivativeMember2025-01-012025-03-310001785056us-gaap:WarrantMember2024-01-012024-03-310001785056trnr:WoodwayWarrantsMember2024-12-310001785056us-gaap:SeriesCPreferredStockMemberus-gaap:SubsequentEventMember2025-04-172025-04-170001785056us-gaap:AdditionalPaidInCapitalMember2025-03-310001785056trnr:CommonStockClassAIncrementalWarrantsJanuaryTwoThousandTwentyFiveMember2024-12-310001785056us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:ExchangeNotesMember2025-02-282025-02-280001785056us-gaap:AdditionalPaidInCapitalMember2024-12-310001785056trnr:AtTheMarketOfferingMemberus-gaap:CommonStockMember2024-12-310001785056us-gaap:CommonStockMember2025-03-310001785056trnr:WoodwayWarrantsMember2025-01-012025-03-310001785056trnr:AssetPurchaseAgreementMember2024-02-022024-02-020001785056trnr:StockOptionsToPurchaseCommonStockMember2024-01-012024-03-3100017850562017-01-012017-12-310001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberus-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-03-310001785056us-gaap:RetainedEarningsMember2024-12-310001785056us-gaap:SeriesCPreferredStockMember2025-03-310001785056us-gaap:CommonStockMember2025-01-280001785056trnr:TermLoanMember2024-01-012024-03-310001785056country:US2025-01-012025-03-310001785056trnr:CommonStockWarrantsRegisteredDirectMember2024-12-310001785056trnr:ExchangeNotesMember2025-02-280001785056us-gaap:WarrantMembertrnr:CommonStockWarrantsBestEffortsPlacementAgentMember2025-03-310001785056trnr:CommonStockClassAIncrementalWarrantsJanuaryTwoThousandTwentyFiveMember2025-03-310001785056us-gaap:SeriesBPreferredStockMember2025-01-012025-03-310001785056us-gaap:CashAndCashEquivalentsMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-12-310001785056trnr:CommonStockWarrantsJanuaryOneTwoThousandTwentyFiveMember2024-12-310001785056trnr:AtTheMarketOfferingMember2025-01-012025-03-310001785056us-gaap:SeriesCPreferredStockMembertrnr:LenderSettlementAgreementMember2025-01-230001785056trnr:CommonStockWarrantsRegisteredDirectPlacementAgentMember2024-12-310001785056trnr:EmbeddedDerivatiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveWarrantsMember2025-01-012025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveWarrantsMember2025-01-280001785056us-gaap:CostOfGoodsTotalMembersrt:MinimumMembertrnr:NoVendorMemberus-gaap:SupplierConcentrationRiskMember2024-01-012024-03-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2024-12-310001785056trnr:CommonStockWarrantsBestEffortsOfferingPreFundedWarrantsMember2025-01-012025-03-310001785056trnr:NovemberTwoThousandTwentyThreeBridgeWarrantsMember2025-01-012025-03-310001785056us-gaap:EmployeeStockOptionMembertrnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2025-01-012025-03-310001785056trnr:TermLoanMembertrnr:LoanModificationAgreementMember2024-04-242024-04-240001785056trnr:DecemberTwoThousandTwentyThreeDerivativeMember2024-01-012024-03-310001785056trnr:CommonStockWarrantsWoodwayMember2024-12-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:RegisteredOfferingWarrantsMember2025-01-012025-03-310001785056trnr:AtTheMarketOfferingMemberus-gaap:CommonStockMember2025-01-012025-03-310001785056us-gaap:PreferredClassBMember2024-12-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleNotesPayableMember2025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2020-03-202020-03-200001785056us-gaap:CommonStockMember2024-12-310001785056trnr:SeriesAConvertiblePreferredStockMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsBestEffortsA2Member2025-03-310001785056trnr:ExchangeNotesMember2025-01-012025-03-310001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2024-12-3100017850562025-04-082025-04-080001785056trnr:CapitalizedSoftwareMember2025-03-310001785056trnr:BusinessToBusinessMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsFebruaryOneTwoThousandTwentyFourMember2024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveClassAMember2025-03-310001785056trnr:RegisteredOfferingWarrantsMember2024-01-012024-03-310001785056trnr:JanuaryTwoThousandTwentyFiveClassAMember2024-12-310001785056trnr:PrincipalStockholderPromissoryNotesMember2019-08-280001785056trnr:WarrantsToPurchaseCommonStockMember2024-01-012024-03-310001785056us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2025-01-012025-03-310001785056trnr:InternalUseSoftwareMember2024-12-310001785056trnr:TreadwayWarrantsMember2024-03-310001785056trnr:CommonStockClassBIncrementalWarrantsJanuaryTwoThousandTwentyFiveMember2025-01-012025-03-310001785056trnr:MarchTwoThousandTwentyFiveDerivativeMember2024-12-310001785056trnr:RegisteredOfferingWarrantsMember2024-01-012024-12-310001785056us-gaap:SeriesAPreferredStockMember2025-01-012025-03-310001785056trnr:ExchangeNotesMember2025-02-052025-03-310001785056trnr:MatureAtMaySeventeenTwoThousandTwentyOneMembertrnr:PrincipalStockholderPromissoryNotesMember2025-03-310001785056trnr:CommonStockWarrantsBestEffortsA2Member2025-01-012025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveClassAIncrementalWarrantsMember2025-01-012025-03-310001785056us-gaap:WarrantMembertrnr:CommonStockWarrantsBestEffortsA1Member2024-07-010001785056us-gaap:SeriesCPreferredStockMember2024-01-012024-03-310001785056us-gaap:CommonStockMembertrnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-02-282025-02-280001785056trnr:AmendedAndRestatedAssetPurchaseAgreementMemberus-gaap:CashMember2024-02-022024-02-020001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-02-290001785056us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001785056us-gaap:DevelopedTechnologyRightsMember2024-12-310001785056trnr:ExchangeNoteFourMember2025-02-042025-02-040001785056srt:MinimumMembertrnr:OtherRelatedPartyTransactionsMember2025-01-012025-03-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-02-010001785056country:US2024-01-012024-03-310001785056trnr:SoftwareDevelopedTechnologyMember2025-03-310001785056us-gaap:SeriesAPreferredStockMember2024-01-012024-03-310001785056us-gaap:SeriesAPreferredStockMembersrt:MaximumMember2024-06-280001785056trnr:WoodwayWarrantsMember2024-01-012024-03-310001785056trnr:TreadwayWarrantsMember2024-01-012024-03-310001785056us-gaap:CommonStockMemberus-gaap:SubsequentEventMembertrnr:PurchaseAgreementMember2025-04-080001785056trnr:CommonStockWarrantsBestEffortsPlacementAgentMember2025-03-310001785056trnr:LossRestorationAgreementDerivativeMember2024-01-012024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveClassBMember2025-01-012025-03-3100017850562025-05-150001785056trnr:JanuaryTwoThousandTwentyFiveMember2024-12-310001785056trnr:RegisteredDirectOfferingWarrantsMember2025-03-310001785056us-gaap:SeriesAPreferredStockMember2025-01-232025-01-230001785056trnr:AccountingStandardsUpdate20540Member2025-03-310001785056us-gaap:CustomerRelatedIntangibleAssetsMember2024-12-310001785056trnr:DecemberSevenTwentyTwentyThreeWarrantsMember2024-01-012024-03-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2025-03-310001785056trnr:UnsecuredPromissoryNoteMemberus-gaap:SubsequentEventMembertrnr:BerenbergCapitalMarketsLLCMember2025-05-012025-05-010001785056us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleNotesPayableMember2024-12-310001785056us-gaap:SeriesCPreferredStockMember2025-01-012025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-02-052025-03-310001785056us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001785056trnr:SeriesCPreferredStockConversionToCommonStockMember2024-01-012024-03-310001785056us-gaap:SeriesCPreferredStockMembersrt:BoardOfDirectorsChairmanMember2025-01-230001785056trnr:MarchTwoThousandTwentyFiveWarrantsMember2025-03-110001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberus-gaap:SellingAndMarketingExpenseMember2024-01-012024-03-310001785056trnr:MarchTwoThousandTwentyFiveMember2025-03-310001785056us-gaap:RetainedEarningsMember2023-12-310001785056trnr:TermLoanMember2024-12-310001785056trnr:ExchangeNotesMember2025-02-040001785056us-gaap:SeriesAPreferredStockMembersrt:MaximumMember2024-04-180001785056trnr:LoanModificationAgreementMember2024-04-242024-04-240001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-12-310001785056trnr:January2025ConvertibleNoteDerivativeMember2024-01-012024-12-310001785056trnr:WarrantsToPurchaseCommonStockMember2025-01-012025-03-310001785056trnr:ClmbrIncMember2024-02-022024-02-0200017850562024-12-310001785056us-gaap:SeriesCPreferredStockMember2025-01-230001785056us-gaap:CommonStockMembertrnr:BestEffortsOfferingMember2024-07-310001785056trnr:SeriesBConvertiblePreferredStockMember2025-03-310001785056trnr:EmbeddedDerivatiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:CommonStockWarrantsRegisteredDirectMember2025-03-310001785056us-gaap:SeriesBPreferredStockMember2025-03-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-12-310001785056trnr:RegisteredDirectPlacementAgentWarrantsMember2024-01-012024-12-310001785056us-gaap:WarrantMember2024-03-310001785056trnr:AtTheMarketOfferingMemberus-gaap:CommonStockMember2024-06-012024-12-310001785056trnr:MatureAtAugustTwentyEightTwoThousandTwentyOneMembertrnr:PrincipalStockholderPromissoryNotesMember2024-12-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-01-012024-03-310001785056trnr:AssetPurchaseAgreementMember2025-01-012025-03-310001785056us-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056us-gaap:CashAndCashEquivalentsMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001785056trnr:RegisteredDirectOfferingWarrantsMemberus-gaap:WarrantMember2025-03-3100017850562023-12-310001785056us-gaap:LoansPayableMember2025-03-310001785056trnr:CommonStockWarrantsBestEffortsPreFundedMember2024-12-310001785056trnr:FORMEMembercountry:US2024-01-012024-03-310001785056us-gaap:WarrantMembertrnr:MarchTwoThousandTwentyFiveWarrantsMember2025-03-110001785056trnr:OtherRelatedPartyTransactionsMembertrnr:RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember2025-03-310001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-01-012024-03-310001785056us-gaap:RestrictedStockMember2025-01-012025-03-310001785056us-gaap:TrademarksAndTradeNamesMember2025-01-012025-03-310001785056trnr:NovemberTenTwentyTwentyThreeWarrantsMember2024-03-310001785056trnr:CommonStockWarrantsBestEffortsPlacementAgentMember2024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2024-01-012024-03-310001785056trnr:CommonStockWarrantsBestEffortsA2Member2024-12-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2025-03-310001785056us-gaap:SeriesAPreferredStockMembersrt:MinimumMember2024-06-280001785056trnr:AtTheMarketOfferingMemberus-gaap:CommonStockMember2025-02-280001785056trnr:FebruaryTwoThousandTwentyFourWarrantsMember2024-02-010001785056trnr:JanuaryTwoThousandTwentyFiveConvertibleNotesMember2024-01-012024-03-310001785056trnr:CommonStockWarrantsBestEffortsOfferingPreFundedWarrantsMember2024-01-012024-03-310001785056us-gaap:SeriesAPreferredStockMembersrt:BoardOfDirectorsChairmanMember2025-01-230001785056us-gaap:SubsequentEventMembertrnr:PurchaseAgreementMemberus-gaap:SeriesEPreferredStockMember2025-04-080001785056trnr:CommonStockWarrantsBestEffortsA2Member2024-01-012024-12-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2024-01-012024-03-3100017850562024-01-012024-03-310001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMembertrnr:ClassAIncrementalWarrantsMember2025-03-110001785056trnr:January2025ConvertibleNoteDerivativeMember2025-01-280001785056trnr:CLMBRMembercountry:US2024-01-012024-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2025-02-042025-02-040001785056trnr:CommonStockWarrantsMember2025-01-012025-03-310001785056trnr:MatureAtFebruaryEighteenTwoThousandTwentyOneMembertrnr:OtherRelatedPartyConvertibleNotesMember2025-03-310001785056us-gaap:SeriesCPreferredStockMembertrnr:LoanRestorationAgreementMember2024-09-300001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2024-01-012024-12-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-02-012024-02-290001785056srt:MaximumMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsFebruaryOneTwoThousandTwentyFourMember2025-01-012025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2021-02-122021-02-120001785056trnr:CommonStockWarrantsWoodwayMember2025-03-310001785056us-gaap:CostOfGoodsTotalMembertrnr:VendorThreeMemberus-gaap:SupplierConcentrationRiskMember2025-01-012025-03-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleNotesPayableMember2024-12-310001785056trnr:FebruaryTwoThousandTwentyFourWarrantsMember2024-01-012024-03-310001785056trnr:MatureAtFebruaryEighteenTwoThousandTwentyOneMembertrnr:OtherRelatedPartyConvertibleNotesMember2024-01-012024-01-310001785056trnr:SeriesAConvertiblePreferredStockMember2024-11-012024-12-310001785056us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:FebruaryTwoThousandTwentyFourWarrantsMembertrnr:WarrantTwoMembertrnr:FebruaryTwoThousandTwentyFourNoteMember2024-02-010001785056trnr:CommonStockWarrantsJanuaryOneTwoThousandTwentyFiveMember2025-01-012025-03-310001785056us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2024-01-012024-12-310001785056us-gaap:WarrantMembertrnr:BridgeNoteFinancingMember2023-11-102023-11-100001785056us-gaap:SeriesCPreferredStockMembertrnr:LenderSettlementAgreementMember2025-03-3100017850562024-01-012024-12-310001785056trnr:SportstechMembertrnr:BindingTransactionAgreementMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2025-02-100001785056trnr:JanuaryTwoThousandTwentyFiveDerivativeMember2024-12-310001785056trnr:HardwareDevelopedTechnologyMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveClassBMember2025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2025-02-040001785056us-gaap:SeriesAPreferredStockMember2025-03-310001785056trnr:SeriesAConvertiblePreferredStockOneMember2024-01-012024-09-300001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-02-012024-02-010001785056trnr:DirectToCustomerSubscriptionMember2025-01-012025-03-310001785056trnr:OtherRelatedPartyConvertibleNotesMember2024-12-310001785056trnr:PrincipalStockholderPromissoryNotesMember2019-08-282019-08-280001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMember2024-12-310001785056trnr:LossRestorationAgreementDerivativeMember2024-01-012024-03-310001785056trnr:RegisteredDirectPlacementAgentWarrantsMember2025-01-012025-03-310001785056trnr:RegisteredDirectOfferingWarrantsMembertrnr:WarrantOneMember2024-05-310001785056srt:MinimumMembertrnr:LoanModificationAgreementMember2024-04-240001785056trnr:CommonStockWarrantsBestEffortsPreFundedMember2024-07-310001785056trnr:CommonStockWarrantsMarchTwoThosuandTwentyFiveMember2025-01-012025-03-310001785056us-gaap:CommonStockMembertrnr:RegisteredOfferingWarrantsMember2024-05-310001785056us-gaap:RetainedEarningsMember2025-03-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:SeriesAPreferredStockConversionToCommonStockMember2025-01-012025-03-310001785056trnr:SeriesCConvertiblePreferredStockMember2025-03-310001785056trnr:AmendedAndRestatedAssetPurchaseAgreementMember2024-02-020001785056trnr:SeriesAPreferredStockConversionToCommonStockMember2024-01-012024-03-310001785056us-gaap:CommonStockMember2024-11-012024-12-310001785056trnr:MatureAtJuneTwelveTwoThousandTwentyTwoMembertrnr:PrincipalStockholderPromissoryNotesMember2024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveClassAIncrementalWarrantsMember2025-01-280001785056trnr:FebruaryTwoThousandTwentyFourWarrantsMember2024-01-012024-12-310001785056trnr:SeriesBConvertiblePreferredStockMember2024-12-310001785056trnr:SeriesAConvertiblePreferredStockOneMember2024-03-290001785056us-gaap:OperatingSegmentsMember2024-01-012024-03-310001785056us-gaap:TrademarksAndTradeNamesMember2025-03-310001785056trnr:DecemberTwoThousandTwentyThreeDerivativeMember2024-03-310001785056trnr:LoanAgreementMember2025-03-310001785056trnr:BridgeNoteFinancingMember2023-12-310001785056trnr:HardwareDistributionMember2024-01-012024-12-310001785056trnr:CommonStockWarrantsBestEffortsA2Member2024-12-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2025-01-012025-03-310001785056trnr:MatureAtMarchTwentyTwoThousandTwentyTwoMembertrnr:PrincipalStockholderPromissoryNotesMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveWarrantsMember2024-01-012024-12-310001785056trnr:WoodwayWarrantsMember2023-12-310001785056trnr:CommonStockWarrantsMember2025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMembertrnr:MatureAtMaySeventeenTwoThousandTwentyOneMember2024-12-310001785056trnr:AmendedAndRestatedAssetPurchaseAgreementMemberus-gaap:SeriesBPreferredStockMember2024-02-022024-02-020001785056us-gaap:SubsequentEventMembertrnr:PurchaseAgreementMember2025-04-080001785056us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001785056us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashAndCashEquivalentsMember2024-12-310001785056trnr:TermLoanMember2025-03-310001785056trnr:MatureAtAugustTwentyEightTwoThousandTwentyOneMembertrnr:PrincipalStockholderPromissoryNotesMember2025-03-3100017850562025-03-310001785056trnr:SeriesBConvertiblePreferredStockMember2025-01-012025-03-310001785056us-gaap:SeriesAPreferredStockMembersrt:MinimumMember2024-04-180001785056us-gaap:GeneralAndAdministrativeExpenseMembertrnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2024-01-012024-03-310001785056trnr:SeriesAConvertiblePreferredStockMember2024-01-012024-03-310001785056us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleNotesPayableMember2025-03-310001785056trnr:OtherRelatedPartyTransactionsMembersrt:MaximumMember2025-01-012025-03-310001785056us-gaap:SalesRevenueNetMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001785056trnr:JanuaryTwoThousandTwentyFiveClassBIncrementalWarrantsMember2025-01-012025-03-310001785056us-gaap:DerivativeMember2025-01-012025-03-310001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveClassBIncrementalWarrantsMember2025-01-280001785056trnr:March2025ConvertibleNoteDerivativeMember2025-01-012025-03-310001785056us-gaap:SeriesAPreferredStockMember2024-09-300001785056us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001785056trnr:IdentifiableIntangibleAssetsMember2024-01-012024-03-310001785056trnr:CapitalizedContentCostsMember2024-12-310001785056trnr:SeriesAConvertiblePreferredStockMember2024-03-310001785056trnr:CommonStockWarrantsBestEffortsPlacementAgentMember2024-12-310001785056trnr:SeriesAConvertiblePreferredStockMembertrnr:BridgeNoteFinancingMember2024-01-012024-03-310001785056us-gaap:SalesRevenueNetMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:CustomerConcentrationRiskMembertrnr:WoodwayUsaIncMember2025-01-012025-03-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2025-01-012025-03-310001785056trnr:MarchTwoThousandTwentyFiveWarrantsMember2025-01-012025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-03-310001785056us-gaap:FairValueInputsLevel3Membertrnr:EmbeddedDerivatiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveClassAIncrementalWarrantsMember2024-01-012024-12-310001785056trnr:NovemberTenTwentyTwentyThreeWarrantsMember2025-01-012025-03-310001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2025-01-012025-03-310001785056trnr:RegisteredDirectPlacementAgentWarrantsMember2025-03-3100017850562025-01-012025-03-310001785056trnr:MatureAtNovemberTwentyEightTwoThousandNineteenMembertrnr:PrincipalStockholderPromissoryNotesMember2024-12-310001785056trnr:AmendedAndRestatedAssetPurchaseAgreementMember2024-02-022024-02-0200017850562024-11-132024-11-130001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2025-03-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveClassBMember2024-12-310001785056trnr:ExchangeNoteOneMember2025-02-042025-02-040001785056trnr:CommonStockWarrantsBestEffortsA2Member2025-01-012025-03-310001785056trnr:ExchangeNoteFiveMember2025-02-042025-02-040001785056us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2021-02-120001785056us-gaap:RetainedEarningsMember2024-01-012024-03-310001785056trnr:OtherRelatedPartyTransactionsMember2025-01-012025-03-310001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMember2025-03-112025-03-110001785056trnr:SeriesAConvertiblePreferredStockMember2025-03-310001785056trnr:MarchTwoThousandTwentyFiveMember2024-12-310001785056us-gaap:RetainedEarningsMember2025-01-012025-03-310001785056trnr:NotePurchaseAgreementMember2024-09-300001785056trnr:PrincipalStockholderPromissoryNotesMember2025-03-310001785056trnr:BridgeNoteFinancingMember2024-03-310001785056trnr:FebruaryOneTwoThousandTwentyFourWarrantsMember2024-12-310001785056trnr:FORMEMember2025-01-012025-03-310001785056trnr:TermLoanMember2025-03-310001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMember2025-01-012025-03-310001785056trnr:CommonStockClassAIncrementalWarrantsJanuaryTwoThousandTwentyFiveMember2025-01-012025-03-310001785056us-gaap:CommonStockMembertrnr:ClmbrIncMember2024-02-020001785056trnr:CommonStockWarrantsBestEffortsA2Member2024-01-012024-03-310001785056us-gaap:AdditionalPaidInCapitalMember2024-03-310001785056trnr:AtTheMarketOfferingMemberus-gaap:CommonStockMember2025-02-012025-02-280001785056trnr:JanuaryTwoThousandTwentyFiveConvertibleNotesMember2025-01-012025-03-310001785056trnr:NovemberTenTwentyTwentyThreeWarrantsMember2025-03-310001785056trnr:CommonStockWarrantsBestEffortsPreFundedMember2025-01-012025-03-310001785056us-gaap:DevelopedTechnologyRightsMember2025-03-310001785056us-gaap:StockAppreciationRightsSARSMember2025-01-012025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-01-012025-03-310001785056trnr:DecemberSevenTwentyTwentyThreeWarrantsMember2024-03-310001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberus-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001785056trnr:ExchangeAgreementMember2024-09-300001785056trnr:PrincipalStockholderPromissoryNotesMember2019-11-280001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberus-gaap:SellingAndMarketingExpenseMember2025-01-012025-03-310001785056us-gaap:CashAndCashEquivalentsMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2019-05-170001785056us-gaap:WarrantMembertrnr:FebruaryTwoThousandTwentyFourWarrantsMembertrnr:FebruaryTwoThousandTwentyFourNoteMember2024-02-010001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveClassBIncrementalWarrantsMember2025-02-280001785056trnr:SeriesCPreferredStockConversionToCommonStockMember2025-01-012025-03-310001785056trnr:TreadwayWarrantsMember2023-12-310001785056us-gaap:CustomerRelatedIntangibleAssetsMember2025-03-310001785056trnr:CapitalizedSoftwareMember2024-12-310001785056trnr:SeriesCConvertiblePreferredStockMember2024-12-310001785056trnr:RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMembertrnr:OtherRelatedPartyTransactionsMember2025-01-012025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2024-01-012024-03-310001785056us-gaap:OperatingSegmentsMember2025-01-012025-03-310001785056trnr:March2025ConvertibleNoteDerivativeMember2024-01-012024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-02-040001785056trnr:CommonStockWarrantsBestEffortsPlacementAgentMember2025-01-012025-03-310001785056us-gaap:SeriesCPreferredStockMember2024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveDerivativeMember2025-03-310001785056us-gaap:RetainedEarningsMembertrnr:SeriesAConvertiblePreferredStockMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2025-01-012025-03-310001785056trnr:LoanAgreementMember2025-01-012025-03-310001785056trnr:PromissoryNotesMember2025-03-310001785056us-gaap:LoansPayableMember2024-12-310001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveWarrantsMember2025-02-280001785056srt:ScenarioForecastMembertrnr:PurchaseAgreementMember2025-10-012026-09-300001785056trnr:RoyaltyArrangementThreePercentageOfCumulativeNetSalesUpTo5MillionMembertrnr:OtherRelatedPartyTransactionsMember2025-03-310001785056trnr:TermLoanMembertrnr:VerticalInvestorsLlcMember2024-02-010001785056trnr:CapitalizedContentCostsMember2025-03-310001785056trnr:SeriesCConvertiblePreferredStockMemberus-gaap:RetainedEarningsMember2025-01-012025-03-310001785056trnr:MarchTwoThousandTwentyFiveDerivativeMember2025-03-310001785056us-gaap:ShareBasedCompensationAwardTrancheTwoMembertrnr:SportstechMembertrnr:BindingTransactionAgreementMember2025-02-100001785056us-gaap:CommonStockMember2024-06-252024-06-250001785056us-gaap:CommonStockMember2024-03-310001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMembertrnr:ClassAIncrementalWarrantsMember2025-03-112025-03-110001785056trnr:CLMBRMember2024-01-012024-03-310001785056trnr:SubscriptionReceivablePreferredStockSeriesAMember2024-03-310001785056trnr:ExchangeAgreementNoteConversionSharesMember2025-02-040001785056trnr:NovemberTwentyTwentyThreeWarrantsMember2024-01-012024-03-310001785056trnr:DecemberSevenTwentyTwentyThreeWarrantsMember2023-12-310001785056trnr:FebruaryTwoThousandTwentyFourWarrantsMembertrnr:FebruaryTwoThousandTwentyFourNoteMembertrnr:WarrantOneMember2024-02-010001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMember2024-01-012024-03-310001785056trnr:LossRestorationAgreementDerivativeMember2025-01-012025-03-310001785056trnr:FORMEMember2024-01-012024-03-310001785056trnr:DirectToCustomerSubscriptionMember2025-03-310001785056trnr:CommonStockWarrantsRegisteredDirectMember2025-01-012025-03-310001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMember2025-03-110001785056trnr:AccountingStandardsUpdate20540Member2025-01-012025-03-310001785056us-gaap:CommonStockMembertrnr:DecemberTwoThousandTwentyThreeConvertibleNotesMember2024-06-012024-06-300001785056trnr:OtherRelatedPartyConvertibleNotesMember2020-02-180001785056trnr:PurchaseAgreementMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsMarchTwoThosuandTwentyFiveMember2025-03-310001785056trnr:BridgeNoteFinancingMember2024-01-012024-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2019-11-282019-11-280001785056trnr:RegisteredOfferingWarrantsMember2024-12-310001785056us-gaap:WarrantMembertrnr:WoodwayWarrantsMember2024-02-200001785056us-gaap:PreferredClassAMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveConvertibleNotesMember2025-01-280001785056us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveClassAIncrementalWarrantsMember2025-03-110001785056trnr:SportstechMembertrnr:BindingTransactionAgreementMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2025-02-100001785056srt:MaximumMember2017-01-012017-12-310001785056trnr:EmbeddedDerivatiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2025-03-310001785056us-gaap:TrademarksAndTradeNamesMember2024-12-310001785056trnr:WoodwayWarrantsMember2024-03-310001785056trnr:CLMBRMembercountry:US2025-01-012025-03-310001785056trnr:LossRestorationAgreementDerivativeMember2024-12-310001785056trnr:SeriesBConvertiblePreferredStockMember2024-01-012024-03-310001785056us-gaap:FairValueInputsLevel1Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001785056trnr:LoanAmountMember2024-09-300001785056us-gaap:CommonStockMember2024-09-012024-11-300001785056us-gaap:WarrantMembertrnr:RegisteredOfferingWarrantsMember2024-05-310001785056trnr:SportstechMembertrnr:BindingTransactionAgreementMember2025-02-100001785056trnr:SeriesAConvertiblePreferredStockOneMembertrnr:LoanRestorationAgreementMember2024-01-012024-09-300001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveClassAIncrementalWarrantsMember2025-03-310001785056trnr:SeriesAConvertiblePreferredStockMember2024-12-310001785056trnr:DecemberTwoThousandTwentyThreeDerivativeMember2023-12-310001785056us-gaap:DerivativeMember2024-12-310001785056us-gaap:CommonStockMember2024-01-012024-06-300001785056trnr:MarchTwoThousandTwentyFiveMember2025-01-012025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2020-03-200001785056trnr:CommonStockClassBIncrementalWarrantsJanuaryTwoThousandTwentyFiveMember2024-12-310001785056trnr:ExchangeNotesMembertrnr:PrincipalStockholderPromissoryNotesMember2025-02-040001785056us-gaap:RetainedEarningsMember2024-03-310001785056trnr:EventOfDefaultMembertrnr:JanuaryTwoThousandTwentyFiveConvertibleNotesMember2025-01-280001785056us-gaap:AdditionalPaidInCapitalMember2023-12-310001785056trnr:ClmbrIncMemberus-gaap:SeriesBPreferredStockMember2024-02-020001785056trnr:AssetPurchaseAgreementMember2025-03-310001785056us-gaap:WarrantMembertrnr:RegisteredDirectPlacementAgentWarrantsMember2024-05-080001785056trnr:DecemberTwoThousandTwentyThreeDerivativeMemberus-gaap:DerivativeMember2024-01-012024-03-310001785056trnr:JanuaryTwoThousandTwentyFiveConvertibleNotesMember2025-03-310001785056us-gaap:CostOfGoodsTotalMembertrnr:NoVendorMemberus-gaap:SupplierConcentrationRiskMember2024-01-012024-03-310001785056us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleNotesPayableMember2024-12-310001785056trnr:NovemberTwentyTwentyThreeWarrantsMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsFebruaryOneTwoThousandTwentyFourMember2025-03-310001785056trnr:MatureAtNovemberTwentyEightTwoThousandNineteenMembertrnr:PrincipalStockholderPromissoryNotesMember2025-03-310001785056trnr:NovemberTenTwentyTwentyThreeWarrantsMember2024-12-310001785056trnr:TermLoanMembertrnr:VerticalInvestorsLlcMember2024-02-012024-02-010001785056us-gaap:SubsequentEventMembertrnr:BerenbergCapitalMarketsLLCMember2025-05-010001785056trnr:PrincipalStockholderPromissoryNotesMember2025-01-012025-03-310001785056trnr:ClmbrIncMember2024-01-012024-03-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2024-12-310001785056trnr:CommonStockWarrantsBestEffortsA1Member2024-12-310001785056trnr:March2025ConvertibleNoteDerivativeMember2025-03-110001785056trnr:JanuaryTwoThousandTwentyFiveConvertibleNotesMember2024-12-310001785056trnr:FebruaryTwoThousandTwentyFourWarrantsMember2025-01-012025-03-310001785056trnr:MatureAtMarchTwentyTwoThousandTwentyTwoMembertrnr:PrincipalStockholderPromissoryNotesMember2024-12-310001785056us-gaap:CommonStockMember2025-01-012025-03-310001785056trnr:OtherRelatedPartyConvertibleNotesMember2020-02-182020-02-180001785056trnr:CommonStockWarrantsBestEffortsPlacementAgentMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveClassBIncrementalWarrantsMember2024-01-012024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveClassAMember2025-01-012025-03-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-11-012024-11-300001785056trnr:EventOfDefaultMembertrnr:MarchTwoThousandTwentyFiveConvertibleNotesMember2025-03-110001785056us-gaap:GeneralAndAdministrativeExpenseMembertrnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2025-01-012025-03-310001785056us-gaap:CommonStockMembertrnr:AmendedAndRestatedAssetPurchaseAgreementMember2024-02-022024-02-020001785056trnr:WoodwayWarrantsMember2025-03-310001785056us-gaap:CommonStockMember2024-11-212024-11-210001785056us-gaap:SeriesCPreferredStockMembersrt:MinimumMember2025-01-012025-03-310001785056trnr:ClmbrIncMember2024-02-020001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveClassAIncrementalWarrantsMember2025-02-280001785056us-gaap:CommonStockMemberus-gaap:HomeEquityMember2024-05-310001785056trnr:FebruaryTwoThousandTwentyFourConvertibleNotesMember2024-01-012024-12-310001785056trnr:CommonStockWarrantsBestEffortsA2Member2025-03-310001785056us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001785056us-gaap:CommonStockMembertrnr:BestEffortsOfferingMember2024-07-012024-07-310001785056trnr:CommonStockWarrantsRegisteredDirectPlacementAgentMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsBestEffortsA2Memberus-gaap:WarrantMember2024-07-010001785056trnr:JanuaryTwoThousandTwentyFiveDerivativeMember2025-01-012025-03-310001785056trnr:HardwareDevelopedTechnologyMember2025-01-012025-03-310001785056trnr:ExchangeNoteThreeMember2025-02-042025-02-040001785056trnr:CommonStockWarrantsBestEffortsPlacementAgentMember2024-01-012024-12-310001785056trnr:LossRestorationAgreementDerivativeMember2025-03-310001785056us-gaap:DerivativeMember2025-03-310001785056trnr:MatureAtJuneTwelveTwoThousandTwentyTwoMembertrnr:PrincipalStockholderPromissoryNotesMember2025-03-310001785056trnr:OtherRelatedPartyTransactionsMembertrnr:RoyaltyArrangementOnePercentageOfCumulativeNetSalesAbove5MillionMember2025-01-012025-03-310001785056trnr:SeriesCConvertiblePreferredStockMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsMember2024-12-310001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-01-012025-03-310001785056trnr:SubscriptionReceivablePreferredStockSeriesAMember2024-01-012024-03-310001785056us-gaap:CommonStockMemberus-gaap:HomeEquityMember2024-01-012024-05-310001785056trnr:CommonStockClassBIncrementalWarrantsJanuaryTwoThousandTwentyFiveMember2025-03-310001785056trnr:JanuaryTwoThousandTwentyFiveMember2025-01-012025-03-310001785056trnr:SoftwareDevelopedTechnologyMember2025-01-012025-03-310001785056trnr:NovemberTenTwentyTwentyThreeWarrantsMember2024-01-012024-12-310001785056trnr:SeriesBPreferredStockConversionToCommonStockMember2024-01-012024-03-310001785056trnr:ClmbrIncMembersrt:RestatementAdjustmentMember2024-02-020001785056srt:ScenarioForecastMembertrnr:PurchaseAgreementMember2026-10-012027-09-3000017850562024-03-310001785056trnr:NovemberTenTwentyTwentyThreeWarrantsMember2023-12-310001785056trnr:SeriesBPreferredStockConversionToCommonStockMember2025-01-012025-03-310001785056trnr:FebruaryOneTwoThousandTwentyFourWarrantsMember2025-01-012025-03-310001785056us-gaap:WarrantMembertrnr:FebruaryTwoThousandTwentyFourWarrantsMembertrnr:FebruaryTwoThousandTwentyFourNoteMember2024-02-012024-02-010001785056us-gaap:PreferredClassBMember2025-03-310001785056trnr:PromissoryNotesMember2025-03-050001785056trnr:TwoThousandTwentyThreeAndTwoThousandTwentyEquityIncentivePlanMember2024-01-012024-03-310001785056trnr:DecemberTwoThousandTwentyThreeConvertibleNotesMember2024-01-012024-06-300001785056trnr:TermLoanMember2024-12-310001785056us-gaap:SeriesAPreferredStockMember2025-01-230001785056us-gaap:CommonStockMember2023-12-310001785056us-gaap:SeriesCPreferredStockMember2024-09-300001785056trnr:ClmbrIncMember2025-01-012025-03-310001785056trnr:PrincipalStockholderPromissoryNotesMember2019-05-172019-05-170001785056trnr:WoodwayWarrantsMember2024-01-012024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveConvertibleNotesMember2025-01-282025-01-280001785056trnr:EmbeddedDerivatiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:RegisteredOfferingWarrantsMember2025-03-310001785056trnr:AtTheMarketOfferingMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001785056trnr:ExchangeNoteTwoMember2025-02-042025-02-040001785056us-gaap:CommonStockMember2024-02-022024-02-020001785056trnr:ExchangeNotesMember2025-03-310001785056trnr:TermLoanMember2025-01-012025-03-310001785056trnr:IdentifiableIntangibleAssetsMember2025-01-012025-03-310001785056trnr:SeriesAConvertiblePreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001785056trnr:CommonStockWarrantsMarchTwoThosuandTwentyFiveMember2024-12-310001785056trnr:JanuaryTwoThousandTwentyFiveExchangeNotesMember2025-02-040001785056trnr:NovemberTenTwentyTwentyThreeWarrantsMember2024-01-012024-03-310001785056us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001785056trnr:FebruaryOneTwoThousandTwentyFourWarrantsMember2025-03-310001785056us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CashAndCashEquivalentsMember2025-03-310001785056trnr:CLMBRMember2025-01-012025-03-310001785056trnr:HardwareDistributionMember2025-03-310001785056trnr:RegisteredDirectPlacementAgentWarrantsMember2024-12-310001785056trnr:MarchTwoThousandTwentyFiveConvertibleNotesMember2025-03-310001785056us-gaap:SeriesAPreferredStockMembersrt:MinimumMember2025-01-012025-03-310001785056us-gaap:PreferredClassAMember2024-12-310001785056trnr:PromissoryNotesMember2024-12-310001785056us-gaap:WarrantMembertrnr:JanuaryTwoThousandTwentyFiveClassBIncrementalWarrantsMember2025-03-310001785056srt:MinimumMember2017-01-012017-12-31trnr:Customeriso4217:EURxbrli:purexbrli:sharestrnr:Segmenttrnr:Vendoriso4217:USD
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
|
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2025
OR
|
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___________ to ________
Commission File Number: 001-41610
INTERACTIVE STRENGTH INC.
(Exact name of registrant as specified in its charter)
|
|
Delaware |
82-1432916 |
( State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
1005 Congress Ave, Suite 925 Austin, Texas |
78701 |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (512) 885-0035
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common stock, $0.0001 par value per share |
|
TRNR |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
Emerging growth company |
|
☒ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
APPLICABLE ONLY TO CORPORATE ISSUERS:
As of May 15, 2025, the registrant had 10,068,435 shares of common stock, $0.0001 par value per share, outstanding.
Unless otherwise indicated, all share numbers and per share totals have been adjusted to reflect the 1-for-40 reverse stock split that was effective on June 14, 2024 and the 1-for-40 reverse stock split that was effective on November 11, 2024.
Item 1. Financial Statements
INTERACTIVE STRENGTH INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
(In thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,207 |
|
|
$ |
138 |
|
Accounts receivable |
|
|
1,764 |
|
|
|
1,426 |
|
Inventories, net |
|
|
3,186 |
|
|
|
3,868 |
|
Derivatives |
|
|
95 |
|
|
|
— |
|
Vendor deposits |
|
|
1,151 |
|
|
|
1,976 |
|
Loan receivable |
|
|
2,183 |
|
|
|
— |
|
Prepaid expenses and other current assets |
|
|
858 |
|
|
|
810 |
|
Total current assets |
|
|
11,444 |
|
|
|
8,218 |
|
Property and equipment, net |
|
|
80 |
|
|
|
116 |
|
Right-of-use-assets |
|
|
338 |
|
|
|
415 |
|
Intangible assets, net |
|
|
5,653 |
|
|
|
6,106 |
|
Long-term inventories, net |
|
|
2,869 |
|
|
|
2,822 |
|
Vendor deposits long term |
|
|
1,172 |
|
|
|
310 |
|
Goodwill |
|
|
13,220 |
|
|
|
13,220 |
|
Other assets |
|
|
3,040 |
|
|
|
2,963 |
|
Total Assets |
|
$ |
37,816 |
|
|
$ |
34,170 |
|
Liabilities and stockholders' equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Accounts payable |
|
$ |
7,698 |
|
|
$ |
11,169 |
|
Accrued expenses and other current liabilities |
|
|
3,311 |
|
|
|
3,975 |
|
Operating lease liability, current portion |
|
|
194 |
|
|
|
261 |
|
Deferred revenue |
|
|
66 |
|
|
|
77 |
|
Loan payable |
|
|
7,282 |
|
|
|
8,569 |
|
Income tax payable |
|
|
7 |
|
|
|
7 |
|
Derivatives |
|
|
959 |
|
|
|
73 |
|
Convertible note payable |
|
|
1,739 |
|
|
|
2,750 |
|
Total current liabilities |
|
|
21,256 |
|
|
|
26,881 |
|
Operating lease liability, net of current portion |
|
|
154 |
|
|
|
170 |
|
Warrant liabilities |
|
|
767 |
|
|
|
4 |
|
Convertible note payable noncurrent |
|
|
1,883 |
|
|
|
— |
|
Total liabilities |
|
$ |
24,060 |
|
|
$ |
27,055 |
|
Commitments and contingencies (Note 15) |
|
|
|
|
|
|
Stockholders' equity |
|
|
|
|
|
|
Series A preferred stock, par value $0.0001; 10,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 4,671,071 and 4,658,737 shares issued and outstanding as of March 31, 2025 and December 31, 2024 respectively. |
|
|
1 |
|
|
|
1 |
|
Series B preferred stock, par value $0.0001; 1,500,000 shares authorized as of March 31, 2025 and December 31, 2024; 439,882 and 1,500,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024 respectively. |
|
|
— |
|
|
|
— |
|
Series C preferred stock, par value $0.0001; 5,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 1,871,210 and 2,861,128 shares issued and outstanding as of March 31, 2025 and December 31, 2024 respectively. |
|
|
1 |
|
|
|
— |
|
Common stock, par value $0.0001; 900,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 7,953,570 and 1,402,120 shares issued and outstanding as of March 31, 2025 and December 31, 2024 respectively. |
|
|
9 |
|
|
|
8 |
|
Additional paid-in capital |
|
|
222,929 |
|
|
|
209,509 |
|
Accumulated other comprehensive income |
|
|
204 |
|
|
|
183 |
|
Accumulated deficit |
|
|
(209,388 |
) |
|
|
(202,586 |
) |
Total stockholders' equity |
|
|
13,756 |
|
|
|
7,115 |
|
Total liabilities and stockholders' equity |
|
$ |
37,816 |
|
|
$ |
34,170 |
|
INTERACTIVE STRENGTH INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(unaudited)
(In thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2025 |
|
|
2024 |
|
Revenue: |
|
|
|
|
|
|
Fitness product revenue |
|
$ |
1,050 |
|
|
$ |
53 |
|
Membership revenue |
|
|
176 |
|
|
|
155 |
|
Training revenue |
|
|
130 |
|
|
|
155 |
|
Total revenue |
|
|
1,356 |
|
|
|
363 |
|
Cost of revenue: |
|
|
|
|
|
|
Cost of fitness product revenue |
|
|
(917 |
) |
|
|
(379 |
) |
Cost of membership |
|
|
(423 |
) |
|
|
(1,019 |
) |
Cost of training |
|
|
(320 |
) |
|
|
(165 |
) |
Total cost of revenue |
|
|
(1,660 |
) |
|
|
(1,563 |
) |
Gross loss |
|
|
(304 |
) |
|
|
(1,200 |
) |
Operating expenses: |
|
|
|
|
|
|
Research and development |
|
|
1,271 |
|
|
|
2,023 |
|
Sales and marketing |
|
|
250 |
|
|
|
256 |
|
General and administrative |
|
|
4,487 |
|
|
|
5,962 |
|
Total operating expenses |
|
|
6,008 |
|
|
|
8,241 |
|
Loss from operations |
|
|
(6,312 |
) |
|
|
(9,441 |
) |
Other (expense) income, net: |
|
|
|
|
|
|
Other (expense) income, net |
|
|
(111 |
) |
|
|
(370 |
) |
Interest expense |
|
|
(1,764 |
) |
|
|
(2,000 |
) |
Interest income |
|
|
158 |
|
|
|
— |
|
Gain (loss) upon extinguishment of debt and accounts payable |
|
|
3,037 |
|
|
|
(1,066 |
) |
Change in fair value of convertible notes |
|
|
(573 |
) |
|
|
(316 |
) |
Change in fair value of derivatives |
|
|
(1,487 |
) |
|
|
— |
|
Change in fair value of warrants |
|
|
449 |
|
|
|
1,799 |
|
Total other expense, net |
|
|
(291 |
) |
|
|
(1,953 |
) |
Loss before provision for income taxes |
|
|
(6,603 |
) |
|
|
(11,394 |
) |
Income tax expense |
|
|
— |
|
|
|
— |
|
Net loss attributable to common stockholders |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
Net loss per share - basic and diluted |
|
$ |
(1.74 |
) |
|
$ |
(2,681.82 |
) |
Weighted average common stock outstanding—basic and diluted |
|
|
3,804,106 |
|
|
|
4,249 |
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2025 |
|
|
2024 |
|
Net loss |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
Other comprehensive (loss) gain: |
|
|
|
|
|
|
Foreign currency translation gain |
|
|
21 |
|
|
|
39 |
|
Total comprehensive loss |
|
$ |
(6,582 |
) |
|
$ |
(11,355 |
) |
INTERACTIVE STRENGTH INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
(unaudited)
(In thousands, except share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock Series B |
|
Convertible Preferred Stock Series A |
|
Convertible Preferred Stock Series B |
|
Convertible Preferred Stock Series C |
|
Common Stock |
|
Subscription Receivable Preferred Stock Series A |
|
Additional Paid-In Capital |
|
Accumulated Other Comprehensive Income |
|
Accumulated Deficit |
|
Total Stockholders' (Deficit) |
|
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2023 |
|
— |
|
$ |
— |
|
|
— |
|
$ |
— |
|
|
— |
|
$ |
— |
|
|
— |
|
$ |
— |
|
|
3,548 |
|
$ |
7 |
|
$ |
— |
|
$ |
161,252 |
|
$ |
100 |
|
$ |
(166,911 |
) |
$ |
(5,552 |
) |
Issuance of preferred stock Series A upon conversion of debt |
|
— |
|
|
— |
|
|
3,430,895 |
|
|
1 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
10,082 |
|
|
— |
|
|
— |
|
|
10,082 |
|
Subscription receivable for issuance of Series A preferred stock |
|
— |
|
|
— |
|
|
1,500,000 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(3,000 |
) |
|
— |
|
|
— |
|
|
— |
|
|
(3,000 |
) |
Issuance of preferred stock series B upon acquisition of CLMBR, Inc. |
|
1,500,000 |
|
|
2,688 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Issuance of common stock upon acquisition of CLMBR, Inc. |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
357 |
|
|
0 |
|
|
— |
|
|
1,014 |
|
|
— |
|
|
— |
|
|
1,014 |
|
Issuance of Common stock upon waiver to enter into Note Agreement |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
63 |
|
|
0 |
|
|
— |
|
|
177 |
|
|
— |
|
|
— |
|
|
177 |
|
Issuance of shares upon issuance of convertible notes |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
188 |
|
|
0 |
|
|
— |
|
|
547 |
|
|
— |
|
|
— |
|
|
547 |
|
Issuance of Common stock from equity line of credit |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
328 |
|
|
0 |
|
|
— |
|
|
692 |
|
|
— |
|
|
— |
|
|
692 |
|
Issuance of Common stock upon conversion of convertible notes |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
371 |
|
|
0 |
|
|
— |
|
|
866 |
|
|
— |
|
|
— |
|
|
866 |
|
Issuance of Common stock upon exercise of stock options |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
4 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Stock-based compensation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
3,586 |
|
|
— |
|
|
— |
|
|
3,586 |
|
Foreign currency translation gain (loss) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
39 |
|
|
— |
|
|
39 |
|
Net loss |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(11,394 |
) |
|
(11,394 |
) |
Balances at March 31, 2024 |
|
1,500,000 |
|
$ |
2,688 |
|
|
4,930,895 |
|
$ |
1 |
|
|
— |
|
$ |
— |
|
|
— |
|
$ |
— |
|
|
4,859 |
|
$ |
7 |
|
$ |
(3,000 |
) |
$ |
178,216 |
|
$ |
139 |
|
$ |
(178,305 |
) |
$ |
(2,942 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock Series B |
|
Convertible Preferred Stock Series A |
|
Convertible Preferred Stock Series B |
|
Convertible Preferred Stock Series C |
|
Common Stock |
|
Subscription Receivable Preferred Stock Series A |
|
Additional Paid-In Capital |
|
Accumulated Other Comprehensive Income |
|
Accumulated Deficit |
|
Total Stockholders' Equity |
|
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2024 |
|
— |
|
$ |
— |
|
|
4,658,737 |
|
$ |
1 |
|
|
1,500,000 |
|
$ |
0 |
|
|
2,861,128 |
|
$ |
0 |
|
|
1,402,102 |
|
$ |
8 |
|
$ |
— |
|
$ |
209,509 |
|
$ |
183 |
|
$ |
(202,586 |
) |
$ |
7,115 |
|
Series A Preferred dividends declared and paid in kind |
|
— |
|
|
— |
|
|
112,334 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
225 |
|
|
— |
|
|
(225 |
) |
|
— |
|
Series C Preferred dividends declared and paid in kind |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
126,515 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
253 |
|
|
— |
|
|
(253 |
) |
|
— |
|
Issuance of Common stock from At the Market offering |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
821,500 |
|
|
— |
|
|
— |
|
|
1,594 |
|
|
— |
|
|
— |
|
|
1,594 |
|
Issuance of Common stock upon conversion of convertible notes |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
3,941,578 |
|
|
1 |
|
|
— |
|
|
5,798 |
|
|
— |
|
|
— |
|
|
5,799 |
|
Issuance of Common stock upon conversion of preferred stock |
|
— |
|
|
— |
|
|
(100,000 |
) |
|
— |
|
|
(1,060,118 |
) |
|
— |
|
|
(2,801,250 |
) |
|
— |
|
|
1,788,390 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Issuance of preferred stock series C upon settlement of loss restoration agreement |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
1,684,817 |
|
|
1 |
|
|
— |
|
|
— |
|
|
— |
|
|
3,127 |
|
|
— |
|
|
— |
|
|
3,128 |
|
Gain on extinguishment of related party promissory notes |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
279 |
|
|
279 |
|
Stock-based compensation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,423 |
|
|
— |
|
|
— |
|
|
2,423 |
|
Foreign currency translation gain (loss) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
21 |
|
|
— |
|
|
21 |
|
Net loss |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(6,603 |
) |
|
(6,603 |
) |
Balances at March 31, 2025 |
|
— |
|
$ |
— |
|
|
4,671,071 |
|
$ |
1 |
|
|
439,882 |
|
$ |
0 |
|
|
1,871,210 |
|
$ |
1 |
|
|
7,953,570 |
|
$ |
9 |
|
$ |
— |
|
$ |
222,929 |
|
$ |
204 |
|
$ |
(209,388 |
) |
$ |
13,756 |
|
INTERACTIVE STRENGTH INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(unaudited)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2025 |
|
|
2024 |
|
Cash Flows From Operating Activities: |
|
|
|
|
|
|
Net loss |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
Foreign currency |
|
|
(22 |
) |
|
|
(49 |
) |
Depreciation |
|
|
36 |
|
|
|
191 |
|
Amortization |
|
|
876 |
|
|
|
1,697 |
|
Non-cash lease expense |
|
|
77 |
|
|
|
54 |
|
Inventory step up amortization |
|
|
100 |
|
|
|
— |
|
Stock-based compensation |
|
|
2,089 |
|
|
|
3,366 |
|
(Gain) Loss on extinguishment of debt and accounts payable |
|
|
(3,037 |
) |
|
|
1,066 |
|
Loss on settlement of accounts payable |
|
|
551 |
|
|
|
— |
|
Interest Income |
|
|
(158 |
) |
|
|
— |
|
Non-cash interest expense |
|
|
1,306 |
|
|
|
671 |
|
Amortization of debt discount |
|
|
370 |
|
|
|
1,329 |
|
Common stock issued to lender in connection with entering Equity Line of Credit Agreement |
|
|
— |
|
|
|
368 |
|
Change in fair value of convertible notes |
|
|
573 |
|
|
|
316 |
|
Loss on issuance of warrants |
|
|
— |
|
|
|
345 |
|
Change in fair value of derivatives |
|
|
1,487 |
|
|
|
(54 |
) |
Change in fair value of warrants |
|
|
(449 |
) |
|
|
(1,799 |
) |
Changes in operating assets and liabilities |
|
|
|
|
|
|
Accounts receivable |
|
|
(338 |
) |
|
|
(42 |
) |
Inventories |
|
|
391 |
|
|
|
(130 |
) |
Prepaid expenses and other current assets |
|
|
(48 |
) |
|
|
198 |
|
Vendor deposits |
|
|
(37 |
) |
|
|
46 |
|
Other assets |
|
|
— |
|
|
|
5 |
|
Accounts payable |
|
|
(580 |
) |
|
|
123 |
|
Accrued expenses and other current liabilities |
|
|
(35 |
) |
|
|
936 |
|
Deferred revenue |
|
|
(11 |
) |
|
|
(146 |
) |
Operating lease liabilities |
|
|
(83 |
) |
|
|
(56 |
) |
Net cash used in operating activities |
|
|
(3,545 |
) |
|
|
(2,959 |
) |
Cash Flows From Investing Activities: |
|
|
|
|
|
|
Loan to Sportstech |
|
|
(2,025 |
) |
|
|
— |
|
Acquisition of business, cash paid, net of cash acquired |
|
|
— |
|
|
|
(1,447 |
) |
Acquisition of software and content |
|
|
(166 |
) |
|
|
(263 |
) |
Net cash used in investing activities |
|
|
(2,191 |
) |
|
|
(1,710 |
) |
Cash Flows From Financing Activities: |
|
|
|
|
|
|
Payments of loans |
|
|
— |
|
|
|
(135 |
) |
Payments of related party loans |
|
|
— |
|
|
|
(240 |
) |
Redemption on convertible notes |
|
|
— |
|
|
|
(90 |
) |
Proceeds from issuance of convertible notes, net of issuance costs |
|
|
2,678 |
|
|
|
4,756 |
|
Proceeds from issuance of common stock from At the Market Offering, net of issuance costs |
|
|
1,594 |
|
|
|
— |
|
Proceeds from exercise of incremental warrants and issuance of convertible notes, net of issuance costs |
|
|
3,499 |
|
|
|
— |
|
Proceeds from the issuance of common stock from equity line of credit |
|
|
— |
|
|
|
324 |
|
Net cash provided by financing activities |
|
|
7,771 |
|
|
|
4,615 |
|
Effect of exchange rate on cash |
|
|
34 |
|
|
|
54 |
|
Net Change In Cash and Cash Equivalents |
|
|
2,069 |
|
|
|
— |
|
Cash and restricted cash at beginning of the period |
|
|
138 |
|
|
|
— |
|
Cash and restricted cash at end of period |
|
$ |
2,207 |
|
|
$ |
— |
|
Supplemental Disclosure Of Cash Flow Information: |
|
|
|
|
|
|
Cash paid for Interest |
|
|
88 |
|
|
|
— |
|
Non-Cash Investing and Financing Information: |
|
|
|
|
|
|
Property & equipment in accounts payable |
|
|
18 |
|
|
|
18 |
|
Inventories in accounts payable and accrued expenses |
|
|
205 |
|
|
|
650 |
|
Issuance of common stock and series B preferred stock for the acquisition of business |
|
|
— |
|
|
|
3,702 |
|
Issuance and offering costs in accounts payable and accrued expenses |
|
|
43 |
|
|
|
69 |
|
Issuance of preferred stock through conversion of debt |
|
|
— |
|
|
|
10,082 |
|
Subscription receivable for issuance of Series A Preferred Stock for modification of loan |
|
|
— |
|
|
|
3,000 |
|
Gain on extinguishment of debt with related party |
|
|
279 |
|
|
|
— |
|
Issuance of common stock upon conversion of convertible notes |
|
|
5,798 |
|
|
|
866 |
|
Issuance of Series C Preferred Stock upon settlement of loss restoration agreement |
|
|
3,127 |
|
|
|
— |
|
Issuance of common stock from convertible notes and conversion of debt |
|
|
— |
|
|
|
547 |
|
Issuance of warrants with convertible notes |
|
|
1,213 |
|
|
|
— |
|
Issuance of embedded derivatives with convertible notes |
|
|
2,104 |
|
|
|
— |
|
Series A Dividends Paid in Kind |
|
|
225 |
|
|
|
— |
|
Series C Dividends Paid in Kind |
|
|
253 |
|
|
|
— |
|
Stock-based compensation capitalized in intangible asset and other assets |
|
|
334 |
|
|
|
220 |
|
INTERACTIVE STRENGTH INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Description of Business and Basis of Presentation
Description and Organization
Interactive Strength Inc. (the "Company") is the parent company of two leading brands serving the commercial and at-home markets with specialty fitness equipment and virtual training: CLMBR and FORME. CLMBR manufactures vertical climbing equipment and provides a unique digital and on-demand training platform. FORME is a hardware manufacturer and digital fitness service provider that combines award-winning smart gyms with live 1:1 personal training (from real humans) to deliver an immersive experience ("Connected Fitness Products"). The combination of technology with expert training leads to better outcomes for both consumers and trainers alike. CLMBR and FORME offer unique fitness solutions for both the commercial and at-home markets. Our Members are defined as any individual who has a FORME or CLMBR account through a paid connected fitness membership.
Binding LOI - Sportstech
On February 10, 2025, the Company, Sportstech and Mr. Ali Ahmad, the sole shareholder of Sportstech, entered into a Binding Transaction Agreement (the “Agreement”), pursuant to which the Company will acquire Sportstech in a transaction (the “Transaction”) comprised of an initial investment (the “Initial Investment”) and three optional investment tranches, which are callable, subject to performance metrics, by Mr. Ahmad or an entity connected to him.
Pursuant to the Agreement, in the Initial Investment, the Company will acquire an approximately 99.8% stake in Sportstech with a $15,000,000 capital increase through contribution in kind of the Company’s Series D Non-voting Convertible Preferred Stock to be newly created, all of which will be issued to Sportstech at the closing of the Transaction. The conversion price of the Initial Investment into the Company’s Common Stock will be determined on June 15, 2026, using the volume-weighted average price (the “VWAP”) of the previous 20 trading days, subject to compliance with Nasdaq Listing Rule 5635(d) (the “Nasdaq Minimum Price Rule”).
Optional Investment A (“Optional Investment A”) provides an option to call a capital increase of up to $10.0 million through contribution in kind of the Company’s Common Stock, which shall vest based on a formula that calculates (x) the EU-sourced EBITDA earned above $3.5 million for the twelve (12) months ended March 2026, (y) multiplied by two (2). The price used to calculate the number of the Company’s Common Stock issued for Optional Investment A will be determined on June 15, 2026 by using the VWAP of the previous 20 trading days, subject to compliance with the Nasdaq Minimum Price Rule.
Optional Investment B (“Optional Investment B”) provides an option to call a capital increase of up to $10.0 million through contribution in kind of the Company’s Common Stock, which shall vest based on a formula that calculates (x) the EU-sourced EBITDA earned above $5.5 million for the twelve (12) months ended March 2027, (y) multiplied by two (2). The price used to calculate the number of the Company’s Common Stock issued for Optional Investment B will be determined on June 15, 2027 by using the VWAP of the previous 20 trading days, subject to compliance with the Nasdaq Minimum Price Rule.
Optional Investment C (“Optional Investment C”) provides an option to call a capital increase of up to $20.0 million through contribution in kind of the Company’s Common Stock, which shall vest based on a formula that calculates (x) the US-sourced EBITDA earned for the twenty-four (24) months ended March 2027, (y) multiplied by three (3). The price used to calculate the number of the Company’s Common Stock issued for Optional Investment C will be determined on June 15, 2027 by using the VWAP of the previous 20 trading days, subject to compliance with the Nasdaq Minimum Price Rule.
In addition, pursuant to the Agreement, Mr. Ahmad will join the Board of Directors of the Company upon closing of the Initial Investment.
Acquisition of CLMBR, Inc.
On October 6, 2023, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with CLMBR and CLMBR1, LLC (collectively, the “Sellers”) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. On January 22, 2024, the Company and the Sellers entered into an amended and restated Asset Purchase Agreement (the “Amended Agreement”). On February 2, 2024, pursuant to the Amended Agreement, the Company completed the acquisition for a total purchase price of approximately $16.1 million, consisting of (i) cash of $30,000, (ii) 357 shares of the Company’s common stock with a fair value in the aggregate of $1.0 million, (iii) 1,500,000 shares of the Company’s non-voting Series B preferred stock with a fair value in the aggregate of $3.0 million, (iv) contingent consideration with a fair value of $1.3 million, and (v) the retirement of $9.4 million of senior debt and $1.4 million in related fees, such retirement to be in the form of a $1.4 million cash payment to the lender of
the senior debt and the issuance of an $8.0 million promissory note to such lender (the “Acquisition”).
The Acquisition was accounted for under the acquisition method of accounting under ASC 805, Business Combinations. Assets acquired and liabilities assumed were recorded in the condensed consolidated balance sheet at their estimated fair values as of February 2, 2024, with the remaining unallocated purchase price recorded as goodwill. See Note 22. that outlines the Company’s consideration transferred and the identifiable net assets acquired at their estimated fair value as of February 2, 2024.
Basis of Presentation and Consolidation
The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements include the accounts of Interactive Strength Inc. and its subsidiaries in which the Company has a controlling financial interest. All intercompany balances and transactions have been eliminated.
In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, cash flows, and the changes in equity for the interim period.
Liquidity and Capital Resources
In accordance with Accounting Standards Update ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), or ASU 205-40, management evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying condensed consolidated financial statements were issued.
As an emerging growth company, the Company is subject to certain inherent risks and uncertainties associated with the development of an enterprise. In this regard, since the Company’s inception, substantially all of management’s efforts have been devoted towards the development of its brands and services, their penetration in the marketplace, and the development of a commercial organization, all at the expense of short-term profitability.
As of the date the accompanying condensed consolidated financial statements were issued (the “issuance date”), management evaluated the following adverse conditions and events present at the Company in accordance with ASU 205-40:
•The Company has incurred significant operating losses and used net cash flows in its operations since its inception. In this regard, the Company incurred a net operating loss of $6.3 million and used net cash in its operations of $3.5 million during the three months ended March 31, 2025, and had an accumulated deficit of $209.4 million as of March 31, 2025.
•In order to execute its emerging growth strategy, the Company has been heavily dependent on financing from lenders and capital from private and public investors (collectively “outside capital”) since its inception and expects to remain heavily dependent on outside capital for the foreseeable future until such time that the Company’s operations reach a scale of profitability that allows it to fund its obligations primarily with cash inflows from operations. However, management can provide no assurance the Company will ever be able to generate sufficient cash inflows to reduce or eliminate its reliance on outside capital.
•The Company’s available liquidity to fund its operations over the next twelve months beyond the issuance date was limited to approximately $0.5 million of unrestricted cash and cash equivalents. However, based on the Company’s anticipated liquidity needs, the foregoing available liquidity will not be sufficient to fund the Company’s obligations as they become over the next year beyond the issuance date due absent management’s ability to secure additional outside capital.
•While the Company is actively seeking to secure additional outside capital (and has historically been able to successfully secure such capital), no additional outside capital has been secured or was deemed probable of being secured as of the issuance date. In addition, management can provide no assurance the Company will be able to secure additional outside capital or on acceptable terms.
•Included in the Company’s anticipated liquidity needs is a substantial amount of outstanding debt that is scheduled to mature over the next twelve months beyond the issuance date. As of disclosed in Notes 11 and 21, the Company had total outstanding debt, including convertible notes, of approximately $10.9 million as of the issuance date, of which approximately $9.0 million is scheduled to mature over the next twelve months beyond the issuance date, for which the Company does not have sufficient liquidity to repay if a cash settlement is required. In the event the Company is unable to refinance its outstanding debt, settle some or all of the debt with shares of the Company’s common or preferred stock, secure additional outside capital, and/or secure amendments or waivers from its lenders to defer or modify the repayment terms, management will be required to seek other strategic alternatives to settle this indebtedness, which may include, among
others, a significant curtailment of the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy protection under the provisions of the U.S. Bankruptcy Code.
•In the past, the Company has been unable to remain in compliance with certain qualifications required by the Nasdaq Capital Markets in order for the Company’s common stock to remain listed on the Nasdaq. These requirements include a minimum stockholders’ equity balance of $2.5 million, a minimum of 500,000 publicly held shares, and a minimum trading price of $1.00 per share for a sustained period of time (collectively the “Rules”). The Company received two notices from the Listing Qualifications staff of the Nasdaq (the “Staff”) with respect to the Company’s noncompliance with these requirements, as follows:
•The first notice dated August 22, 2023, notified the Company that it did not comply with the minimum $2.5 million stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b)(1) (the “Rule 1”) but was granted a period of time to regain compliance. On November 25, 2024, the Company received a letter from the Staff stating that the Company has demonstrated compliance with Rule 1. The letter also stated that the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with the requirements of Nasdaq Listing Rule 5815(d)(4)(B). If, within that one-year monitoring period, the Staff finds that the Company failed to remain in compliance with Rule 1, the Company will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency, the Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, and the Company will not be afforded an applicable cure or compliance period. Instead, the Staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing with the Panel. While the Company will have the opportunity to present to the Panel, no assurance can be provided that the Staff will grant the Company a compliance plan and allow the Company’s securities to remain listed on the Nasdaq.
•The second notice dated November 13, 2024 notified the Company that it did not comply with the minimum 500,000 publicly held shares requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(4) (“Rule 2”) but was granted a period of time to regain compliance. On December 23, 2024, the Company received a letter from the Staff confirming that the Company has demonstrated compliance with Rule 2. The letter also stated that the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with the requirements of Nasdaq Listing Rule 5815(d)(4)(B). If, within that one-year monitoring period, the Staff finds that the Company failed to remain in compliance with Rule 2, the Company will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency, the Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, and the Company will not be afforded an applicable cure or compliance period. Instead, the Staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing with the Panel. While the Company will have the opportunity to present to the Panel, no assurance can be provided that the Staff will grant the Company a compliance plan and allow the Company’s securities to remain listed on the Nasdaq.
As of March 31, 2025 and through the issuance date, the Company was in compliance with the Rules. However, management can provide no assurance that the Company will be able to remain in compliance with the Rules over the next twelve months beyond the issuance date and, if compliance is not maintained, the Staff will not require the Company’s securities to be delisted from the Nasdaq. If a delisting occurs, the Company will be faced with a number of material adverse consequences, including limited availability of market quotations for its common stock; limited news and analyst coverage; decreased ability to obtain additional financing; limited liquidity for the Company’s stockholders due to thin trading; and a potential loss of confidence by investors, employees and other third parties who do business with the Company.
These uncertainties raise substantial doubt about our ability to continue as a going concern. The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying condensed consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties.
2. Summary of Significant Accounting Policies
Unaudited Interim Financial Information
The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, or GAAP, for interim financial reporting and as required by Regulation S-X, Rule 10-01. Accordingly, these unaudited condensed consolidated financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements as certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These unaudited condensed consolidated financial statements should be read in
conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 31, 2025.
The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated annual financial statements for the years ended December 31, 2024 and 2023 and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company’s condensed consolidated balance sheet as of March 31, 2025 the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2025 and 2024, the condensed consolidated statement of stockholders' equity as of March 31, 2025 and condensed consolidated statements of cash flows for the three months ended March 31, 2025 and 2024. The financial data and other information disclosed in these notes related to the three months ended March 31, 2025 and 2024 are unaudited. The results for the three months ended March 31, 2025, are not necessarily indicative of results to be expected for the year ending December 31, 2025, any other interim periods, or any future year or period.
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, fair value measurements, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, stock-based compensation expense, warrant liabilities, accrual of acquisition earn-outs, estimated legal accruals, valuation of deferred taxes, valuation of derivatives, fair value of goodwill and other intangible assets, and commitments and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates.
Segment Information
Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance. The Company has one operating segment, the development and sale of its at-home fitness technology platform. The Company’s chief operating decision maker, its chief executive officer, manages the Company’s operations on a consolidated basis for the purpose of allocating resources. As the Company has one reportable segment, all required segment financial information is presented in the condensed consolidated financial statements. The Company currently operates in the United States, the United Kingdom, and Taiwan. As of March 31, 2025 and 2024, substantially all of the Company’s long-lived assets are held in the United States.
Significant Accounting Policies
During the three months ended March 31, 2025, there were no significant changes to the Company’s significant accounting policies as described in the Company’s audited consolidated financial statements as of and for the year ended December 31, 2024, except as described below.
Loan Receivable
Loan receivable consists of a loan agreement entered into with Sportstech as a form of bridge financing until the acquisition is closed. The loan agreement provides for a $2.3 million loan facility (the “Loan”) that terminates on April 30, 2025 (the “Termination Date”). The Loan accrues interest at a rate of 10% per annum, subject to adjustment from time to time as set forth in the loan agreement, and has a discount at an amount equal to 10% of the principal amount. Pursuant to the Loan Agreement, Sportstech has the option, upon delivery of a written request, to extend the term of the Loan for an additional eight-month period, such that the Termination Date will be extended to December 30, 2025. Net loan origination fees and certain direct origination expenses of $0.2 million were deferred and amortized to interest income over the contractual life of the loan using the effective interest method. The Company is currently negotiating with Sportstech to extend the Termination Date.
Recently Issued Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”), or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s condensed consolidated financial statements upon adoption. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and has elected not to “opt out” of the extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company will adopt the new or revised standard at the time public companies adopt the new or revised standard and will do so until such time that the Company either (i) irrevocably elects
to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company. As noted below, certain new or revised accounting standards were early adopted.
Accounting Pronouncements Recently Adopted
ASU 2023-07
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendments in the ASU improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit and loss, and provide new segment disclosure requirements for entities with a single reportable segment, among other disclosure requirements. We adopted this standard on a retrospective basis for the 2024 annual period, and for interim periods beginning January 1, 2025. The impact is limited to financial statement disclosures. See Note 3 - Segment Reporting.
Accounting Pronouncements Not Yet Adopted
ASU 2020-04 and ASU 2022-06
In March 2020, the FASB issued ASU 2020-04, “Reference rate reform (Topic 848): Facilitation of the effects of reference rate reform on financial reporting.” The ASU provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions affected by reference rate reform. The amendments apply only to contracts and hedging relationships that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued due to reference rate reform. The amendments are elective and are effective upon issuance. In December 2022, the FASB issued ASU 2022-06, “Reference rate reform (Topic 848): Deferral of the sunset date of Topic 848” which defers the expiration date for Topic 848 from December 31, 2022 until December 31, 2024. The Company is currently evaluating the potential impact of adopting this new accounting guidance, but does not expect the adoption of the standard to have a material impact on its condensed consolidated financial statements.
ASU 2023-09
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The ASU modifies income tax disclosures by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliations and (ii) the disclosure of income taxes paid disaggregated by jurisdiction, among other requirements. This ASU is effective for fiscal years beginning after December 31, 2024 and should be applied on a prospective basis, with the option to apply the standard retrospectively. Early adoption is permitted. We are currently evaluating the impact of the new standard, which is limited to financial statement disclosures.
ASU 2024-03
In November 2024, the FASB issued ASU 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses". The amendments in ASU 2024-03 address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the income statement. This guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating this guidance to determine the impact it may have on its condensed consolidated financial statements.
3. Segment Reporting
We are organized into one operating and one reportable segment that engages in the development and sales of specialty fitness equipment and virtual training and are managed on a consolidated basis. Our chief operating decision maker (“CODM”) is our chief executive officer. Our CODM regularly reviews financial information at the operating segment level to allocate resources and to assess performance. Our CODM evaluates segment profit (loss) based on net loss, which is reported on the condensed consolidated statement of operations and comprehensive loss as net loss. The measure of segment assets is reported on the condensed consolidated balance sheets as total assets. Our CODM uses net loss to allocate resources, including property and equipment and financial or capital resources, to the segments and to assess their performance by monitoring budget-to-actual and year-over-year variances.
The following tables present revenue and significant segment expenses that are included within net loss:
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
Total Revenues |
|
$ |
1,356 |
|
|
$ |
363 |
|
|
Less: |
|
|
|
|
|
|
|
Cost of fitness product revenue (excluding depreciation and amortization) |
|
|
759 |
|
|
|
338 |
|
|
Cost of membership (excluding depreciation and amortization) |
|
|
— |
|
|
|
2 |
|
|
Cost of training |
|
|
320 |
|
|
|
165 |
|
|
Research and development (excluding stock based compensation) |
|
|
572 |
|
|
|
792 |
|
|
General and administrative (excluding stock based compensation, depreciation and amortization) |
|
|
2,040 |
|
|
|
2,426 |
|
|
Interest expense |
|
|
1,764 |
|
|
|
2,000 |
|
|
Interest income |
|
|
(158 |
) |
|
|
— |
|
|
(Gain) loss upon extinguishment of debt and accounts payable |
|
|
(3,037 |
) |
|
|
1,066 |
|
|
Change in fair value of derivatives |
|
|
1,487 |
|
|
|
— |
|
|
Change in fair value of warrants |
|
|
(449 |
) |
|
|
(1,799 |
) |
|
Depreciation and amortization expense |
|
|
1,012 |
|
|
|
1,862 |
|
|
Stock-based compensation expense |
|
|
2,089 |
|
|
|
3,366 |
|
|
Transaction related expenses (1) |
|
|
299 |
|
|
|
764 |
|
|
Vendor Settlements (2) |
|
|
458 |
|
|
|
— |
|
|
Other segment items (3) |
|
|
803 |
|
|
|
775 |
|
|
Net loss |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
|
|
|
|
|
|
|
|
|
Reconciliation of net loss |
|
|
|
|
|
|
|
Adjustments and reconciling items |
|
|
— |
|
|
|
— |
|
|
Consolidated net loss |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
|
(1) Transaction costs related to acquisition of CLMBR, Inc.
(2) Costs related to vendor settlements.
(3) Other segment items included in consolidated net loss includes sales and marketing (excluding stock based compensation, depreciation and amortization), other expense, and change in fair value of convertible notes.
See Note 4. Revenues for details of revenue from external customers by geography and by product.
4. Revenue Recognition
The Company’s primary source of revenue is substantially derived from the United States from sales of its Connected Fitness Products and related accessories and associated recurring Membership revenue, as well as from sales of personal training services recorded within Training revenue.
The Company determines revenue recognition through the following steps:
•Identification of the contract, or contracts, with a customer;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, the Company satisfies a performance obligation.
Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s revenue is reported net of sales returns, discounts and incentives as a reduction of the transaction price.
The Company applies the practical expedient as per ASC 606-10-50-14 and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less.
Connected Fitness Products
Connected Fitness Products include the Company’s portfolio of Connected Fitness Products and related accessories, delivery and installation services, and extended warranty agreements. The Company recognizes Connected Fitness Product revenue net of sales
returns and discounts on the date the product has been delivered to the customer or at shipping point if the customer is responsible for shipping, except for extended warranty revenue which is recognized over the warranty period. The Company allows customers to return products within thirty days of purchase, as stated in its return policy.
Amounts paid for payment processing fees for credit card sales for Connected Fitness Products are included as a reduction to fitness product revenue in the Company’s condensed consolidated statements of operations and comprehensive loss.
Membership
The Company’s memberships provide unlimited access to content in its library of on-demand fitness classes. The Company’s memberships are offered on a month-to-month basis.
Amounts paid for membership fees are included within deferred revenue on the Company’s condensed consolidated balance sheets and recognized ratably over the membership term. The Company records payment processing fees for its monthly membership charges within cost of membership in the Company’s condensed consolidated statements of operations and comprehensive loss.
Training
The Company’s training services are personal training services delivered through the Connected Fitness Products, third-party mobile devices and in-studio classes. Training revenue is recognized at the time the services are delivered.
Standard Product Warranty
The Company offers a standard product warranty that its Connected Fitness Products and related accessories will operate under normal, non-commercial use for a period of one year which covers the touchscreen, frame and all incorporated elements, and related accessories from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices.
The Company also offers the option for customers in some markets to purchase a third-party extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of 24 to 48 months.
For third-party extended warranty service sold along with the Company’s Connected Fitness Products, the Company does not obtain control of the warranty before transferring it to the customers. Therefore, the Company accounts for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission it retains. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it can establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product.
The Company sells connected fitness equipment and digital fitness services across Business to Business ("B2B") and Business to Customer ("B2C") channels in the United States. The Company also sells fitness equipment across B2B channel in Europe and Asia.
The following table presents a summary of total revenues by geographic location:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2025 |
(in thousands) |
|
CLMBR |
|
|
FORME |
|
|
Total |
|
|
Revenue |
|
|
|
|
|
|
|
|
|
|
United States |
|
|
|
|
|
|
|
|
|
|
Fitness Product Revenue |
|
$ |
989 |
|
|
$ |
61 |
|
|
$ |
1,050 |
|
|
Membership Revenue |
|
|
138 |
|
|
|
38 |
|
|
|
176 |
|
|
Training Revenue |
|
|
90 |
|
|
|
40 |
|
|
|
130 |
|
|
Total Revenue |
|
$ |
1,217 |
|
|
$ |
139 |
|
|
$ |
1,356 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2024 |
(in thousands) |
|
CLMBR |
|
|
FORME |
|
|
Total |
|
|
Revenue |
|
|
|
|
|
|
|
|
|
|
United States |
|
|
|
|
|
|
|
|
|
|
Fitness Product Revenue |
|
$ |
— |
|
|
$ |
53 |
|
|
$ |
53 |
|
|
Membership Revenue |
|
|
109 |
|
|
|
46 |
|
|
|
155 |
|
|
Training Revenue |
|
|
73 |
|
|
|
82 |
|
|
|
155 |
|
|
Total Revenue |
|
$ |
182 |
|
|
$ |
181 |
|
|
$ |
363 |
|
|
The following table presents a summary of total revenues by product:
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
2025 |
|
|
2024 |
|
|
|
|
(in thousands) |
|
|
CLMBR |
|
$ |
989 |
|
|
$ |
— |
|
|
FORME |
|
|
61 |
|
|
|
53 |
|
|
Total Fitness Product Revenue |
|
|
1,050 |
|
|
|
53 |
|
|
CLMBR |
|
|
138 |
|
|
|
109 |
|
|
FORME |
|
|
38 |
|
|
|
46 |
|
|
Total Membership Revenue |
|
|
176 |
|
|
|
155 |
|
|
CLMBR |
|
|
90 |
|
|
|
73 |
|
|
FORME |
|
|
40 |
|
|
|
82 |
|
|
Total Training Revenue |
|
|
130 |
|
|
|
155 |
|
|
Total Revenue |
|
$ |
1,356 |
|
|
$ |
363 |
|
|
5. Inventories, net
Inventories consist of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Finished products |
|
$ |
3,186 |
|
|
$ |
3,868 |
|
Finished products - Long Term |
|
|
2,291 |
|
|
|
2,244 |
|
Raw materials - Long Term |
|
|
578 |
|
|
|
578 |
|
Total inventories, net |
|
$ |
6,055 |
|
|
$ |
6,690 |
|
Finished products - Long Term represents inventory not expected to be sold in the next twelve months. Raw materials - Long Term represents the components and parts currently being stored in our Taiwan facility that will be shipped to our manufacturing partners and will not be used within one year.
6. Property and Equipment, net
Property and equipment consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Pre-production tooling |
|
$ |
3,094 |
|
|
$ |
3,094 |
|
Machinery and equipment |
|
|
191 |
|
|
|
191 |
|
Leasehold improvements |
|
|
186 |
|
|
|
186 |
|
Furniture and fixtures |
|
|
25 |
|
|
|
25 |
|
Exercise equipment |
|
|
13 |
|
|
|
13 |
|
Total |
|
|
3,509 |
|
|
|
3,509 |
|
Less: Accumulated depreciation |
|
|
(3,429 |
) |
|
|
(3,393 |
) |
Total property and equipment, net |
|
$ |
80 |
|
|
$ |
116 |
|
Depreciation expense amounted to $0.04 million and $0.2 million for each of the three months ended March 31, 2025 and 2024, respectively.
7. Goodwill and Intangible Assets, net
Goodwill
There were no changes in the carrying amount of goodwill for the three months ended March 31, 2025. As of March 31, 2025, there was no goodwill impairment. Refer to Note 22. Acquisitions for more information.
Intangible Assets, Net
Identifiable intangible assets, net consist of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, |
|
|
As of December 31, |
|
|
|
2025 |
|
|
2024 |
|
(in thousands) |
|
Cost |
|
|
Accumulated Amortization |
|
|
Net Book Value |
|
|
Cost |
|
|
Accumulated Amortization |
|
|
Net Book Value |
|
Internal-use software |
|
$ |
6,248 |
|
|
$ |
(5,913 |
) |
|
$ |
335 |
|
|
$ |
6,248 |
|
|
$ |
(5,649 |
) |
|
$ |
599 |
|
Developed technology |
|
|
1,400 |
|
|
|
(271 |
) |
|
|
1,129 |
|
|
|
1,400 |
|
|
|
(213 |
) |
|
|
1,187 |
|
Customer related |
|
|
4,000 |
|
|
|
(507 |
) |
|
|
3,493 |
|
|
|
4,000 |
|
|
|
(398 |
) |
|
|
3,602 |
|
Trademark and trade name |
|
|
800 |
|
|
|
(104 |
) |
|
|
696 |
|
|
|
800 |
|
|
|
(82 |
) |
|
|
718 |
|
Total identifiable intangible assets |
|
$ |
12,448 |
|
|
$ |
(6,795 |
) |
|
$ |
5,653 |
|
|
$ |
12,448 |
|
|
$ |
(6,342 |
) |
|
$ |
6,106 |
|
Amortization expense amounted to $0.5 million and $0.7 million for each of the three months ended March 31, 2025 and 2024, respectively. As of March 31, 2025 and 2024, there was no intangible asset impairment.
As of March 31, 2025, estimated annual amortization expense for each of the next five fiscal years is as follows:
|
|
|
|
|
Fiscal Years Ending December 31, |
|
(in thousands) |
|
|
|
2025 (remaining) |
|
|
824 |
|
2026 |
|
|
703 |
|
2027 |
|
|
598 |
|
2028 |
|
|
537 |
|
2029 |
|
|
531 |
|
Thereafter |
|
|
2,460 |
|
Total |
|
$ |
5,653 |
|
8. Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Security deposit |
|
|
96 |
|
|
|
96 |
|
Prepaid licenses |
|
|
143 |
|
|
|
50 |
|
Research and development tax credit |
|
|
329 |
|
|
|
419 |
|
Other receivables |
|
|
20 |
|
|
|
20 |
|
Insurance |
|
|
119 |
|
|
|
46 |
|
Other prepaid |
|
|
151 |
|
|
|
179 |
|
Total prepaid expenses and other current assets |
|
$ |
858 |
|
|
$ |
810 |
|
9. Other Assets, net
Other assets, net consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, |
|
|
As of December 31, |
|
|
|
2025 |
|
|
2024 |
|
(in thousands) |
|
Cost |
|
|
Accumulated Amortization |
|
|
Net Book Value |
|
|
Cost |
|
|
Accumulated Amortization |
|
|
Net Book Value |
|
Capitalized content costs |
|
$ |
6,789 |
|
|
$ |
(6,097 |
) |
|
$ |
692 |
|
|
$ |
6,789 |
|
|
$ |
(5,968 |
) |
|
$ |
821 |
|
Capitalized software |
|
$ |
7,204 |
|
|
$ |
(4,856 |
) |
|
$ |
2,348 |
|
|
$ |
6,705 |
|
|
$ |
(4,563 |
) |
|
$ |
2,142 |
|
Total other assets |
|
$ |
13,993 |
|
|
$ |
(10,953 |
) |
|
$ |
3,040 |
|
|
$ |
13,494 |
|
|
$ |
(10,531 |
) |
|
$ |
2,963 |
|
Amortization expense amounted to $0.4 million and $1.0 million for the three months ended March 31, 2025 and 2024, respectively.
10. Accrued Expenses and Other Current Liabilities
Accrued expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Accrued bonus |
|
$ |
65 |
|
|
$ |
155 |
|
Accrued payroll |
|
|
5 |
|
|
|
7 |
|
Accrued PTO |
|
|
21 |
|
|
|
21 |
|
Accrued legal settlement |
|
|
2,000 |
|
|
|
2,050 |
|
Accrued royalties |
|
|
236 |
|
|
|
231 |
|
Accrued professional fees |
|
|
282 |
|
|
|
454 |
|
Customer deposits |
|
|
191 |
|
|
|
135 |
|
Loss restoration settlement |
|
|
— |
|
|
|
570 |
|
Other accrued expenses and current liabilities |
|
|
511 |
|
|
|
352 |
|
Total accrued expenses and other current liabilities |
|
$ |
3,311 |
|
|
$ |
3,975 |
|
Accrued legal settlement of $2.0 million represents the payments due following settlement of a lawsuit which was an assumed liability as part of the Acquisition and is further discussed in Note 15. Commitments and Contingencies.
11. Debt
Debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
Principal stockholder promissory notes |
|
$ |
— |
|
|
$ |
5,348 |
|
|
Promissory notes |
|
|
3,993 |
|
|
|
— |
|
|
Term Loan |
|
|
3,289 |
|
|
|
3,221 |
|
|
Total Loan Payable |
|
$ |
7,282 |
|
|
$ |
8,569 |
|
|
Other related party convertible notes |
|
|
198 |
|
|
|
193 |
|
|
February 2024 convertible notes |
|
|
1,541 |
|
|
|
2,557 |
|
|
Total Convertible note payable |
|
$ |
1,739 |
|
|
$ |
2,750 |
|
|
January 2025 convertible notes |
|
|
— |
|
|
|
— |
|
|
March 2025 convertible notes |
|
|
1,883 |
|
|
|
— |
|
|
Total Convertible note payable long term |
|
$ |
1,883 |
|
|
$ |
— |
|
|
Total debt |
|
$ |
10,904 |
|
|
$ |
11,319 |
|
|
Principal Stockholder Promissory Notes
During 2019, 2020, and 2021, the Company entered into promissory notes with a then-principal stockholder (the "former principal stockholder”) of the Company. As the 2019, 2020 and 2021 notes were not paid upon maturity, these loans were in default and on August 4, 2023, the Company received a notice of default from the principal stockholder. The Company accrued for the default fee on the date of default and the additional default interest following that date. See Note 20. Related Party Transactions. On January 29, 2025, the Former Principal Stockholder assigned the Former Principal Stockholder Notes to an accredited investor. On February 4, 2025, the Company and the accredited investor entered into an exchange agreement pursuant to which the Company issued (the “Exchange”) five new secured convertible promissory notes (the “ January 2025 Exchange Notes”). At the time of the Exchange, (1) the Company has negative cash flows from operations, history of losses, and significant accumulated deficit that raise substantial doubt about our ability
to continue as a going concern and (2) the accredited investor accepted an interest rate of 5.0% on the January 2025 Exchange Notes, which is significantly lower than the default rates on the promissory notes at the time of the Exchange and therefore indicative of a concession. As a result, the Company will account for the Exchange as a troubled debt restructuring in accordance with ASC 470-60 Troubled Debt Restructurings by Debtors. The fair value of the January 2025 Exchange Notes on February 4, 2025 was $5.1 million and the carrying value of the Former Principal Stockholder Notes was $5.4 million resulting in a gain on extinguishment of $0.3 million which was recorded in the condensed consolidated statement of stockholders equity. See description of the January 2025 Exchange Notes in Note 11. Debt under heading "January 2025 Exchange Notes".
Promissory Notes
On March 5, 2025, the Company entered into an agreement to settle outstanding liabilities with prior Law Firm by issuing to the Law Firm an unsecured promissory note in the principal amount of $3.9 million which has a maturity date of October 15, 2025 and accrues interest at a rate of 12% per annum. Total interest expense of $0.03 million was recorded in the condensed consolidated statement of operations for the three months ended March 31, 2025.
Term Loan
On February 1, 2024, the Company entered into a Credit Agreement (the "Term Loan") with Vertical Investors LLC, (the “Lender”) pursuant to which the Company agreed to borrow from the Lender a term loan in the aggregate principal amount of approximately $8.0 million. The term loan bears interest at Daily Simple Secured Overnight Financing Rate ("SOFR-Based Rate"), and the Company shall pay a guarantee fee of $2.3 million due on the maturity date. The guarantee fee was treated as a debt discount and accreted through interest expense through maturity date. The maturity date of the Term Loan was originally June 28, 2024. On March 29, 2024, the Company issued 1,500,000 shares of the Company’s Series A Convertible Preferred Stock to the Lender in exchange for reduction of outstanding debt of $3.0 million which was effective upon entering into the Loan Modification Agreement (the “Modification Agreement”) on April 24, 2024.
On April 24, 2024, (the “Effective Date”) the Company entered into the Modification Agreement with the Lender reducing the outstanding debt by $3.0 million and extending the maturity date to December 31, 2024. The Loan Modification Agreement was evaluated and determined to be a modification as the effective borrowing rate was not reduced therefore no concession were made at the time of the modification.
Pursuant to the Modification Agreement, the Company agreed to make monthly payments of interest in the amount of $60,000 to the Lender. In addition, the Company agreed to make mandatory principal payments simultaneously with the closing of all future capital raises by the Company or any affiliate of the Company. The first principal payment will be the greater of (i) $3.0 million (the “Minimum Payment”) or (ii) 20% of the net amount raised from any source of debt, equity, synthetic equity instruments or otherwise less any reasonable expenses paid to third parties (the “Net Capital Raise”). At each capital raise thereafter, the Company shall make a mandatory principal payment to the Lender of 20% of the Net Capital Raise. As of the Effective Date, the outstanding principal amount of the Loan was approximately $5.0 million.
On April 24, 2024, the Company entered into a Loan Restoration Agreement with the Lender (the “Restoration Agreement”) which was amended on September 30, 2024. The Amendment revised the definition of Preferred Stock to “2,861,128 shares of Series C Preferred Stock”. Prior to the Amendment, the definition of Preferred Stock read “1,500,000 shares of Series A Preferred Stock”. The definition of Net Trade Value was amended and restated in its entirety to include the disposition of the shares of Common Stock issued pursuant to the exchange agreements entered into by and between the Borrower and the Lender and the Net Trade Value shall be determined by Lender. Furthermore, the Amendment revised the date on which the Net Trade Value received will be calculated from December 31, 2024 to December 31, 2025. The Restoration Agreement was accounted for as a derivative in the Company’s condensed consolidated balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The derivative liability or asset will be remeasured at each reporting period using a Monte Carlo simulation with changes in fair value recorded in the condensed consolidated statements of operations in change in fair value of derivatives. See Note 13. for further details.
On September 30, 2024, the Lender was issued 59,668 shares of Series A Preferred Stock as a dividend in kind on the shares of Series A Preferred Stock owned by the Lender (the 59,668 shares of Series A Preferred Stock combined with the 1,500,000 shares of Series A Preferred Stock already owned by the Lender is referred to herein as the “Series A Preferred Shares”). As of September 30, 2024, the outstanding principal amount of the Loan was $4.3 million (the “Loan Amount”). On September 30, 2024, the Company and the Lender entered into an Exchange and Settlement Agreement (the “Exchange Agreement”). Pursuant to the Exchange Agreement, the Company and Lender agreed to exchange (a) the Series A Preferred Shares and (b) the Loan Amount (minus $2 million) for a total of 2,861,128 shares of the Company’s Series C Preferred Stock (“Series C Preferred Shares”). In connection with the Exchange Agreement, on September 30, 2024, the Company and the Lender reduced the principal amount of the Note Purchase Agreement previously entered into by the Company and the Lender to $2.0 million. The Company evaluated and determined the Exchange Agreement should be
accounted for as an extinguishment. The Series C Preferred stock shares was consideration paid to settle a portion of the Loan Amount and was recognized at fair value as of the date of issuance per ASC 470. The difference between the portion of the Loan Amount settled and the fair value of Series C Preferred stock on settlement date was recognized in earnings in loss upon extinguishment of debt in the condensed consolidated statements of operations.
On January 23, 2025, the Company and the Lender entered into a Settlement Agreement, pursuant to which the Company issued 496,246 shares of the Company’s Series C Preferred Stock, par value $0.0001 per share, to the Lender as payment of the $992,492 Net Trade Value as of the settlement date pursuant to the Loss Restoration Agreement.
On March 31, 2025, the Company and the Lender entered into a Settlement Agreement, pursuant to which the Company issued 1,188,571 shares of the Company’s Series C Preferred Stock, par value $0.0001 per share, to the Lender as payment of the $2,377,142 Net Trade Value as of the settlement date pursuant to the Loss Restoration Agreement.
The carrying value of the Term Loan is as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Principal and interest |
|
$ |
1,047 |
|
|
$ |
1,019 |
|
Guarantee fees |
|
|
2,348 |
|
|
|
2,348 |
|
Unamortized debt discount |
|
|
(106 |
) |
|
|
(146 |
) |
Aggregate carrying value |
|
$ |
3,289 |
|
|
$ |
3,221 |
|
Interest expense recognized on the Term Loan is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
Contractual interest expense |
|
$ |
20 |
|
|
$ |
58 |
|
|
Amortization of debt discount |
|
|
40 |
|
|
|
339 |
|
|
Total |
|
$ |
60 |
|
|
$ |
397 |
|
|
Convertible Notes
Other Related Party Convertible Notes
On February 18, 2020, the Company entered into a $0.1 million note with interest at the rate of 12.0% per annum and a maturity date of February 18, 2021. The note was amended in January 2024 to include a conversion provision whereby at any time while outstanding the lender has the right to convert any outstanding and unpaid principal and accrued interest of the note into shares of the Company's Series A Preferred Stock at a conversion price of $2.00 per share. The total outstanding balance at March 31, 2025 and December 31, 2024, including accrued interest, was $0.2 million and $0.2 million, respectively, and is included in convertible note payable on the condensed consolidated balance sheet.
February 2024 Convertible Notes
On February 1, 2024, the Company entered into a Senior Secured Convertible Promissory Note (the "February 2024 Convertible Note") with Treadway Holdings LLC, a lender, in the aggregate principal amount of $6.0 million, which is convertible into shares of Common Stock. The Note accrues interest at a rate of 2.0% per month.
The original maturity date of the February 2024 Convertible Note was December 15, 2024. Interest payments are guaranteed through the Maturity date regardless of whether the February 2024 Convertible Note is earlier converted or redeemed. The February 2024 Convertible Note is convertible (in whole or in part) at any time prior to the Maturity Date into the number of shares of Common Stock equal to the quotient resulting by dividing the outstanding principal balance of the February 2024 Convertible Note to be converted by a conversion price of $8,000.00 per share. The February 2024 Convertible Note sets forth certain standard events of default upon the occurrence of which the Company is required to deliver written notice to the Treadway Holdings LLC within two (2) business days. At any time after the earlier of (a) Treadway Holdings LLC’s receipt of a notice of default and (b) Treadway Holdings LLC becoming aware of the event of default, the Treadway Holdings LLC may require the Company to redeem all or any portion of the February 2024 Convertible Note. Upon an event of default, the February 2024 Convertible Note shall bear interest at a rate of 4.0% per month.
In November 2024, the Company and Treadway Holdings LLC entered into an Amended and Restated Senior Secured Convertible Promissory Note (the “Amended and Restated Note”) that amended and restated the February 2024 Convertible Note in its entirety. The Amended and Restated Note has a principal amount of $4,000,000 (the “Principal Amount”). Pursuant to the Amended and Restated Note, the conversion price of the February 2024 Convertible Note was changed to $4.79 per share (the Common Stock’s Nasdaq Official Closing Price (as reflected on Nasdaq.com) on November 11, 2024. The amendment to the Note represents the addition of a substantive conversion feature and as a result the Company recorded a loss on extinguishment upon issuance and the remaining unamortized discount was written off upon extinguishment. The Company elected the fair value option for the February 2024 Convertible Notes under ASC 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. The fair value of the February 2024 Convertible Notes and change to were determined using a discounted cash flow analysis at a discount rate of 16.3%. The fair value of the February 2024 Convertible Notes of $4.0 million was recorded as a current liability upon fair value election.
On December 13, 2024, the Company and Treadway Holdings LLC entered into a Letter Agreement (the “Letter Agreement”) that amends the Note Purchase Agreement. Pursuant to the Letter Agreement, Section 3.2(a) of the Note Purchase Agreement was amended to allow the Company to extend the maturity date of the Amended and Restated Note (the “Maturity Date”) upon written notice to Treadway Holdings LLC and payment of the Extension Fee (as defined below) to extend the Maturity Date for an additional thirty-day period (each an “Extension”). The Company shall be entitled to up to three Extensions.
Pursuant to the Letter Agreement, each “Extension Fee” shall be an amount in cash, calculated as of the Maturity Date prior to giving effect to such Extension, equal to five percent (5%) of the sum of (A) the outstanding principal balance of the Amended and Restated Note plus (B) the principal amount of converted Amended and Restated Note for which Treadway Holdings LLC is still holding the resulting conversion shares. For each Extension period, if the principal amount of the Amended and Restated Note converted by Treadway Holdings LLC during such Extension period is less than the purchase price received by Treadway Holdings LLC upon the sale of the resulting conversion shares (such difference, the “Conversion Profit”), then the Extension Fee for the following Extension shall be reduced by an amount equal to such Conversion Profit (but not less than zero).
In connection with the Letter Agreement, the Company exercised its option for the first Extension on December 13, 2024, and paid the applicable Extension Fee of $0.2 million and reimbursed the Purchaser’s accrued but unpaid legal fees of $0.02 million. As of December 13, 2024, the Maturity Date was extended to January 14, 2025.
On January 14, 2025, Treadway Holdings LLC sold the Amended and Restated Note to Woodway USA, Inc. (the “Purchaser”). The Purchaser was the guarantor of the Note Purchase Agreement and is currently the largest customer of the Company, pursuant to the previously disclosed Exclusive Distribution Agreement, by and between the Company and the Purchaser, dated as of February 20, 2024. On March 3, 2025, the Purchaser sold the Amended and Restated Note to TR Opportunities II LLC (the “Current Holder”). The transfer of the Amended and Restated Note on January 14, 2025 and March 3, 2025 were both exchanges between creditors without any involvement of the Company, therefore on either exchange date there was no accounting impact to the Company.
For the three months ended March 31, 2025, the Current Holder converted a total of $1.2 million owed pursuant to the Amended and Restated Note into a total of 471,750 shares of Common Stock and the Company recorded a gain on extinguishment of debt of $0.09 million.
|
|
|
|
|
|
|
February 2024 |
|
(in thousands) |
|
Convertible Notes |
|
Fair value at December 31, 2024 |
|
|
2,557 |
|
Cash paid for interest |
|
|
(88 |
) |
Conversion to common stock |
|
|
(1,212 |
) |
Change in estimated fair value of convertible notes |
|
|
284 |
|
Fair value at March 31, 2025 |
|
$ |
1,541 |
|
January 2025 Exchange Notes
As previously disclosed, from 2019 to 2021, the Company entered into five promissory notes (collectively, the “Former Principal Stockholder Notes”) with a then-principal stockholder (the "Former Principal Stockholder”) of the Company.
On January 29, 2025, the Former Principal Stockholder assigned the Former Principal Stockholder Notes to an accredited investor that is managed by an ATW Partners related entity (the “Exchange Agreement Investor”). The Selling Stockholder is also managed by an ATW Partners related entity.
On February 4, 2025, the Company and the Exchange Agreement Investor entered into an Exchange Agreement (the “Exchange Agreement”), pursuant to which the Company and the Exchange Agreement Investor exchanged the Former Principal Stockholder Notes for five new secured promissory notes of the Company secured by the Company’s assets (the “January 2025 Exchange Notes”). Note 1 was exchanged for “Exchange Note 1”, Note 2 was exchanged for “Exchange Note 2”, Note 3 was exchanged for “Exchange Note 3”, Note 4 was exchanged for “Exchange Note 4”, and Note 5 was exchanged for “Exchange Note 5”. The January 2025 Exchange Notes were offered, sold, and issued by the Company to the Exchange Agreement Investor pursuant to the exemption provided in Section 3(a)(9) under the Securities Act.
The principal amounts of the January 2025 Exchange Notes are as follows: Exchange Note 1 principal amount: $2.8 million, Exchange Note 2 principal amount: $1.6 million, Exchange Note 3 principal amount: $0.3 million, Exchange Note 4 principal amount: $0.4 million, and Exchange Note 5 principal amount: $0.4 million.
The January 2025 Exchange Notes accrue interest at a rate of 5% per annum, subject to adjustment from time to time as set forth in the Exchange Notes. The maturity date of Exchange Note 1 and Exchange Note 3 is May 5, 2025. The maturity date of Exchange Note 2, Exchange Note 4 and Exchange Note 5 is April 4, 2025.
The January 2025 Exchange Notes are convertible (in whole or in part) at any time prior to the maturity date into the number of shares of Common Stock equal to (x) the sum of (A) the portion of the principal of the January 2025 Exchange Notes to be converted, redeemed or otherwise with respect to which this determination is being made, (B) accrued and unpaid interest with respect to the principal of the Exchange Note, (C) accrued and unpaid late charges with respect to the principal of the Exchange Note and interest, and (D) any other unpaid amounts pursuant to the Exchange Agreement, if any, divided by (y) a conversion price of $2.04 per share, subject to adjustment as provided in the Exchange Notes (such shares, the “Exchange Agreement Note Conversion Shares”).
The January 2025 Exchange Notes, in the aggregate principal amount of $5.4 million were fully converted into 2,642,878 shares of Common Stock in February 2025 and the Company recorded a gain on extinguishment of debt of $2.1 million.
The Company has elected the fair value option to account for its January 2025 Exchange Notes upon issuance in February 2025 as the exchange was accounted for as an extinguishment.
|
|
|
|
|
|
|
January 2025 |
|
(in thousands) |
|
Exchange Notes |
|
Carrying amount at February 4, 2025 |
|
|
5,380 |
|
Conversion to common stock |
|
|
(5,391 |
) |
Gain on extinguishment of debt with related party |
|
|
(279 |
) |
Change in estimated fair value of convertible notes |
|
|
290 |
|
Fair value at March 31, 2025 |
|
$ |
— |
|
January 2025 Convertible Notes
On January 28, 2025, the Company sold a senior secured convertible note (the “January 2025 Convertible Notes”) in the aggregate principal amount of $3.3 million, which is convertible into shares of the Company’s common stock, par value $0.0001 per share. The January 2025 Convertible Notes carries an original issue discount of 10.0% and accrues interest at a rate of 12% per annum, subject to adjustment from time to time as set forth in the agreement with a maturity date of January 24, 2028.
The January 2025 Convertible Notes is convertible (in whole or in part) at any time prior to the Maturity Date into the number of shares of Common Stock equal to (x) 110% of the sum of (i) the portion of the principal amount of the January 2025 Convertible Notes to be converted or redeemed, (ii) accrued and unpaid Interest with respect to such principal amount of the January 2025 Convertible Notes, (iii) the Make-Whole Amount, (iv) accrued and unpaid Late Charges with respect to such principal amount of the Note, Make-Whole Amount and Interest, and (v) any other unpaid amounts pursuant to the Transaction Documents, if any, divided by (y) a conversion price of $3.133 per share, subject to adjustment as provided in the January 2025 Convertible Notes agreement.
The January 2025 Convertible Notes sets forth certain standard events of default (each such event, an “Event of Default”), upon the occurrence of which the Company is required to deliver written notice to the Investor within one business day (an “Event of Default Notice”). At any time after the earlier of (a) the Investor’s receipt of an Event of Default Notice, and (b) the Investor becoming aware of an Event of Default, the Investor may require the Company to redeem all or any portion of the Note. Upon an Event of Default, the Note shall bear interest at a rate of the sum of (x) the applicable Interest Rate in effect for such determination and (y) 8.0% per annum.
For the three months ended March 31, 2025, the Investor converted a total of $2.0 million owed pursuant to the January 2025 Convertible Notes into a total of 826,950 shares of Common Stock and the Company recorded a gain on extinguishment of debt of $0.7 million.
The $3.3 million of aggregate principal received from the issuance of the January 2025 Convertible Notes was initially allocated to the aggregate issuance date fair value of the embedded derivatives and the warrants issued in connection with the issuance of the January 2025 Convertible Notes (see Note 13. Fair Value Measurements for more information), original issue discount and the remainder of the proceeds from the issuance of the January 2025 Convertible Notes was allocated to the convertible notes, resulting in a debt discount of $2.0 million. In addition, the Company incurred $0.3 million of debt issuance costs. The Company has recorded the debt discount and debt issuance costs as a direct reduction to the face value of the January 2025 Convertible Notes and will amortize these amounts over the life of January 2025 Convertible Notes as a component of interest expense on the condensed consolidated statement of operations. The January 2025 Convertible Notes will remain on the consolidated balance sheet at amortized cost.
The carrying value of the January 2025 Convertible Notes is as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Principal and interest |
|
$ |
1,960 |
|
|
$ |
— |
|
Unamortized debt discount |
|
|
(1,711 |
) |
|
|
— |
|
Unamortized issuance costs |
|
|
(249 |
) |
|
|
— |
|
Aggregate carrying value |
|
$ |
— |
|
|
$ |
— |
|
Interest expense recognized on the January 2025 Convertible Notes is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
Contractual interest expense |
|
$ |
699 |
|
|
$ |
— |
|
|
Amortization of debt discount |
|
|
253 |
|
|
|
— |
|
|
Amortization of debt issuance costs |
|
|
37 |
|
|
|
— |
|
|
Total |
|
$ |
989 |
|
|
$ |
— |
|
|
March 2025 Convertible Notes
On March 11, 2025, the Investor elected to exercise 829,876 Class A Incremental Warrants to purchase the Class A Incremental Notes (the "March 2025 Convertible Notes") for an aggregate principal amount of $4.0 million. The March 2025 Convertible Notes carry an original issue discount of 10.0% and accrues interest at a rate of 12% per annum, subject to adjustment from time to time as set forth in the March 2025 Convertible Notes agreement. The maturity date of the March 2025 Convertible Notes is January 24, 2028.
The March 2025 Convertible Notes are convertible (in whole or in part) at any time prior to the Maturity Date into the number of shares of Common Stock equal to (x) 110% of the sum of (i) the portion of the principal amount of the March 2025 Convertible Notes to be converted or redeemed, (ii) accrued and unpaid Interest with respect to such principal amount of the March 2025 Convertible Notes, (iii) the Make-Whole Amount, (iv) accrued and unpaid Late Charges with respect to such principal amount of the Note, Make-Whole Amount and Interest, and (v) any other unpaid amounts pursuant to the transaction documents, if any, divided by (y) a conversion price of $1.989 per share, subject to adjustment as provided in the March 2025 Convertible Notes agreement.
The March 2025 Convertible Notes sets forth certain standard events of default (each such event, an “Event of Default”), upon the occurrence of which the Company is required to deliver written notice to the Investor within one business day (an “Event of Default Notice”). At any time after the earlier of (a) the Investor’s receipt of an Event of Default Notice, and (b) the Investor becoming aware of an Event of Default, the Investor may require the Company to redeem all or any portion of the Note. Upon an Event of Default, the Note shall bear interest at a rate of the sum of (x) the applicable Interest Rate in effect for such determination and (y) 8.0% per annum.
The $4.0 million of aggregate principal received from the issuance of the March 2025 Convertible Notes was initially allocated to the aggregate issuance date fair value of the embedded derivatives and the warrants issued in connection with the issuance of the March 2025 Convertible Notes (see Note 13. Fair Value Measurements for more information), original issue discount and the remainder of the proceeds from the issuance of the March 2025 Convertible Notes was allocated to the convertible notes, resulting in a debt discount of $2.1 million. In addition, the Company incurred $0.1 million of debt issuance costs. The Company has recorded the debt discount and debt issuance costs as a direct reduction to the face value of the March 2025 Convertible Notes and will amortize these amounts over the life of March 2025 Convertible Notes as a component of interest expense on the condensed consolidated statement of operations. The March 2025 Convertible Notes will remain on the consolidated balance sheet at amortized cost.
The carrying value of the March 2025 Convertible Notes is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
Principal and interest |
|
$ |
4,027 |
|
|
$ |
— |
|
|
Unamortized debt discount |
|
|
(2,039 |
) |
|
|
— |
|
|
Unamortized issuance costs |
|
|
(105 |
) |
|
|
— |
|
|
Aggregate carrying value |
|
$ |
1,883 |
|
|
$ |
— |
|
|
Interest expense recognized on the March 2025 Convertible Notes is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
Contractual interest expense |
|
$ |
27 |
|
|
$ |
— |
|
|
Amortization of debt discount |
|
|
38 |
|
|
|
— |
|
|
Amortization of debt issuance costs |
|
|
2 |
|
|
|
— |
|
|
Total |
|
$ |
67 |
|
|
$ |
— |
|
|
12. Warrants
The following is a schedule of changes in warrants issued and outstanding from December 31, 2024 to March 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Warrants February 2024 |
|
|
Common Stock Warrants Woodway |
|
|
Common Stock Warrants Registered Direct Placement Agent |
|
|
Common Stock Warrants Registered Direct |
|
|
Common Stock Warrants Best Efforts A-1 |
|
|
Common Stock Warrants Best Efforts A-2 |
|
|
Common Stock Warrants Best Efforts Placement Agent |
|
|
Common Stock Warrants January 2025 |
|
|
Common Stock Class A Incremental Warrants January 2025 |
|
|
Common Stock Class B Incremental Warrants January 2025 |
|
|
Common Stock Warrants March 2025 |
|
|
Total Common Stock Warrants |
|
Outstanding as of December 31, 2024 |
|
|
750 |
|
|
|
200 |
|
|
|
107 |
|
|
|
1,420 |
|
|
|
28,369 |
|
|
|
28,369 |
|
|
|
2,128 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
61,342 |
|
Warrants issued |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
674,274 |
|
|
|
2,697,097 |
|
|
|
4,149,380 |
|
|
|
829,876 |
|
|
|
8,350,627 |
|
Warrants exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(829,876 |
) |
|
|
— |
|
|
|
— |
|
|
|
(829,876 |
) |
Warrants canceled |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding as of March 31, 2025 |
|
|
750 |
|
|
|
200 |
|
|
|
107 |
|
|
|
1,420 |
|
|
|
28,369 |
|
|
|
28,369 |
|
|
|
2,128 |
|
|
|
674,274 |
|
|
|
1,867,221 |
|
|
|
4,149,380 |
|
|
|
829,876 |
|
|
|
7,582,093 |
|
The warrants are classified as other long-term liabilities within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings.
November 2023 Bridge Warrants
In connection with the November Bridge Notes issued in November 2023, the Company entered into a warrant agreement whereby the holders are eligible to receive warrants based on the occurrence of future events as defined in the agreement. No warrants have been issued as of March 31, 2025.
February 2024 Warrants
On February 1, 2024, the Company issued an aggregate 750 warrants to purchase shares of common stock to an accredited investor in conjunction with the issuance of its $6.0 million February 2024 Note. The Warrants are exercisable for 375 shares of Common Stock, at a price of $5,000.00 per share (“Warrant 1”) and $7,000.00 per share (“Warrant 2” and, together with Warrant 1, the “Warrants”) (the “Exercise Prices”). The Warrants may be exercised during the period commencing February 1, 2024 and ending on February 1, 2034. The Exercise Prices are subject to voluntary adjustments and adjustments upon subdivision or combinations of shares of Common Stock.
Woodway Warrants
On February 20, 2024, the Company issued 200 warrants in connection with an Exclusive Distribution Agreement with WOODWAY USA, INC ("Woodway"). Each warrant has a strike price of $5,000.00 per share. The warrants may be exercised during the period commencing February 20, 2024 and ending February 20, 2034.
Registered Direct Placement Agent Warrants
On May 8, 2024, the Company entered into an engagement agreement with H.C. Wainwright & Co., LLC (the "Placement Agent"), pursuant to which the Placement Agent agreed to act as the exclusive placement agent in connection with the Registered Offering. The Company has agreed to issue the Placement Agent or its designees as compensation in connection with the Offering, warrants to purchase up to an aggregate of 107 shares of Common Stock (equal to 7.5% of the aggregate number of Shares sold in the Registered Offering)
and will have a term of five years from the commencement of sales in the Registered Offering and an exercise price of $880.00 per share.
Registered Direct Offering Warrants
Pursuant to the securities purchase agreement, in a concurrent private placement (together with the Registered Offering, the “Offering”), the Company has also agreed to issue to the Investors unregistered warrants to purchase up to an aggregate of 1,420 shares of Common Stock, which represent 100% of the shares of Common Stock to be issued and sold in the Registered Offering. The Warrants have an exercise price of $704.00 per share, and will expire on the five and one-half (5.5) year anniversary from the Stockholder Approval Date on May 31, 2024.
Best Efforts Offering A-1 and A-2 Warrants
On July 1, 2024, the Company issued Series A-1 warrants to purchase up to an aggregate of 28,369 shares of common stock and Series A-2 warrants to purchase up to an aggregate of 28,369 shares of common stock. The public offering price for each Share and accompanying Warrants was $141.00 (which is the last reported sale price of the Common Stock on The Nasdaq Capital Market on June 28, 2024). Each Warrant has an exercise price of $141.00 per share and is exercisable beginning on the effective date of stockholder approval on August 30, 2024. The Series A-1 Warrant will expire on the five-year anniversary of the initial issuance date. The Series A-2 Warrant will expire on the eighteen-month anniversary of the initial issuance date.
Best Efforts Placement Agent Warrants
The Company entered into an engagement agreement with H.C. Wainwright & Co., LLC (the "Placement Agent"), pursuant to which the Placement Agent agreed to act as the exclusive placement agent in connection with the Best Efforts Offering. The Company has agreed to issue the Placement Agent or its designees as compensation in connection with the Offering, warrants to purchase up to an aggregate of 2,128 shares of Common Stock (equal to 7.5% of the aggregate number of Shares sold in the Best Efforts Offering) and will have a term of five years from the commencement of sales in the Best Efforts Offering and an exercise price of $176.30 per share.
January 2025 Warrants
On January 28, 2025, the Company issued warrants to purchase 674,274 shares of common stock. The warrants are exercisable for shares of common stock at a price of $4.82 per share. The warrants may be exercised during the period commencing January 28, 2025 and ending January 28, 2032. The warrant exercise price is subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of common stock.
January 2025 Class A Incremental Warrants
On January 28, 2025, the Company issued 2,697,097 Class A incremental warrants to purchase senior secured convertible notes in the aggregate principal amount of $13.0 million. On March 11, 2025 the Investor elected to exercise 829,876 Class A Incremental Warrants to purchase Class A Incremental Notes of $4.0 million. The Incremental Warrants are exercisable during the period commencing January 28, 2025 and ending on the two year anniversary of the effectiveness of the Registration Statement at an exercise price of equal to 90% of the principal amount of the Incremental Notes issued to such purchaser, subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of Common Stock and the like. The Incremental Warrants contain call options that allow the Company to repurchase the incremental warrants if certain conditions are present.
January 2025 Class B Incremental Warrants
On January 28, 2025, the Company issued 4,149,380 Class B incremental warrants to purchase senior secured convertible notes in the aggregate principal amount of $20.0 million. The Incremental Warrants are exercisable during the period commencing January 28, 2025 and ending on the two year anniversary of the effectiveness of the Registration Statement at an exercise price of equal to 90% of the principal amount of the Incremental Notes issued to such purchaser, subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of Common Stock and the like. The Incremental Warrants contain call options that allow the Company to repurchase the incremental warrants if certain conditions are present.
March 2025 Warrants
On March 11, 2025, the Company issued warrants to purchase 829,876 shares of common stock. The warrants are exercisable for shares of common stock at a price of $3.06 per share. The warrants may be exercised during the period commencing January 28, 2025 and ending January 28, 2032. The warrant exercise price is subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of common stock.
13. Fair Value Measurements
The Company’s financial instruments consist of derivatives, convertible notes held at fair value, and warrants.
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2025 and December 31, 2024 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
December 31, 2024 |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
|
|
(in thousands) |
(in thousands) |
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,207 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
138 |
|
|
$ |
— |
|
|
$ |
— |
|
|
Derivatives |
|
|
— |
|
|
|
— |
|
|
|
95 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Total |
|
$ |
2,207 |
|
|
$ |
— |
|
|
$ |
95 |
|
|
$ |
138 |
|
|
$ |
— |
|
|
$ |
— |
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
959 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
73 |
|
|
Convertible Notes |
|
|
— |
|
|
|
— |
|
|
|
1,541 |
|
|
|
— |
|
|
|
— |
|
|
|
2,557 |
|
|
Warrants |
|
|
— |
|
|
|
— |
|
|
|
767 |
|
|
|
— |
|
|
|
— |
|
|
|
4 |
|
|
Total |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,267 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,634 |
|
|
During the three months ended March 31, 2025, there were no transfers between Level 1 and Level 2, nor into and out of Level 3. The carrying values of the Company’s prepaid expenses and other current assets, accounts payable and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities.
The following summarizes the activity for the Company Level 3 assets and liabilities measured at fair value on a recurring basis for the three months ended March 31, 2025.
Derivative Assets
|
|
|
|
|
|
|
Loss Restoration |
|
(in thousands) |
|
Derivative |
|
Fair value at December 31, 2024 |
|
$ |
— |
|
Change in estimated fair value of derivatives |
|
|
95 |
|
Fair value at March 31, 2025 |
|
$ |
95 |
|
Derivative Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss Restoration |
|
|
Jan 2025 |
|
|
Mar 2025 |
|
|
Total |
|
(in thousands) |
|
Derivative |
|
|
Derivative |
|
|
Derivative |
|
|
Derivatives |
|
Fair value at December 31, 2024 |
|
$ |
73 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
73 |
|
Issuance of derivatives |
|
|
— |
|
|
|
963 |
|
|
|
1,141 |
|
|
|
2,104 |
|
Derivative settlement |
|
|
(2,800 |
) |
|
|
— |
|
|
|
— |
|
|
|
(2,800 |
) |
Change in estimated fair value of derivatives |
|
|
2,727 |
|
|
|
(741 |
) |
|
|
(404 |
) |
|
|
1,582 |
|
Fair value at March 31, 2025 |
|
$ |
— |
|
|
$ |
222 |
|
|
$ |
737 |
|
|
$ |
959 |
|
Loss Restoration Derivative Asset / Liability
In connection with the Company entering into the Loss Restoration Agreement the Company recorded the Loss Restoration Derivative as a derivative asset or a derivative liability in the Company’s condensed consolidated balance sheet depending on the fair value in accordance with FASB ASC 815, Derivatives and Hedging. Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, discount rate, dividend rate and risk-free interest rate. The Company recognized a gain equal to $2.6 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively, related to change in fair value of the Loss Restoration Derivative recorded in the condensed consolidated statements of operations in change in fair value of derivatives. The assumptions used to estimate the fair value of the Loss Restoration Derivative are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.1 |
% |
|
|
4.2 |
% |
Weighted-average expected term (in years) |
|
|
0.75 |
|
|
|
1.00 |
|
Weighted-average expected volatility |
|
|
123.1 |
% |
|
|
111.7 |
% |
Expected dividend yield |
|
|
15.0 |
% |
|
|
15.0 |
% |
January 2025 Convertible Note Derivative
In connection with the Company issuing the January 2025 Convertible Notes, the Company recorded the January 2025 Convertible Note Derivatives (the "January 2025 Derivative") as a liability in the Company’s condensed consolidated balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The fair value of the January 2025 Derivative as of January 28, 2025 was $1.0 million and was determined using a Monte Carlo simulation. The Monte Carlo Simulation valuation model incorporates assumptions as to stock price volatility, discount rate, dividend rate and risk-free interest rate. The Company recognized a gain equal to $0.7 million for three months ended March 31, 2025, respectively, related to change in fair value of the January 2025 Derivative recorded in the condensed consolidated statements of operations in change in fair value of derivatives. The assumptions used to estimate the fair value are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
3.9 |
% |
|
|
— |
% |
Weighted-average expected term (in years) |
|
|
2.82 |
|
|
|
— |
|
Weighted-average expected volatility |
|
|
95.0 |
% |
|
|
— |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
March 2025 Convertible Note Derivative
In connection with the Company issuing the March 2025 Convertible Notes, the Company recorded the March 2025 Convertible Note Derivatives (the "March 2025 Derivative") as a liability in the Company’s condensed consolidated balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The fair value of the March 2025 Derivative as of March 11, 2025 was $1.1 million and was determined using a Monte Carlo simulation. The Monte Carlo Simulation valuation model incorporates assumptions as to stock price volatility, discount rate, dividend rate and risk-free interest rate. The Company recognized a gain equal to $0.4 million for three months ended March 31, 2025, respectively, related to change in fair value of the March 2025 Derivative recorded in the condensed consolidated statements of operations in change in fair value of derivatives. The assumptions used to estimate the fair value are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
3.9 |
% |
|
|
— |
% |
Weighted-average expected term (in years) |
|
|
2.95 |
|
|
|
— |
|
Weighted-average expected volatility |
|
|
95.0 |
% |
|
|
— |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Convertible Notes
February 2024 Convertible Notes
The Company entered into a convertible note arrangement in February 2024. The amendment to the Note represents the addition of a substantive conversion feature and as a result the Company recorded a loss on extinguishment upon issuance and the remaining unamortized discount was written off upon extinguishment. The Company elected the fair value option for the February 2024 Convertible Notes under ASC 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. The fair value of the February 2024 Convertible Notes were determined using a discounted cash flow analysis at a discount rate of 16.3%. The fair value of the February 2024 Convertible Notes of $4.0 million was recorded as a current liability upon issuance. The Company recorded a change in fair value adjustment of $0.3 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively.
|
|
|
|
|
|
|
February 2024 |
|
(in thousands) |
|
Convertible Notes |
|
Fair value at December 31, 2024 |
|
|
2,557 |
|
Cash paid for interest |
|
|
(88 |
) |
Conversion to common stock |
|
|
(1,212 |
) |
Change in estimated fair value of convertible notes |
|
|
284 |
|
Fair value at March 31, 2025 |
|
$ |
1,541 |
|
January 2025 Exchange Notes
On February 4, 2025, the Company and the Exchange Agreement Investor entered into an Exchange Agreement (the “Exchange Agreement”), pursuant to which the Company and the Exchange Agreement Investor exchanged the Former Principal Stockholder Notes for five new secured promissory notes of the Company secured by the Company’s assets (the “January 2025 Exchange Notes”). The amendment to the Note represents the addition of a substantive conversion feature and as a result the Company recorded a gain on extinguishment included in condensed consolidated statement of stockholders equity. The Company elected the fair value option for the January 2025 Exchange Notes under ASC 825, Financial Instruments, with changes in fair value recorded in earnings each reporting period. The fair value of the January 2025 Exchange Notes were determined using a discounted cash flow analysis at a discount rate of 16.3%. The fair value of the January 2025 Exchange Notes of $5.1 million was recorded as a current liability upon issuance. The January 2025 Exchange Notes, in the aggregate principal amount of $5.4 million were fully converted into 2,642,878 shares of Common Stock in February 2025. The Company recorded a change in fair value adjustment of $0.3 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively.
|
|
|
|
|
|
|
January 2025 |
|
(in thousands) |
|
Exchange Notes |
|
Carrying amount at February 4, 2025 |
|
|
5,380 |
|
Conversion to common stock |
|
|
(5,391 |
) |
Gain on extinguishment of debt with related party |
|
|
(279 |
) |
Change in estimated fair value of convertible notes |
|
|
290 |
|
Fair value at March 31, 2025 |
|
$ |
— |
|
Warrants
The following table summarizes the activity for the Company Level 3 warrant liabilities measured at fair value on a recurring basis for the three months ended March 31, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands) |
|
Nov 2023 |
|
|
Feb 2024 |
|
|
Woodway |
|
|
Registered Direct |
|
|
Registered Direct Agent |
|
|
Best Efforts Pre-Funded |
|
|
Best Efforts A-1 |
|
|
Best Efforts A-2 |
|
|
Best Efforts Agent |
|
|
Jan 2025 Class A |
|
|
Jan 2025 Class B |
|
|
Jan 2025 |
|
|
Mar 2025 |
|
|
Total |
|
|
Fair value at December 31, 2024 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4 |
|
|
Issuance of warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
677 |
|
|
|
535 |
|
|
|
1,212 |
|
|
Change in estimated fair value of warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(337 |
) |
|
|
(108 |
) |
|
|
(449 |
) |
|
Fair value at March 31, 2025 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
340 |
|
|
$ |
427 |
|
|
$ |
767 |
|
|
November 2023 Warrants
On November 10, 2023, the Company issued warrants to two accredited investors to purchase shares of Common Stock. The fair value of the warrants was determined using the Monte Carlo Simulation, given the variable number of shares issuable upon exercise of the warrant. For the outstanding warrants as of March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) and risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $0.1 million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the November 2023 Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.0 |
% |
|
|
4.4 |
% |
Weighted-average expected term (in years) |
|
|
4.17 |
|
|
|
4.42 |
|
Weighted-average expected volatility |
|
|
81.2 |
% |
|
|
81.2 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
February 2024 Warrants
On February 1, 2024, the Company issued an aggregate 75,000 warrants to purchase shares of common stock to an accredited investor in conjunction with the issuance of its $6.0 million February 2024 Note. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as of March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $1.2 million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the February 2024 Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.2 |
% |
|
|
4.6 |
% |
Weighted-average expected term (in years) |
|
|
8.97 |
|
|
|
9.22 |
|
Weighted-average expected volatility |
|
|
93.3 |
% |
|
|
93.3 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Woodway Warrants
On February 20, 2024, the Company issued warrants in connection with an Exclusive Distribution Agreement with WOODWAY USA, INC. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $0.3 million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the Woodway Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.2 |
% |
|
|
4.6 |
% |
Weighted-average expected term (in years) |
|
|
9.02 |
|
|
|
9.27 |
|
Weighted-average expected volatility |
|
|
66.6 |
% |
|
|
66.6 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Registered Direct Placement Agent Warrants
On May 8, 2024, the Company issued warrants in connection with an agreement with the Placement Agent, pursuant to which the Placement Agent agreed to act as the exclusive placement agent in connection with the Registered Offering. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, and (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the Placement Agent Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.0 |
% |
|
|
4.4 |
% |
Weighted-average expected term (in years) |
|
|
4.20 |
|
|
|
4.45 |
|
Weighted-average expected volatility |
|
|
81.5 |
% |
|
|
81.5 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Registered Direct Offering Warrants
On May 20, 2024, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the Registered Offering Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.0 |
% |
|
|
4.4 |
% |
Weighted-average expected term (in years) |
|
|
4.71 |
|
|
|
4.96 |
|
Weighted-average expected volatility |
|
|
77.8 |
% |
|
|
77.8 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Best Efforts Offering Pre-Funded Warrants
On July 1, 2024, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively. The warrants were exercised in full in July 2024.
Best Efforts A-1 Warrants
On July 1, 2024, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.004 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the Best Efforts A-1 Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.0 |
% |
|
|
4.4 |
% |
Weighted-average expected term (in years) |
|
|
4.31 |
|
|
|
4.57 |
|
Weighted-average expected volatility |
|
|
80.0 |
% |
|
|
80.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Best Efforts A-2 Warrants
On July 1, 2024, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $0.0
million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the Best Efforts A-2 Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.1 |
% |
|
|
4.2 |
% |
Weighted-average expected term (in years) |
|
|
0.77 |
|
|
|
1.02 |
|
Weighted-average expected volatility |
|
|
116.7 |
% |
|
|
116.7 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
Best Efforts Placement Agent Warrants
On July 1, 2024, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. For the outstanding warrants as March 31, 2025 and December 31, 2024, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million and $0.0 million for three months ended March 31, 2025 and 2024, respectively. The assumptions used to estimate the fair value of the Best Efforts Placement Agent Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.0 |
% |
|
|
4.4 |
% |
Weighted-average expected term (in years) |
|
|
4.31 |
|
|
|
4.56 |
|
Weighted-average expected volatility |
|
|
80.0 |
% |
|
|
80.0 |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
January 2025 Warrants
On January 28, 2025, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. The fair value of the January 2025 Warrants of $0.7 million was recorded as a long-term liability upon issuance. For the outstanding warrants as March 31, 2025, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.3 million for the three months ended March 31, 2025. The assumptions used to estimate the fair value of the January 2025 Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.1 |
% |
|
|
— |
% |
Weighted-average expected term (in years) |
|
|
6.83 |
|
|
|
— |
|
Weighted-average expected volatility |
|
|
150.0 |
% |
|
|
— |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
January 2025 Class A Incremental Warrants
On January 28, 2025, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Monte Carlo simulation and the determined value as of issuance date was $0.0 million. For the outstanding warrants as March 31, 2025, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million for the three months ended March 31, 2025. The assumptions used to estimate the fair value of the January 2025 Class A Incremental Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
3.9 |
% |
|
|
— |
% |
Weighted-average expected term (in years) |
|
|
2.82 |
|
|
|
— |
|
Weighted-average expected volatility |
|
|
95.0 |
% |
|
|
— |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
January 2025 Class B Incremental Warrants
On January 28, 2025, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Monte Carlo simulation and the determined value as of issuance date was $0.0 million. For the outstanding warrants as March 31, 2025, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.0 million for the three months ended March 31, 2025. The assumptions used to estimate the fair value of the January 2025 Class B Incremental Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
3.9 |
% |
|
|
— |
% |
Weighted-average expected term (in years) |
|
|
2.82 |
|
|
|
— |
|
Weighted-average expected volatility |
|
|
95.0 |
% |
|
|
— |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
March 2025 Warrants
On March 11, 2025, the Company issued warrants in connection with a securities purchase agreement with certain institutional investors. The fair value of the warrants was determined using a Black-Scholes-Merton model, in which the probability and timing of potential future events is considered in order to estimate the fair value of the warrants as of each valuation date. The fair value of the March 2025 Warrants of $0.5 million was recorded as a long-term liability upon issuance. For the outstanding warrants as March 31, 2025, management determined the fair value of the warrants using the following significant unobservable inputs: (1) probability and timing of events, (2) expected future equity value of the underlying shares at the time of conversion, (3) dividend yield and (4) a risk free rate. The Company recorded a change in fair value of warrants of $0.1 million for the three months ended March 31, 2025. The assumptions used to estimate the fair value of the March 2025 Warrants are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
|
2025 |
|
|
2024 |
|
Weighted-average risk-free interest rate |
|
|
4.1 |
% |
|
|
— |
% |
Weighted-average expected term (in years) |
|
|
6.95 |
|
|
|
— |
|
Weighted-average expected volatility |
|
|
150.0 |
% |
|
|
— |
% |
Expected dividend yield |
|
|
— |
% |
|
|
— |
% |
The following summarizes the activity for the Company Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2024:
Derivatives
In connection with the Company’s issuance of its December 2023 Note, the Company bifurcated the embedded conversion option and redemption rights and recorded embedded conversion option and redemption rights as a short term derivative liability in the Company’s balance sheet in accordance with FASB ASC 815, Derivatives and Hedging. The fair value of the embedded derivative was determined using a lattice model. The Company recognized gains equal to $0.05 million for the three months ended March 31, 2024 related to changes in fair value of the embedded derivative for the December 2023 Note recorded in the condensed consolidated statements of operations in other expense (income).
|
|
|
|
|
(in thousands) |
|
Derivatives |
|
Fair value at December 31, 2023 |
|
$ |
122 |
|
Change in estimated fair value of financial instruments |
|
|
(54 |
) |
Fair value at March 31, 2024 |
|
$ |
68 |
|
November 2023 Bridge Notes
On November 10, 2023, the Company issued the November Bridge Notes. The fair value of the bridge notes were determined using a discounted cash flow analysis at a discount rate of 21.0%. The Company amended the Bridge notes into convertible notes in January 2024 and subsequently converted the notes into Preferred Stock Series A in February 2024 and March 2024. The Company recognized a loss equal to $0.3 million on the extinguishment of debt and loss on change in fair value of $0.3 million upon conversion to Series A Preferred Stock for the three months ended March 31, 2024.
|
|
|
|
|
(in thousands) |
|
Bridge Notes |
|
Fair value at December 31, 2023 |
|
$ |
1,717 |
|
Loss on extinguishment of debt upon conversion to convertible notes |
|
|
275 |
|
Change in estimated fair value of financial instruments |
|
|
316 |
|
Conversion to Series A Preferred Stock |
|
|
(2,308 |
) |
Fair value at March 31, 2024 |
|
$ |
— |
|
Warrants
The change in fair value of warrants for the three months ended March 31, 2024 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 10, 2023 |
|
|
December 7, 2023 |
|
|
Treadway |
|
|
Woodway |
|
|
Total |
|
(in thousands) |
|
Warrants |
|
|
Warrants |
|
|
Warrants |
|
|
Warrants |
|
|
Warrants |
|
Fair value at December 31, 2023 |
|
$ |
165 |
|
|
$ |
426 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
591 |
|
Issuance of warrants |
|
|
— |
|
|
|
— |
|
|
|
1,800 |
|
|
|
345 |
|
|
|
2,145 |
|
Change in estimated fair value of financial instruments |
|
|
(124 |
) |
|
|
(179 |
) |
|
|
(1,245 |
) |
|
|
(251 |
) |
|
|
(1,799 |
) |
Fair value at March 31, 2024 |
|
$ |
41 |
|
|
$ |
247 |
|
|
$ |
555 |
|
|
$ |
94 |
|
|
$ |
937 |
|
14. Leases
Lease Obligations
The Company adopted ASC 842 on January 1, 2022, using the effective date transition method, which requires a cumulative-effect adjustment to the opening balance of retained earnings on the effective date.
The Company has made certain assumptions and judgements when applying ASC 842 including the adoption of the package of practical expedients available for transition. The practical expedients allowed the Company to not reassess (i) whether expired or existing contracts contained leases, (ii) lease classification for expired or existing leases and (iii) previously capitalized initial direct costs. The Company also elected not to recognize right-of-use assets and lease liabilities for short-term leases (leases with a term of twelve months or less).
Operating lease arrangements primarily consist of office and warehouse leases expiring at various years through 2028. The facility leases have original lease terms of two to seven years and contain options to extend the lease up to 5 years or terminate the lease. Options to extend are included in leased right-of-use assets and lease liabilities in the condensed consolidated balance sheet when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments.
As of March 31, 2025, the weighted average discount rate for operating leases was 7.38% and the weighted average remaining lease term for operating leases was 2.2 years, respectively. As of December 31, 2024, the weighted average discount rate for operating leases was 6.89% and the weighted average remaining lease term for operating leases was 2.3 years, respectively.
The Company has entered into various short-term operating leases for office and warehouse space, with an initial term of twelve months or less. These short-term leases are not recorded on the Company’s condensed consolidated balance sheets. The components of lease expense and other information for three months ended March 31, 2025 and 2024 were as follows.
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
2025 |
|
|
2024 |
|
|
|
|
(in thousands) |
|
|
Operating lease costs |
|
$ |
82 |
|
|
$ |
64 |
|
|
Variable lease costs |
|
|
36 |
|
|
|
13 |
|
|
Short-term lease costs |
|
|
10 |
|
|
|
10 |
|
|
Total lease costs |
|
|
128 |
|
|
|
87 |
|
|
Other information: |
|
|
|
|
|
|
|
Cash paid for amounts included in the measurement of operating lease liability |
|
$ |
118 |
|
|
$ |
77 |
|
|
The following represents the Company’s minimum annual rental payments under operating leases for each of the next five years and thereafter:
|
|
|
|
|
Fiscal Year Ending December 31, |
|
Operating |
|
|
|
(in thousands) |
|
2025 (remaining) |
|
|
193 |
|
2026 |
|
|
78 |
|
2027 |
|
|
78 |
|
2028 |
|
|
33 |
|
2029 |
|
|
— |
|
Thereafter |
|
|
— |
|
Total future minimum lease payments |
|
|
382 |
|
Less: imputed interest |
|
|
(34 |
) |
Present value of operating lease liability |
|
$ |
348 |
|
|
|
|
|
Less: current portion of lease liability |
|
|
194 |
|
Non-current portion of lease liability |
|
|
154 |
|
Present value of operating lease liability |
|
$ |
348 |
|
15. Commitments and Contingencies
Royalty Agreement
In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3% of cumulative FORME net sales up to $5.0 million and 1% of cumulative FORME net sales above $5.0 million, up to a maximum total royalty of $1.0 million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $0.2 million shall be paid in the first 12 months after the product's initial retail release as an advance towards the royalty payments which was accrued as of March 31, 2025. The Company recorded royalty expense of $0.005 million and $0.004 million for three months ended March 31, 2025 and 2024, respectively.
Legal Proceedings
On March 7, 2024, a petition was filed by Tung Keng Enterprise Co., Ltd. d/b/a DK City Co., Ltd. (“DK City”) against CLMBR, Inc. and the Company in the United States District Court for the District of Colorado to enforce a monetary arbitration award of approximately $2.25 million against CLMBR, Inc. (the “Petition”). The Company was not involved in that prior arbitration, which involved alleged breaches of an equipment manufacturing agreement between CLMBR, Inc. and DK City. On June 25, 2024, CLMBR, Inc. and the Company collectively resolved the dispute via a Confidential Settlement Agreement and Mutual Release with DK City. Pursuant to that agreement, the Company is required to make certain payments to DK City, CLMBR Inc. and the Company will be released from liability, and the Petition will be voluntarily dismissed without prejudice. Total remaining payments as of March 31, 2025 of $2.0 million are all due within one year from March 31, 2025 and are included in Accrued Expenses and other current liabilities in the condensed consolidated balance sheet. The Company is in default per the agreement as a result of not following the payment plan.
The Company has been sued for breach of contract and related claims by one of its former financial services consultants (“the Plaintiff”). On or about February 20, 2025, an action was filed and is presently pending in the Superior Court of Massachusetts, Suffolk County. The Plaintiff is seeking damages in the amount of $2.2 million (plus interest and attorneys’ fees, costs, and expenses) related to the Company’s alleged breach of an agreement between the parties for financial services Plaintiff allegedly provided to the Company. The parties are currently engaged in good faith settlement discussions to fully resolve all allegations and/or claims. In the event of an unfavorable final judgment against the Company, management believes it will not have a material impact on the Company’s financial position but it could have a material impact on the Company’s cash flows. The Company believes it is adequately accrued as of March 31, 2025.
The Company is involved in legal proceedings in the normal course of business. The Company currently believes that any ultimate liability arising out of such proceedings will not have a material adverse effect on the Company’s financial position, results of operations or cash flows.
16. Stockholders’ Equity (Deficit)
Common Stock
The Company’s authorized common stock consisted of 900,000,000 shares at $0.0001 par value, as of March 31, 2025 and December 31, 2024. The issued and outstanding common stock was 7,953,570 shares and 1,402,102 shares as of March 31, 2025 and December 31, 2024, respectively.
On February 2, 2024, the Company issued 357 shares of common stock in connection with acquisition of CLMBR, Inc. as part of the purchase price.
From January 2024 through June 2024, the Company issued 2,882 shares of common stock upon conversions of $1.9 million from the December 2023 Convertible Note.
On February 1, 2024, the Company issued 188 shares of common stock to the February 2024 Convertible Note holder, pursuant to a securities purchase agreement.
On February 1, 2024, the Company issued 63 shares of common stock to the December 2023 Convertible Note holder and the Equity Line Investor for granting a waiver to the Company to allow the Company to issue the February 2024 Convertible Note and to enter into the Term Loan.
In January 2024 through May 2024, the Company issued 407 shares of common stock, par value $0.0001, from equity line of credit.
In May 2024, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market an aggregate of 1,420 shares of common stock, par value $0.0001, of the Company, at an offering price of $704.00 per share.
In June 2024, the Company issued 231 shares of common stock upon exercising of warrants associated with the December 2023 Convertible Note.
In July 2024, the Company commenced a best efforts public offering of an aggregate of 2,100 shares of common stock, par value $0.0001 per share, of the Company, at an offering price of $141.00 and issued 26,269 shares of common stock from exercise of pre-funded warrants of common stock, par value $0.0001, of the Company, at an offering price of $140.90 per share.
In June 2024 through December 2024, the Company issued 648,700 shares of common stock, par value $0.0001, from At the Market offering.
The Reverse Stock Split on June 14, 2024 decreased the number of shares of Common Stock issued and outstanding but such reduction was subject to adjustment for the rounding up of fractional shares. On June 25, 2024 due to the rounding up of fractional shares, a total of 1,003 shares of Common Stock were issued to certain shareholders who owed shares of Common Stock on June 14, 2024.
The Reverse Stock Split on November 11, 2024 decreased the number of shares of Common Stock issued and outstanding but such reduction was subject to adjustment for the rounding up of fractional shares. On November 21, 2024 due to the rounding up of fractional shares, a total of 217,717 shares of Common Stock were issued to certain shareholders who owed shares of Common Stock on November 11, 2024.
From September 2024 through November 2024, the Company issued 235,161 shares of common stock upon conversion of $2.4 million of debt.
From November 2024 through December 2024, the Company issued 262,051 shares of common stock upon conversion of 919,794 shares of Series A Preferred Stock.
In February 2025, the Company issued 821,500 shares of common stock, par value $0.0001, from At the Market offering.
From January 2025 through March 2025, the Company issued 3,941,578 shares of common stock upon conversion of $8.6 million of convertible notes.
From January 2025 through March 2025, the Company issued 1,788,390 shares of common stock upon conversion of 100,000 shares of Series A Preferred Stock, 1,060,118 shares of Series B Preferred Stock and 2,801,250 shares of Series C Preferred Stock.
Preferred Stock
In January 2024, our board authorized the proposed issuance of shares of non-voting Series A and Series B convertible preferred stock. The Company's authorized preferred stock consists of 200,000,000 shares at $0.0001 par value as of December 31, 2024. The Series A Certificate designated 5,000,000 shares of the Company’s preferred stock as Series A Preferred Stock. The Series B Certificate designated 1,500,000 shares of the Company’s preferred stock as Series B Preferred Stock. In September 2024, our board authorized the proposed issuance of shares of non-voting Series C convertible preferred stock. The Series C Certificate designated 5,000,000 shares of the Company’s preferred stock as Series C Preferred Stock. The remaining unissued shares of our authorized preferred stock are undesignated. On April 18, 2024, the Series A Certificate was amended increasing designated shares from 5,000,000 to 7,000,000. On June 28, 2024 the Series A Certificate was amended increasing designated shares from 7,000,000 to 10,000,000.
The Series A convertible preferred stock is subject to certain rights, preferences, privileges, and obligations, including voluntary and mandatory conversion provisions, as well as beneficial ownership restrictions and share issuance caps, as described below and as set forth in the Series A Certificate. The Series A convertible preferred stock can be issued at any time and any subsequent mandatory or voluntary conversion into common stock shall be at a conversion price at least equal to or above the closing price per share of the Common Stock as reported on Nasdaq on the last trading day immediately preceding the date that the Series A Certificate was approved by our board of directors, subject to customary adjustments for stock splits and combinations.
The Series A convertible preferred stock includes the following:
•Subject to certain restrictions specified in the Series A Certificate, and applicable legal and regulatory requirements, including without limitation, the listing requirements of the Nasdaq Stock Market, (i) each share of Series A convertible preferred stock is convertible, at the option of the holder, at any time, provided that such conversion occurs at least 12 months following the Original Issuance Date (as defined in the Series A Certificate), into such whole number of fully paid and non-assessable shares of common stock as is determined by dividing the Original Issue Price (as defined in the Series A Certificate) by the Conversion Price (as defined in the Series A Certificate) in effect at the time of conversion, and (ii) upon the earliest Mandatory Conversion Time (as defined in the Series A Certificate) all outstanding shares of Series A convertible preferred stock shall automatically be converted into shares of common stock;
•In no event shall any share of Series A convertible preferred stock convert into shares of common stock if the total number of shares of common stock issued would exceed 19.99% of the total number of our shares of common stock outstanding as of immediately prior to the adoption of the Series A Certificate;
•Dividends accrue on each share of Series A convertible preferred stock at the rate per annum of 8% of the Original Issue Price of such share, plus the amount of previously accrued dividends, compounded annually, subject to certain restrictions and provisions as set forth in the Series A Certificate; and
•The Series A convertible preferred stock does not have any voting rights, other than any vote required by law or our certificate of incorporation (which does not currently provide for any such voting rights).
On January 23, 2025 the Board of Directors of the Company declared a dividend on the shares of Series A Preferred Stock issued and outstanding as of the record date for such dividend, as a dividend in kind, in the form of 112,334 shares of Series A Preferred Stock. The Company issued 112,334 Dividend Shares on January 23, 2025.
There are no circumstances outside the Company's control other than final liquidation that would require the Company to settle the Series A Preferred Stock in cash therefore the Company classified the Series A Preferred Stock as permanent equity as of March 31, 2025.
The Series B convertible preferred stock includes the following:
•Subject to certain restrictions specified in the Series B Certificate, and applicable legal and regulatory requirements, including without limitation, the listing requirements of the Nasdaq Stock Market, (i) each share of Series B convertible preferred stock is convertible, at the option of the holder, at any time, into such whole number of fully paid and non-assessable shares of common stock as is determined by dividing the Original Issue Price (as defined in the Series B Certificate) by the Conversion Price (as defined in the Series B Certificate) in effect at the time of conversion.
•In the event that stockholder approval is not obtained, the holders of the Series B Preferred Stock may voluntarily convert the Series B Preferred Stock into Common Stock, provided that in no event shall the number of shares of Common Stock issued upon such voluntary conversion exceed 19.99% of the total number of shares of Common Stock outstanding as of immediately prior to the execution of the Asset Purchase Agreement.
•The Series B Preferred Stock does not have any voting rights, other than any vote required by law or the Company’s certificate of incorporation (which does not currently provide for any such voting rights) and is not entitled to any dividends.
The Company classifies Series B Preferred Stock in accordance with ASC 480, Distinguishing Liabilities from Equity, as there are conversion features that are subject to shareholder approval which is outside of the Company and therefore the securities should be classified outside of permanent stockholders’ deficit. Upon shareholder approval on May 31, 2024, the Company classified the Series B Preferred Stock as permanent equity.
The Series C convertible preferred stock includes the following:
•Subject to certain restrictions specified in the Series C Certificate, and applicable legal and regulatory requirements, including without limitation, the listing requirements of the Nasdaq Stock Market, (i) each share of Series C convertible preferred stock is convertible, at the option of the holder, at any time, provided that such conversion occurs at least 18 months following the Original Issuance Date (as defined in the Series C Certificate), into such whole number of fully paid and non-assessable shares of common stock as is determined by dividing the Original Issue Price (as defined in the Series C Certificate) by the Conversion Price (as defined in the Series C Certificate) in effect at the time of conversion, and (ii) upon the earliest Mandatory Conversion Time (as defined in the Series C Certificate) all outstanding shares of Series C convertible preferred stock shall automatically be converted into shares of common stock;
•In the event that stockholder approval is not obtained, the holders of the Series C convertible preferred stock may voluntarily convert the Series C convertible preferred stock, provided that in no event shall the number of shares of Common Stock issued upon such voluntary conversion exceed 19.99% of the total number of shares of Common Stock outstanding as of immediately prior to the Effective Date (as defined in the Series C Certificate);
•Dividends accrue on each share of Series C convertible preferred stock at the rate per annum of 15% of the Original Issue Price of such share, plus the amount of previously accrued dividends, compounded annually, subject to certain restrictions and provisions as set forth in the Series C Certificate; and
•The Series C convertible preferred stock does not have any voting rights, other than any vote required by law or our certificate of incorporation (which does not currently provide for any such voting rights).
There are no circumstances outside the Company's control other than final liquidation that would require the Company to settle the Series C Preferred Stock in cash therefore the Company classified the Series C Preferred Stock as permanent equity as of March 31, 2025.
On January 23, 2025, the Board of Directors of the Company declared a dividend on the shares of Series C Preferred Stock issued and outstanding as of the record date for such dividend, as a dividend in kind, in the form of 126,515 shares of Series C Preferred Stock. The Company issued 126,515 Dividend Shares on January 23, 2025.
17. Equity-Based Compensation
2023 and 2020 Equity Incentive Plan
Presented below is a summary of the compensation cost recognized in the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2025 and 2024.
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
|
Research and development |
|
$ |
699 |
|
|
$ |
1,231 |
|
|
Sales and marketing |
|
|
- |
|
|
|
75 |
|
|
General and administrative |
|
|
1,390 |
|
|
|
2,060 |
|
|
Total |
|
$ |
2,089 |
|
|
$ |
3,366 |
|
|
For the three months ended March 31, 2025 and 2024, $0.3 million and $0.2 million of stock-based compensation was capitalized as software costs, respectively.
During the three months ended March 31, 2025, the Company did not grant any shares under the 2023 and 2020 Plan. The Company has not granted any restricted stock or stock appreciation rights.
The following summary sets forth the stock option activity under the 2023 and 2020 Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of options |
|
|
Weighted average exercise price |
|
|
Weighted average remaining contractual term (in years) |
|
|
Aggregate intrinsic value (in thousands) |
|
Outstanding as of December 31, 2024 |
|
|
796 |
|
|
$ |
10,154.03 |
|
|
|
8.3 |
|
|
$ |
— |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
Cancelled or forfeited |
|
|
(1 |
) |
|
|
2,051.40 |
|
|
|
|
|
|
|
Outstanding as of March 31, 2025 |
|
|
795 |
|
|
$ |
10,160.08 |
|
|
|
8.0 |
|
|
$ |
— |
|
Options exercisable as of March 31, 2025 |
|
|
452 |
|
|
$ |
4,749.08 |
|
|
|
7.9 |
|
|
$ |
— |
|
Options unvested as of March 31, 2025 |
|
|
398 |
|
|
$ |
17,651.89 |
|
|
|
8.2 |
|
|
$ |
— |
|
The aggregate intrinsic value of options outstanding, exercisable and unvested were calculated as the difference between the exercise price of the options and the estimated fair market value of the Company’s common stock, as of March 31, 2025.
With respect to the 2023 and 2020 Plan, the Company recognized stock compensation expense of $2.1 million and $3.4 million for the three months ended March 31, 2025 and 2024, respectively, of which $0.3 million and $0.2 million of stock-based compensation was capitalized as software costs, respectively. As of March 31, 2025 and December 31, 2024, the Company had $1.9 million and $4.4 million of unrecognized stock-based compensation expense that is expected to be recognized over a weighted-average period of 0.5 years and 0.7 years, respectively.
18. Concentration of Credit Risk and Major Customers and Vendors
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company’s cash and cash equivalents are maintained with high-quality financial institutions, the compositions and maturities of which are regularly monitored by management.
For three months ended March 31, 2025, Woodway our exclusive distributor represents 71% of the Company’s total revenue. For three months ended March 31, 2024, there were no customers representing greater than 10% of the Company’s total revenue.
At March 31, 2025, one customer had an accounts receivable balance greater than 10% of accounts receivable, representing 97% of accounts receivable in the aggregate. At December 31, 2024, one customer had an accounts receivable balance greater than 10% of accounts receivable, representing 96% of accounts receivable in the aggregate.
The Company had one vendor representing greater than 10% of total finished goods for the three months ended March 31, 2025. The Company had no vendors representing greater than 10% of total finished goods for the three months ended March 31, 2024.
19. Benefit Plans
The Company established a defined contribution savings plan under Section 401(k) of the Internal Revenue Code. This plan covers all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pre-tax basis. Matching contributions to the plan may be made at the discretion of the Company’s board of directors. During the three months ended March 31, 2025 and 2024, the Company did not make any contributions to the plan.
20. Loss Per Share
The computation of loss per share is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
2025 |
|
|
2024 |
|
|
(in thousands, except share and per share amounts) |
|
(in thousands, except share and per share amounts) |
|
|
Numerator: |
|
|
|
|
|
|
|
Net loss |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
|
Net loss attributable to common stockholders |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
|
Denominator: |
|
|
|
|
|
|
|
Weighted average common stock outstanding - basic and diluted |
|
|
3,804,106 |
|
|
|
4,249 |
|
|
Net loss per share attributable to common stockholders - basic and diluted |
|
$ |
(1.74 |
) |
|
$ |
(2,681.82 |
) |
|
The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
|
2025 |
|
|
2024 |
|
|
Warrants to purchase common stock |
|
|
7,582,093 |
|
|
|
1,464 |
|
|
Series A Preferred Stock conversion to common stock |
|
|
2,984,710 |
|
|
|
— |
|
|
Series B Preferred Stock conversion to common stock |
|
|
268 |
|
|
|
— |
|
|
Series C Preferred Stock conversion to common stock |
|
|
1,151,514 |
|
|
|
— |
|
|
Stock options to purchase common stock |
|
|
795 |
|
|
|
853 |
|
|
Total |
|
|
11,719,380 |
|
|
|
2,317 |
|
|
21. Related Party Transactions
In the ordinary course of business, we may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal stockholders (commonly referred to as “related parties”).
Principal Stockholder Promissory Notes
On January 29, 2025, the Former Principal Stockholder assigned the Former Principal Stockholder Notes of $5.4 million to an accredited investor that is managed by an ATW Partners related entity (the “Exchange Agreement Investor”) and the outstanding principal balance is $0 million as of March 31, 2025. See Note 11 for further information.
During 2019, 2020, and 2021 the Company entered into the following promissory notes with a then-principal stockholder (the "former principal stockholder”) of the Company.
•On May 17, 2019, a $2.0 million note with interest at the rate of 2.5% per annum and maturity date of May 17, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 7.5%. This note was secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest continued until all obligations under the note were satisfied. The total outstanding principal balance including accrued interest as of March 31, 2025 and December 31, 2024 was $0.0 million and $2.8 million, respectively.
•On August 28, 2019, a $1.0 million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5.0% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note was secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest continued until all obligations under the note were satisfied. The total outstanding principal balance including accrued interest as of March 31, 2025 and December 31, 2024 was $0.0 million and $1.5 million, respectively.
•On November 28, 2019, a $0.3 million note with interest at the rate of 5.0% per annum and a maturity date of August 28, 2021. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note was secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest continued until all obligations under the note were satisfied. The total outstanding principal balance including accrued interest as of March 31, 2025 and December 31, 2024 was $0.0 million and $0.3 million, respectively.
•On March 20, 2020, a $0.3 million note with interest at the rate of 5.0% per annum and a maturity date of March 20, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note was secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest continued until all obligations under the note were satisfied. The total outstanding principal balance including accrued interest as of March 31, 2025 and December 31, 2024 was $0.0 million and $0.4 million, respectively.
•On February 12, 2021, a $0.6 million note with interest at the rate of 5.0% per annum and a maturity date of June 12, 2022. The note includes additional interest and fees associated with it upon the occurrence of default for late payment. Upon default, the Company shall pay a fee of 5% of the outstanding principal balance and accrued interest and from that point further interest shall accrue at an additional rate of 10.0%. This note is secured by a lien on and security interest in all right, title and interest of the Company’s assets. The security interest continued until all obligations under the note were satisfied. The total outstanding principal balance including accrued interest as of March 31, 2025 and December 31, 2024 was $0.0 million and $0.4 million, respectively.
As of December 31, 2024, all outstanding promissory notes with respect to the former principal stockholder are included within the loan payable on the condensed consolidated balance sheet for a total of $5.3 million, including accrued interest and default interest of $1.8 million. Interest expense, including default interest, recorded in the condensed consolidated statement of operations was $0.03 million and $0.3 million for the three months ended March 31, 2025 and 2024, respectively.
Loan payable included the following as of March 31, 2025 and December 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Principal stockholder promissory notes |
|
|
— |
|
|
|
5,348 |
|
Total principal stockholder and related party promissory notes |
|
$ |
— |
|
|
$ |
5,348 |
|
Other Related Party Transactions
In 2017, the Company entered into a royalty agreement with Fuseproject and agreed to pay 3% of cumulative net FORME fitness product sales up to $5.0 million and 1% of cumulative net FORME fitness product sales above $5.0 million, up to a maximum total royalty of $1.0 million. Regardless of the level of cumulative net sales, a guaranteed minimum payment of $0.2 million shall be paid in the first 12 months after the products initial retail release as an advance towards the royalty payments which was accrued as of March 31, 2025. As of March 31, 2025 the Company has accrued $0.2 million in royalty payments. The Company recorded royalty expense of $0.005 million and $0.004 million for three months ended March 31, 2025 and 2024, respectively.
22. Acquisition
On October 6, 2023, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with CLMBR and CLMBR1, LLC (collectively, the “Sellers”) to purchase and acquire substantially all of the assets and assume certain liabilities of the Sellers. On January 22, 2024, the Company and the Sellers entered into an amended and restated Asset Purchase Agreement (the “Amended Agreement”). On February 2, 2024, pursuant to the Amended Agreement, the Company completed the acquisition for a total purchase price of approximately $16.1 million, consisting of (i) cash of $30,000, (ii) 357 shares of the Company’s common stock with an aggregate fair value of $1.0 million, (iii) 1,500,000 shares of the Company’s non-voting Series B preferred stock with an aggregate fair value of $3.0 million, (iv) contingent consideration with a fair value of $1.3 million (as further described below), and (v) the retirement of $9.4 million of senior debt and $1.4 million in related fees, such retirement to be in the form of a $1.4 million cash payment to the lender of the senior debt and the issuance of an $8.0 million promissory note to such lender (the “Acquisition”).
|
|
|
|
|
Consideration |
|
(in thousands) |
|
Cash Paid to Seller |
|
|
30 |
|
Common stock issued |
|
|
1,015 |
|
Series B preferred stock issued |
|
|
2,954 |
|
Payoff of Vertical debt (plus accrued interest) |
|
|
1,447 |
|
Retirement of Vertical Debt (including fees) |
|
|
9,379 |
|
Fair value of earn-out consideration |
|
|
1,300 |
|
Total |
|
|
16,125 |
|
The CLMBR, acquisition was a strategic acquisition that helped accelerate the Company’s commercialization path and help achieve immediate scale, resulting in a high growth, profitable platform that sells connected fitness equipment and digital fitness services across B2B and B2C channels.
The CLMBR acquisition was accounted for as a purchase business combination in accordance with ASC 805 “Business Combinations.” Assets acquired and liabilities assumed were recorded in the condensed consolidated balance sheet at their estimated fair values as of February 2, 2024, with the remaining unallocated purchase price recorded as goodwill.
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands) |
|
Preliminary Purchase Price Allocation as of February 2, 2024 (a) |
|
|
Measurement Period Adjustments (b) |
|
|
Purchase Price Allocation as of February 2, 2024 (a) (as adjusted) |
|
Cash |
|
$ |
50 |
|
|
$ |
— |
|
|
$ |
50 |
|
Accounts receivable, net of allowances |
|
|
134 |
|
|
|
(8 |
) |
|
|
126 |
|
Inventories, net |
|
|
3,490 |
|
|
|
70 |
|
|
|
3,560 |
|
Vendor deposits |
|
|
61 |
|
|
|
— |
|
|
|
61 |
|
Prepaid expenses and other current assets |
|
|
63 |
|
|
|
— |
|
|
|
63 |
|
Property and equipment, net |
|
|
139 |
|
|
|
— |
|
|
|
139 |
|
Right-of-use-assets |
|
|
412 |
|
|
|
— |
|
|
|
412 |
|
Other assets |
|
|
30 |
|
|
|
200 |
|
|
|
230 |
|
Goodwill |
|
|
13,165 |
|
|
|
55 |
|
|
|
13,220 |
|
Intangible assets, net |
|
|
6,900 |
|
|
|
(700 |
) |
|
|
6,200 |
|
Total assets acquired |
|
$ |
24,444 |
|
|
$ |
(383 |
) |
|
$ |
24,061 |
|
Accounts payable |
|
|
(3,557 |
) |
|
|
326 |
|
|
|
(3,231 |
) |
Accrued expenses and other current liabilities |
|
|
(2,438 |
) |
|
|
163 |
|
|
|
(2,275 |
) |
Operating lease liability, current portion |
|
|
(263 |
) |
|
|
— |
|
|
|
(263 |
) |
Deferred revenue |
|
|
(261 |
) |
|
|
160 |
|
|
|
(101 |
) |
Loan payable |
|
|
(1,887 |
) |
|
|
— |
|
|
|
(1,887 |
) |
Operating lease liability, net of current portion |
|
|
(179 |
) |
|
|
— |
|
|
|
(179 |
) |
Net assets acquired |
|
$ |
15,859 |
|
|
$ |
266 |
|
|
$ |
16,125 |
|
(a) As previously reported in the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2024.
(b) The adjustments to goodwill resulted from finalization of assets acquired and liabilities assumed as the Company obtained additional information during the measurement period. The purchase price allocation period closed as of December 31, 2024.
The Company recorded a step-up in the fair value of inventory of approximately $0.6 million and is being amortized through Cost of Fitness product as the underlying product is sold.
The identified intangible assets of $6.2 million are comprised of hardware developed technology of $1.1 million that have an estimated useful life of 7 years, software developed technology of $0.3 million that have an estimated useful life of 4 years, hardware distribution of $3.7 million that have an estimated useful life of 13 years, direct-to-customer subscription of $0.3 million that have an estimated useful live of 9 years, and trademarks and trade name of $0.8 million that have an estimated useful life of 9 years. Significant assumptions utilized in the valuation of identified intangible assets were based on company specific information and projections which are not observable in the market and are thus considered Level 3 measurements as defined by U.S. GAAP. Estimated annual amortization expense for each of the next five fiscal years is included in Note 7.
Accrued Earn Out
As part of the Acquisition of CLMBR, Inc., the Sellers shall be entitled to receive a contingent payment in the form of shares of Common Stock (collectively, the “Earn-Out Shares”) calculated in the manner set forth in the Asset Purchase Agreement based on the 2024 Unit Sales (as defined in the Asset Purchase Agreement) and the volume-weighted average price (“VWAP”) for the Company’s common stock based on the 10 consecutive trading days ending on (and including) December 31, 2024, subject to the VWAP Collar. In addition, there were 2 contingent payments (1) based on total CLMBR sales in 2024 (5,000 units sold in 2024) and (2) based on CLMBR sales through B2B channel in 2024 (2,400 in B2B channel in 2024). Contingent payment (1) was determined at inception to be remote and therefore, $0 was recognized for the earn out as of the acquisition date. Contingent payment (2) was probable and a contingent liability of $1.3 million was recorded based on in the event the 2024 Unit Sales include at least 2,400 Units sold in the business-to-business channel, the Sellers shall be entitled to an additional number of Earn-Out Shares calculated in the manner set forth in the Asset Purchase Agreement subject to total maximum number of 5,666 Earn-Out Shares. The Company assessed the fair value as of December 31, 2024 and it was determined based on current sales that achieving the projection and likelihood of contingent payment (2) was deemed remote and as a result the Company marked the contingent liability to $0 in 2024.
The following unaudited pro forma summary presents condensed consolidated information of the Company, including CLMBR as if the. acquisition had occurred as of January 1, 2024, the earliest year presented herein:
|
|
|
|
|
|
|
|
Proforma |
|
|
Three Months Ended March 31, |
|
|
2024 |
|
|
|
|
(in thousands) |
Revenue |
|
$ |
473 |
|
|
Operating Loss |
|
|
(9,633 |
) |
|
Net Loss |
|
|
(11,608 |
) |
|
Net loss per share – basic and diluted |
|
$ |
(2,732.19 |
) |
|
The unaudited pro forma consolidated results for the three month periods were prepared using the acquisition method of accounting and are based on the historical financial information of CLMBR, Inc. and the Company. The unaudited pro forma consolidated results incorporate historical financial information for all significant acquisitions pursuant to SEC regulations since January 1, 2024. The historical financial information has been adjusted to give effect to pro forma adjustments that are: (i) directly attributable to the acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results. The unaudited pro forma consolidated results are not necessarily indicative of what the Company’s consolidated results of operations actually would have been had it completed these acquisitions on January 1, 2024. The following unaudited condensed consolidated results of operations included in the condensed consolidated statements of loss for the three months ended March 31, 2024.
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
2024 |
|
|
Revenue |
|
$ |
267 |
|
|
Operating Loss |
|
|
(173 |
) |
|
Net Loss |
|
|
(279 |
) |
|
23. Subsequent Events
The Company has evaluated subsequent events through the financial statement issuance date, pursuant to ASC 855-10 Subsequent Events.
Binding LOI
On April 8, 2025, the Company entered into an Agreement for the Sale and Purchase of the Entire Issued Share Capital and Loan Notes of Wattbike (Holdings) Limited (“Wattbike”) (the “Purchase Agreement”) with the shareholders of Wattbike and holders of certain promissory notes (the “Notes’) issued by Wattbike (the “Noteholders,” and together with the Shareholders, the “Sellers”) to acquire the entire issued share capital and Notes of Wattbike (the “Transaction”).
Pursuant to the Purchase Agreement, the Company would acquire all of the issued and outstanding shares of Wattbike held by the Shareholders in exchange for £1.00, payable at the closing of the Transaction (the “Closing”). In addition, the Company would acquire the Notes in exchange for paying the Noteholders (a) shares of the Company’s Series E Preferred Stock, par value $0.0001 per share (“Series E Preferred Stock”) to be newly created, which upon the mandatory conversion date of June 15, 2026, will be convertible into the Company’s common stock, par value $0.0001 per share (“Common Stock”), payable at Closing (the “Initial Consideration”), and (b) subject to the satisfaction of applicable milestones, additional consideration consisting of Common Stock:
(i)If the revenues of Wattbike for the period from October 1, 2025 to September 30, 2026 (“FY26”) (“FY26 Revenues”) exceed £17,500,000, the additional consideration for FY26 shall be an amount equal to 50% of the amount by which FY26 revenues exceeded £17,500,000, subject to a cap of £1,500,000. If FY26 Revenues did not exceed £17,500,000, there shall be no additional consideration paid for FY26.
(ii)If the revenues of Wattbike for the period from October 1, 2026 to September 30, 2027 (“FY27”) (“FY27 Revenues”) exceed £20,000,000, the additional consideration for FY27 shall be an amount equal to 50% of the amount by which FY26 revenues exceeded £20,000,000, subject to a cap of £1,500,000. If FY27 Revenues did not exceed £20,000,000, there shall be no additional consideration paid for FY27.
The Closing is subject to: (a) the receipt of Wattbike of the written consent (the “FCA Consent”) from the Financial Conduct Authority in the United Kingdom (“FCA”) regarding the change of control of Wattbike on Closing pursuant to the terms of its authorization from the FCA to carry out consumer credit activities, or (b) if the FCA Consent is not provided to Wattbike prior to July 31, 2025, Wattbike shall have received written confirmation from the FCA that Wattbike’s authorization from the FCA to carry out consumer credit activities has been cancelled. If this condition is not satisfied on or before September 30, 2026, or an Insolvency Event (as defined in the Purchase Agreement) occurs, the Purchase Agreement shall be terminated automatically on September 30, 2026, or on the date that the Insolvency Event occurs.
Pursuant to the Purchase Agreement, the Warrantors (as defined in the Purchase Agreement) undertake to the Company that, during the period beginning on the date of the Purchase Agreement and ending at the earliest of (i) the Closing, (ii) September 30, 2026, and (iii) the termination of the Purchase Agreement, they shall use reasonable endeavors to procure that Wattbike and its subsidiaries operate within a 10% margin of the Total Budgeted Costs (as defined in the Purchase Agreement). If the Company is not satisfied that Wattbike and its subsidiaries have operated within such 10% margin, then the Company shall have the right to terminate the Purchase Agreement by paying to the Noteholders the Initial Consideration as a break fee.
In the Purchase Agreement, each of the Company and the Sellers have made customary representations, warranties and covenants. The Transaction is expected to close as early as the second quarter of 2025, subject to the satisfaction or waiver (if permitted) of customary conditions, including, among others, the receipt of any required stockholder approval and contemplation of applicable regulatory filings.
The board of directors of the Company and the Shareholders have approved the Purchase Agreement and the transactions contemplated therein.
Preferred Stock Dividends
Pursuant to the Certificate of Designations of Series C Preferred Stock, on April 17, 2025, the Board of Directors of the Company declared a dividend on the shares of Series C Preferred Stock issued and outstanding as of the record date for such dividend, as a dividend in kind, in the form of 46,727 shares of Series C Preferred Stock in the aggregate.
Pursuant to the Certificate of Designations of Series A Preferred Stock, on January 23, 2025, the Board of Directors of the Company declared a dividend on the shares of Series A Preferred Stock issued and outstanding as of the record date for such dividend, as a dividend in kind, in the form of 81,464 shares of Series A Preferred Stock in the aggregate.
The Company issued the Series A Preferred Stock and Series C Preferred Stock dividend shares on April 17, 2025.
Vendor Settlement
Prior to May 1, 2025, the Company received advisory services from Berenberg Capital Markets LLC (the “Recipient”). As of May 1, 2025, the Company owed the Recipient $0.5 million (the “Liability”). On May 1, 2025, the Company and the Recipient entered into a Settlement Agreement, pursuant to which the Company and the Recipient agreed to settle the Liability by issuing to the Recipient an unsecured promissory note in the principal amount of $0.5 million (the “Settlement Note”). The Settlement Note has a maturity date of May 1, 2026 and accrues interest at a rate of 5% per annum.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes and other financial information included in Part I, Item 1. of this Form 10-Q, and together with our audited condensed consolidated financial statements and the related notes and other information for the year ended December 31, 2024. Historic results are not necessarily indicative of future results.
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” “trajectory” or the negative of these terms or other comparable terms. However, the absence of these words does not mean that the statements are not forward-looking. Forward-looking statements include, but are not limited to, statements regarding:
•our future financial performance, including our expectations regarding our revenue, cost of revenue, gross profit, operating expenses including changes in research and development, sales and marketing, and general and administrative expenses (including any components of the foregoing), and our ability to achieve and maintain future profitability;
•our business model, growth strategy, and our ability to effectively manage our growth, the factors which may affect our performance and the potential impact thereof and the potential significance and indicators and impact of our key operational and business metrics;
•anticipated trends, growth rates, and challenges in our business and in the markets in which we operate;
•our market opportunity, including our potential or anticipated growth of the fitness and wellness industry, including the smart home gym and connected fitness sector of this industry;
•market acceptance of our connected fitness hardware and services;
•beliefs and objectives for future operations, products, and services;
•our ability to maintain and increase sales of our CLMBR and FORME Studio equipment, increase memberships to the CLMBR and Forme platform, and expand our product and service offerings;
•our ability to attract and retain qualified trainers, including personal trainers, and to contract with fitness instructors and other content production personnel;
•our expectations regarding potential changes to our membership or pricing models or to our products and services;
•our plans to expand our commercial and corporate wellness customer base;
•our ability to develop new content, features, equipment, and other services to integrate with or complement the CLMBR and FORME platform and bring them to market in a timely manner;
•our expectations regarding content costs included in our products and services;
•the effects of seasonal trends on our results of operations;
•our expectations concerning relationships with third-party manufacturers, suppliers, content providers, ecosystem partners, and other third parties, as well as current and potential strategic relationships;
•our expectations regarding our manufacturing and supply chain, including any defects or warranty claims;
•our ability to maintain, protect, and enhance our intellectual property;
•our international expansion plans and ability to continue to expand internationally;
•the effects of increased competition in our markets and our ability to compete effectively;
•our ability to stay in compliance with laws and regulations that currently apply or become applicable to our business both in the United States and internationally;
•economic and industry trends, projected growth, or trend analysis;
•our liquidity position, capital requirements and need for additional financing;
•our expectations regarding the period during which we qualify as an emerging growth company under the JOBS Act and as a smaller reporting company; and
•the imposition of new tariffs or changes in existing tariff rates.
These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause or contribute to a material difference include those discussed below and under Item 1A. Risk Factors, as well as the risks discussed in the Company’s other filings with the Securities and Exchange Commission (the “SEC”). All forward-looking statements set forth in this Quarterly Report are qualified by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequence to or effects on the Company or its business or operations. Forward-looking statements set forth in this Quarterly Report speak only as of the date hereof, and we do not undertake any obligation to update forward-looking statements to reflect subsequent events or circumstances, changes in expectations or the occurrence of unanticipated events, except to the extent required by law. You should carefully read the “Risk Factors” section to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements.
Overview
Interactive Strength Inc. is the parent company of two leading brands serving the commercial and at-home markets with specialty fitness equipment and virtual training: CLMBR and FORME. CLMBR manufactures vertical climbing equipment and provides a unique digital and on-demand training platform. FORME is a hardware manufacturer and digital fitness service provider that combines award-winning smart gyms with live 1:1 personal training (from real humans) to deliver an immersive experience. The combination of technology with expert training leads to better outcomes for both consumers and trainers alike. CLMBR and FORME offer unique fitness solutions for both the commercial and at-home markets
Key milestones in our growth history include:
•May 2017 – Interactive Strength Inc. founded
•July 2021 – Commenced commercial delivery of FORME Studio (fitness mirror), our first connected fitness hardware product
•July 2022 – Live 1:1 personal training service launched
•August 2022 – Commenced commercial delivery of FORME Studio Lift (fitness mirror and cable-based digital resistance)
•April 2023 – Interactive Strength went public on NASDAQ with ticker TRNR
•February 2024 – Acquired substantially all of the assets of CLMBR, Inc.
Our revenue is primarily generated from the sale of our connected fitness hardware products and associated recurring membership revenue. As we launched our first connected fitness hardware product in July 2021, we began generating revenue from sales of our products starting in the second half of 2021.
During the three months ended March 31, 2025 and 2024, we generated total revenue of $1.4 million and $0.4 million, respectively, and incurred net losses of $(6.6) million and $(11.4) million, respectively. As we generated recurring net losses and negative operating cash flow during the research and development stage of the FORME Studio and FORME Studio Lift products, we have funded our operations primarily with gross proceeds from the sales of our redeemable convertible preferred stock, the sale of our SAFE notes, the issuance of convertible notes, the issuance of promissory notes, and the issuance of common stock.
Business Model and Growth Strategy
Acquire complementary businesses that generate attractive synergies
We acquired CLMBR, Inc. in February 2024 and believe that there are other compelling businesses to be acquired. We expect that we will be able to acquire revenue-generating businesses, which would generate higher earnings and cashflow through synergies with our existing business. Our team has significant experience in M&A and we are one of the few companies in our industry with a public currency, which we believe makes us an attractive acquiror.
Leverage well established equipment distributors to scale in commercial channels
We have high value partnerships with distributors, including Woodway, to sell CLMBR and FORME products into a variety of commercial environments. These relationships allow us to leverage the sales knowledge, relationships and specialization of third parties to accelerate our sales initiatives. Importantly, this construct allows us to make the vast majority of our sales related expenses variable, as we typically pay commissions only when units are sold.
Expand into new geographies
We intend to expand the international reach of our product and service offerings. With more than 180 million people belonging to gyms globally in 2019, according to IHRSA, we believe there is significant opportunity to grow internationally. For example, we are currently evaluating potential international expansion in the United Kingdom and Canada, although we have not yet made any definitive plans regarding such expansion or the potential timing thereof. We plan to continue to pursue disciplined international expansion by targeting countries with high fitness penetration and spend, as well as the presence of boutique fitness, where we believe both CLMBR and FORME’s value propositions will resonate.
Increase uptake of add-on services through compelling member experience
We intend to increase the uptake of our add-on memberships and services by providing compelling member experience focused on introducing our members to the variety of services available on our platform and specifically, the value-added benefits of our coaching and personal training offering. We believe our ability to provide service offerings at a number of price points will serve as a valuable lever for growth by increasing overall service revenues over time.
Reduce the cost of personal training and expand addressable market without sacrificing quality
We intend to continue to explore ways to leverage our products, technology, and proprietary trainer education platform to bring the cost of coaching down incrementally, while maintaining an unwavering focus on the quality of the coaching experience we deliver to our members. This strategy is key to our medium- to long-term objectives, as we believe we can expand the addressable market for coaching services by reducing the per session cost and increasing accessibility of expert coaching services through our hardware and mobile experiences.
Build out partnership ecosystem
We intend to continue to build our strategic partner ecosystem with a focus on relationships that enable us to extend our platform to new audiences. We are pursuing opportunities in a number of attractive verticals, including sports, physical therapy and rehabilitation, and telemedicine. We are continuously identifying and evaluating opportunities to apply our coaching know-how in new and innovative ways to expand our reach and impact.
Expand corporate wellness
We intend to expand our recently launched corporate wellness initiative. Historically, corporate wellness programs were generally one-size-fits-all solutions for employees, such as corporate gyms. The rise of the hybrid workforce has made robust corporate wellness both an imperative and a challenge for many companies. We believe our comprehensive product portfolio makes us a better fit for modern corporate wellness programs than many existing alternatives. Our solution enables corporations to provide all of their employees with a coaching platform regardless of whether they work from home, in the office, or both. Our multi-pronged service offering also provides a new level of customization that can be adapted to employees at virtually all levels of tenure.
Target Sport Specific Markets
We intend to reach sport specific markets, specifically golf, tennis and pickleball, which have historically been underserved by the fitness market. Golf is one of the fastest growing sports in the United States. According to the National Golf Foundation, golf participation grew 10% year-over-year surpassing 41.1 million in 2022. In 2023, on-course golfers rose for the fifth consecutive year. Similarly for tennis, according to data from the United States Tennis Association, and the Tennis Industry Association Participation and Engagement Study, in 2022 there were 23.6 million players, a 33% increase since the beginning of 2020. Pickleball has solidified its status as America's fastest-growing sport for the third consecutive year. According to the 2023 Sports & Fitness Industry Association's (SFIA) Topline Participation Report, participation in pickleball almost doubled in 2022, showing an 85.7 percent increase year-over-year and a staggering 158.6 percent increase over the past three years. Each of these sports, as well as others, benefit greatly from high
quality strength and conditioning as well as the style of training that can be provided by both a cable-based system and vertical climbing. Providing greater access to quality training is a high value service in both commercial and direct to consumer markets.
Factors Affecting Our Performance
Our financial condition and results of operations have been, and will continue to be, affected by a number of factors, including the following:
•We have a limited operating history; and our past financial results may not be a reliable indicator of our ability to successfully establish our product and service offerings in the marketplace, or of our future performance, and our revenue growth rate is likely to slow as our business matures.
•We derive a significant majority of our revenue from sales of our CLMBR, FORME Studio and FORME Studio Lift equipment and if sales of our CLMBR, FORME Studio and FORME Studio Lift equipment decline, it would materially and negatively affect our future revenue and results of operations.
•Our membership revenue is largely dependent on our ability to sell our CLMBR, FORME Studio equipment and if sales of our FORME Studio equipment decline, our membership revenue would decline, and it would materially and negatively affect our future revenue and results of operations. Similarly, we may be unable to attract and retain members, which could have an adverse effect on our business and rate of growth.
•If we fail to compete successfully against existing and future competitors, we may fail to obtain a meaningful market share, which in turn would harm our business, financial condition, and results of operations.
•Increases in component and equipment costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and negatively impact our business, financial condition, and results of operations.
•The sufficiency of our liquidity and capital resources, and our ability to obtain additional funding as needed for our operations and to execute on our strategy.
•Our ability to execute or realize the anticipated benefits of any strategic acquisition or transaction.
We have experienced, and expect to continue to experience, some disruptions to parts of our supply chain, including procuring necessary components or parts in a timely fashion, with suppliers increasing lead times or placing products on allocation and raising prices. In addition, disruptions to commercial transportation infrastructure have increased delivery times for materials and components or parts of our fitness equipment, and has impacted, and could in the future impact, our ability to timely deliver our products to customers. These supply chain disruptions have not materially affected our business outlook and goals or our operating results, including our sales, revenue, or liquidity or capital resources, and we have not implemented any mitigation efforts to date as a result. However, we cannot predict the impact to us of any future or prolonged supply chain disruptions or any mitigation efforts we may take going forward. For example, as a result of these supply chain disruptions, we may be required to increase customer order lead times and place some products on allocation. In addition, we may consider additional or alternative third-party manufacturing and logistics providers or suppliers. Such mitigation efforts may result in cost increases and any attempts to offset such increases with price increases may result in reduced sales, increased customer dissatisfaction, or otherwise harm our reputation. Further, if we were to elect to transition or add manufacturing or logistics providers or suppliers, it may result in temporary or additional delays in product delivery or risks related to consistent product quality or reliability. This in turn may limit our ability to fulfill customer orders and we may be unable to satisfy all of the demand for our products. We may in the future also purchase components further in advance, which in return can result in less capital being allocated to other activities such as marketing and other business needs. We cannot quantify the impact of such disruptions at this time or predict the impact of any mitigation efforts we may take in response to supply chain disruptions on our business, financial condition, and results of operations.
In addition, customer demand for our products may be impacted by weak economic conditions, inflation, weak growth, recession, equity market volatility, or other negative economic factors in the United States or other nations. The United States has recently experienced historically high levels of inflation. If the inflation rate continues to increase, it will likely affect our expenses, including, but not limited to, employee compensation expenses, increased manufacturing and supplier costs, and increasing market prices of certain components, parts, supplies, and commodity raw materials, which are incorporated into our products or used by our suppliers to manufacture our products. These components, parts, supplies, and commodities may from time to time become restricted, or general market factors and conditions may affect pricing of such components, parts, supplies and commodities, such as inflation or supply chain constraints. Given our limited operating history, we cannot predict how ongoing or increasing recessionary or inflationary pressures may impact our business, financial condition, and results of operations in the future.
Components of Our Operating Results
We generate revenue from sales of our connected fitness products, membership revenue, and personal training revenue. We identify our reportable segment based on the information used by management to monitor performance and make operating decisions. See Note 2. of the notes to our condensed consolidated financial statements included elsewhere in this report for additional information regarding our reportable segment.
Revenue
Connected Fitness Product
Connected Fitness Product revenue consists of sales of our connected fitness products and related accessories, delivery and installation services, and extended warranty agreements offered through a third-party. Fitness Product revenue is recognized at the time of delivery, except for extended warranty revenue which is recognized over the warranty period. For the third-party extended warranty service sold along with the connected fitness products, we do not obtain control of the warranty before transferring it to the customers. Therefore, we account for revenue related to the fees paid to the third-party extended warranty provider on a net basis, by recognizing only the net commission we retain. Connected fitness product revenue represented 77% and 15% of total revenue for the three months ended March 31, 2025 and 2024, respectively.
Membership
Membership revenue consists of revenue generated from our monthly Connected Fitness membership. Membership revenue represented 13% and 43% of total revenue for the three months ended March 31, 2025 and 2024, respectively.
Training
Training revenue consists of sales of our personal training services delivered through our connected fitness products and third-party mobile devices. Training revenue is recognized at the time of delivery. Training revenue represented 10% and 43% of total revenue for the three months ended March 31, 2025 and 2024, respectively.
Cost of Revenue
Connected Fitness Product
Connected Fitness Product cost of revenue consists of CLMBR and Studio and Studio Lift and accessories product costs, including manufacturing costs, duties and other applicable importing costs, shipping and handling costs, packaging, warranty replacement costs, fulfillment costs, warehousing costs, and certain allocated costs related to management and facilities expenses associated with supply chain logistics.
Membership
Membership cost of revenue includes costs associated with personnel related expenses, filming and production costs, hosting fees, music royalties, and amortization of capitalized software development costs.
Training
Training cost of revenue includes costs associated with personnel related expenses and rent expense.
Operating Expenses
Research and Development
Research and development expense primarily consists of personnel and facilities-related expenses, engineering costs, consulting and contractor expenses, tooling and prototype materials, and software platform expenses. We capitalize certain qualified costs incurred in connection with the development of internal-use software and software to be sold or marketed which may also cause research and development expenses to vary from period to period.
Sales and Marketing
Sales and marketing expense consists of performance marketing media spend, asset creation, and other brand creative, all showroom expenses and related lease payments, payment processing fees incurred in connection with the sale of our connected fitness products, and sales and marketing personnel-related expenses.
General and Administrative
General and administrative expense includes personnel-related expenses and facilities-related costs primarily for our executive, finance, accounting, legal, human resources, and IT functions. General and administrative expense also includes fees for professional services principally comprised of legal, audit, tax and accounting services, and insurance.
We expect to incur additional general and administrative expenses as a result of operating as a public company, including expenses related to compliance and reporting obligations of public companies, and increased costs for insurance, investor relations expenses, and professional services. As a result, we expect that our general and administrative expenses will increase in absolute dollars in future periods and vary from period to period as a percentage of revenue, but we expect to leverage these expenses over time as we grow our revenue and member base.
Other (Expense) Income, Net
Other (expense) income, net consists of unrealized currency gains and losses, expenses related to equity line of credit commitment, loss on exchange of warrants for equity, and fair value of issuance of Loss Restoration Agreement derivative.
Interest Expense
Interest expense consists of interest associated with the related party loans, term loans, promissory notes and convertible notes.
Interest Income
Interest income consists of interest associated with the loan receivable.
(Gain) loss upon extinguishment of debt and accounts payable
(Gain) loss on debt extinguishment was a result of conversion of promissory loans, convertible notes and senior secured debt into convertible notes.
Change in Fair Value of Convertible Notes
The change in fair value of convertible notes consists of the change in the fair value of the outstanding convertible notes since the previous reporting period
Change in Fair Value of Derivatives
The change in fair value of derivatives consists of the change in the fair value of the outstanding derivatives since the previous reporting period.
Change in Fair Value of Warrants
The change in fair value of warrants consists of the change in the fair value of the outstanding warrants notes since the previous reporting period.
Provision for Income Taxes
The provision for income taxes consists primarily of income taxes related to foreign and state jurisdictions in which we conduct business. We maintain a full valuation allowance on our federal and state deferred tax assets as we have concluded that it is more likely than not that the deferred assets will not be utilized.
Results of Operations
The following tables set forth our condensed consolidated results of operations in dollars and as a percentage of total revenue for the periods presented. The period-to-period comparisons of our historical results are not necessarily indicative of the results that may be expected in the future.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Change |
|
|
|
|
2025 |
|
|
2024 |
|
|
Amount |
|
|
% |
|
|
Revenue: |
|
(in thousands) |
|
|
(in thousands) |
|
|
|
|
|
Fitness product revenue |
|
$ |
1,050 |
|
|
$ |
53 |
|
|
$ |
997 |
|
|
|
1,881 |
% |
|
Membership revenue |
|
|
176 |
|
|
|
155 |
|
|
|
21 |
|
|
|
14 |
% |
|
Training revenue |
|
|
130 |
|
|
|
155 |
|
|
|
(25 |
) |
|
|
(16 |
%) |
|
Total revenue |
|
|
1,356 |
|
|
|
363 |
|
|
|
993 |
|
|
|
274 |
% |
|
Cost of revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of fitness product revenue (2) |
|
|
(917 |
) |
|
|
(379 |
) |
|
|
(538 |
) |
|
|
142 |
% |
|
Cost of membership (2) |
|
|
(423 |
) |
|
|
(1,019 |
) |
|
|
596 |
|
|
|
(58 |
%) |
|
Cost of training |
|
|
(320 |
) |
|
|
(165 |
) |
|
|
(155 |
) |
|
|
94 |
% |
|
Total cost of revenue |
|
|
(1,660 |
) |
|
|
(1,563 |
) |
|
|
(97 |
) |
|
|
6 |
% |
|
Gross loss |
|
|
(304 |
) |
|
|
(1,200 |
) |
|
|
896 |
|
|
|
(75 |
%) |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development (1) |
|
|
1,271 |
|
|
|
2,023 |
|
|
|
(752 |
) |
|
|
(37 |
%) |
|
Sales and marketing (1) (2) |
|
|
250 |
|
|
|
256 |
|
|
|
(6 |
) |
|
|
(2 |
%) |
|
General and administrative (1) (2) |
|
|
4,487 |
|
|
|
5,962 |
|
|
|
(1,475 |
) |
|
|
(25 |
%) |
|
Total operating expenses |
|
|
6,008 |
|
|
|
8,241 |
|
|
|
(2,233 |
) |
|
|
(27 |
%) |
|
Loss from operations |
|
|
(6,312 |
) |
|
|
(9,441 |
) |
|
|
3,129 |
|
|
|
(33 |
%) |
|
Other (expense) income, net: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (expense) income, net: |
|
|
(111 |
) |
|
|
(370 |
) |
|
|
259 |
|
|
|
(70 |
%) |
|
Interest expense |
|
|
(1,764 |
) |
|
|
(2,000 |
) |
|
|
236 |
|
|
|
(12 |
%) |
|
Interest income |
|
|
158 |
|
|
|
— |
|
|
|
158 |
|
|
|
100 |
% |
|
Gain (loss) upon extinguishment of debt and accounts payable |
|
|
3,037 |
|
|
|
(1,066 |
) |
|
|
4,103 |
|
|
|
(385 |
%) |
|
Change in fair value of convertible notes |
|
|
(573 |
) |
|
|
(316 |
) |
|
|
(257 |
) |
|
|
81 |
% |
|
Change in fair value of derivatives |
|
|
(1,487 |
) |
|
|
— |
|
|
|
(1,487 |
) |
|
|
(100 |
%) |
|
Change in fair value of warrants |
|
|
449 |
|
|
|
1,799 |
|
|
|
(1,350 |
) |
|
|
(75 |
%) |
|
Total other expense, net |
|
|
(291 |
) |
|
|
(1,953 |
) |
|
|
1,662 |
|
|
|
(85 |
%) |
|
Loss before provision for income taxes |
|
|
(6,603 |
) |
|
|
(11,394 |
) |
|
|
4,791 |
|
|
|
(42 |
%) |
|
Income tax benefit (expense) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
- |
|
|
Net loss |
|
$ |
(6,603 |
) |
|
$ |
(11,394 |
) |
|
$ |
4,791 |
|
|
|
(42 |
%) |
|
(1)Includes stock-based compensation expense as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
2025 |
|
|
2024 |
|
|
|
(in thousands) |
|
Research and development |
|
$ |
699 |
|
|
$ |
1,231 |
|
Sales and marketing |
|
|
— |
|
|
|
75 |
|
General and administrative |
|
|
1,390 |
|
|
|
2,060 |
|
Total stock-based compensation expense |
|
$ |
2,089 |
|
|
$ |
3,366 |
|
For the three months ended March 31, 2025 and 2024, $0.3 million and $0.2 million of stock-based compensation was capitalized as software costs, respectively.
(2)Includes depreciation and amortization expense as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Change |
|
|
|
|
2025 |
|
|
2024 |
|
|
Amount |
|
|
% |
|
|
|
|
(in thousands) |
|
|
(in thousands) |
|
|
Cost of membership |
|
$ |
423 |
|
|
$ |
1,017 |
|
|
$ |
(594 |
) |
|
|
(58 |
%) |
|
Cost of fitness product revenue |
|
|
158 |
|
|
|
41 |
|
|
|
117 |
|
|
|
285 |
% |
|
General and administrative |
|
|
300 |
|
|
|
712 |
|
|
|
(412 |
) |
|
|
(58 |
%) |
|
Sales and marketing |
|
|
131 |
|
|
|
92 |
|
|
|
39 |
|
|
|
42 |
% |
|
Total depreciation and amortization expense |
|
$ |
1,012 |
|
|
$ |
1,862 |
|
|
$ |
(850 |
) |
|
|
(46 |
%) |
|
Comparison of the three months ended March 31, 2025 and 2024
Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Change |
|
|
|
2025 |
|
|
2024 |
|
|
Amount |
|
|
% |
|
Revenue: |
|
(in thousands) |
|
|
|
|
|
|
|
Fitness product |
|
$ |
1,050 |
|
|
$ |
53 |
|
|
$ |
997 |
|
|
1881% |
|
Membership |
|
|
176 |
|
|
|
155 |
|
|
|
21 |
|
|
14% |
|
Training |
|
|
130 |
|
|
|
155 |
|
|
|
(25 |
) |
|
-16% |
|
Total revenue |
|
|
1,356 |
|
|
|
363 |
|
|
|
993 |
|
|
274% |
|
Percentage of revenue |
|
|
|
|
|
|
|
|
|
|
|
|
Fitness product |
|
|
77 |
% |
|
|
15 |
% |
|
|
|
|
|
|
Membership |
|
|
13 |
% |
|
|
43 |
% |
|
|
|
|
|
|
Training |
|
|
10 |
% |
|
|
43 |
% |
|
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
|
For the three months ended March 31, 2025, the Company reported total Fitness product revenue of $1.1 million, compared to $0.05 million for the comparable prior year period, representing an increase of $1.0 million, or 1881%. The increase in Fitness Product revenue was the result of the acquisition of CLMBR, Inc. in February 2024 and increased units sold through distribution agreement signed with Woodway in February 2024.
For the three months ended March 31, 2025, the Company reported total Membership revenue of $0.2 million, compared to $0.2 million for the comparable prior year period, representing an increase of $0.02 million, or 14%. The increase in Membership revenue was the result of the acquisition of CLMBR, Inc. in February 2024.
For the three months ended March 31, 2025, the Company reported total Training revenue of $0.1 million, compared to $0.2 million for the comparable prior year period, representing an decrease of $0.03 million, or 16%. The decrease was a result of a decrease in Live 1:1 training sessions.
Cost of Revenue and Gross Loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Change |
|
|
2025 |
|
|
2024 |
|
|
Amount |
|
|
% |
Cost of Revenue: |
|
(in thousands) |
|
|
|
|
|
|
Fitness product |
|
$ |
917 |
|
|
$ |
379 |
|
|
$ |
538 |
|
|
142% |
Membership |
|
|
423 |
|
|
|
1,019 |
|
|
|
(596 |
) |
|
(58%) |
Training |
|
|
320 |
|
|
|
165 |
|
|
|
155 |
|
|
94% |
Total cost of revenue |
|
|
1,660 |
|
|
|
1,563 |
|
|
|
97 |
|
|
6% |
Gross Loss: |
|
|
|
|
|
|
|
|
|
|
|
Fitness product |
|
|
133 |
|
|
|
(326 |
) |
|
|
459 |
|
|
(141%) |
Membership |
|
|
(247 |
) |
|
|
(864 |
) |
|
|
617 |
|
|
(71%) |
Training |
|
|
(190 |
) |
|
|
(10 |
) |
|
|
(180 |
) |
|
1800% |
Total gross loss |
|
|
(304 |
) |
|
|
(1,200 |
) |
|
|
896 |
|
|
(75%) |
Gross Margin: |
|
|
|
|
|
|
|
|
|
|
|
Fitness product |
|
|
13 |
% |
|
|
(615 |
%) |
|
|
|
|
|
Membership |
|
|
(140 |
%) |
|
|
(557 |
%) |
|
|
|
|
|
Training |
|
|
(146 |
%) |
|
|
(6 |
%) |
|
|
|
|
|
Total |
|
|
(22 |
%) |
|
|
(331 |
%) |
|
|
|
|
|
For the three months ended March 31, 2025, the Company reported total Fitness product cost of revenue of $0.9 million, compared to $0.4 million for the comparable prior year period, representing an increase of $0.5 million, or 142%. The increase is mostly due to the increase in sales related to the acquisition of CLMBR, Inc. in February 2024 and increase in units sold through distribution agreement signed with Woodway in February 2024.
For the three months ended March 31, 2025, the Company reported total Membership cost of revenue of $0.4 million, compared to $1.0 million for the comparable prior year period, representing a decrease of $0.6 million, or 58%. The decrease is primarily related to the decrease in content amortization offset by increase in amortization of intangible assets from the acquisition of CLMBR, Inc.
For the three months ended March 31, 2025, the Company reported total Training cost of revenue of $0.3 million, compared to $0.2 million for the comparable prior year period, representing an increase of $0.2 million, or 94%. The increase is primarily attributable to the acquisition of CLMBR, Inc. with addition of in-training studio expenses including rent of $0.1 million.
Our gross loss decreased by $0.9 million or 75% for the three months ended March 31, 2025 compared to the three months ended March 31, 2024, mostly due the increase in fitness product sales from the acquisition of CLMBR, Inc. and increase in units sold through distribution agreement signed with Woodway in February 2024.
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Change |
|
|
|
2025 |
|
|
2024 |
|
|
Amount |
|
|
% |
|
Operating Expenses: |
|
(in thousands) |
|
|
|
|
|
|
|
Research and development |
|
$ |
1,271 |
|
|
$ |
2,023 |
|
|
$ |
(752 |
) |
|
(37%) |
|
Sales and marketing |
|
|
250 |
|
|
|
256 |
|
|
|
(6 |
) |
|
(2%) |
|
General and administrative |
|
|
4,487 |
|
|
|
5,962 |
|
|
|
(1,475 |
) |
|
(25%) |
|
Total operating expenses |
|
|
6,008 |
|
|
|
8,241 |
|
|
$ |
(2,233 |
) |
|
(27%) |
|
Research and Development
Research and development expense decreased $0.8 million or 37% for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024 due to a decrease in personnel-related costs of $0.1 million, a decrease in stock-based compensation expense of $0.5 million, and a decrease of $0.2 million in software and subscriptions.
Sales and Marketing
Sales and marketing expense was flat for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024 driven by increase in demo units of $0.04 million and content amortization of $0.04 million offset by decrease in stock-based compensation of $0.1 million.
General and Administrative
General and administrative expense decreased $1.5 million or 25% for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024. The decrease was driven by decrease of $0.7 million in stock-based compensation expense, a decrease of $0.4 million in consulting, a decrease of $0.4 million in depreciation and amortization, and decease in personal related expenses of $0.5 million, offset by increase in vendor settlements of $0.5 million, with the remaining difference due to change in other miscellaneous expenses.
Other (Expense) Income, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
Change |
|
|
|
2025 |
|
|
2024 |
|
|
Amount |
|
|
% |
|
Other (expense) income, net |
|
(in thousands) |
|
|
|
|
|
|
|
Other (expense) income, net: |
|
$ |
(111 |
) |
|
$ |
(370 |
) |
|
$ |
259 |
|
|
(70%) |
|
Interest expense |
|
|
(1,764 |
) |
|
|
(2,000 |
) |
|
|
236 |
|
|
(12%) |
|
Interest income |
|
|
158 |
|
|
|
— |
|
|
|
158 |
|
|
100% |
|
Gain (loss) upon extinguishment of debt and accounts payable |
|
|
3,037 |
|
|
|
(1,066 |
) |
|
|
4,103 |
|
|
(385%) |
|
Change in fair value of convertible notes |
|
|
(573 |
) |
|
|
(316 |
) |
|
|
(257 |
) |
|
81% |
|
Change in fair value of derivatives |
|
|
(1,487 |
) |
|
|
— |
|
|
|
(1,487 |
) |
|
(100%) |
|
Change in fair value of warrants |
|
|
449 |
|
|
|
1,799 |
|
|
|
(1,350 |
) |
|
(75%) |
|
Total other expense, net |
|
$ |
(291 |
) |
|
$ |
(1,953 |
) |
|
$ |
1,662 |
|
|
(85%) |
|
Other (Expense) Income, net
Other (expense) income increased $0.3 million for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024 driven by loss on issuance of warrants for convertible notes of $0.1 million for the three months ended March 31, 2025
offset by issuance of common stock to lender in connection with entering Equity Line of Credit Agreement of $0.4 million for the three months ended March 31, 2024, with the remaining immaterial differences attributable to foreign currency adjustments.
Interest Expense
Interest expense decreased $0.2 million for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024. The decrease in interest expense was attributable to decrease in interest from December 2023 convertible note of $0.4 million, decrease in interest from Term Loan of $0.3 million, decrease in interest from February 2024 convertible note of $0.9 million, and decrease in interest expense attributable to Equity Line of Credit of $0.2 million, offset by an increase of $1.1 million in amortization and interest expense from the January 2025 and March 2025 convertible notes and interest portion of vendor settlement of $0.6 million
Interest Income
Interest income increased $0.2 million for the three months ended March 31, 2025, as compared to the three months ended March 31, 2024 as a result of loan agreement entered into with Sportstech in January 2025.
Gain (loss) on extinguishment of debt and accounts payable
Gain (loss) on extinguishment of debt and accounts payable was a result of gain on conversion of convertible notes of $2.8 million for the three months ended March 31, 2025 and gain on settlement of loss restoration agreement of $0.2 million compared to a loss of $1.1 million from conversion of debt and accounts payable to Series A Preferred Stock for the three months ended March 31, 2024.
Change in Fair Value of Derivatives
Change in fair value of derivatives was a result of change in fair value of loss restoration agreements of $2.6 million offset by change in fair value of derivatives from the January 2025 and March 2025 convertible notes.
Change in Fair Value of Convertible Notes and Change in Fair Value of Warrants
Change in fair value of convertible notes and warrants for the three months ended March 31, 2025 and 2024 were due to change in fair value of these financial instruments.
Liquidity and Capital Resources
In accordance with Accounting Standards Update ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), or ASU 205-40, management evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying condensed consolidated financial statements were issued.
As an emerging growth company, the Company is subject to certain inherent risks and uncertainties associated with the development of an enterprise. In this regard, since the Company’s inception, substantially all of management’s efforts have been devoted to making investments in research and development including the development of revenue generating products and services and the development of a commercial organization, all at the expense of short-term profitability.
As of the date the accompanying condensed consolidated financial statements were issued (the “issuance date”), management evaluated the following adverse conditions and events present at the Company in accordance with ASU 205-40:
•The Company has incurred significant operating losses and used net cash flows in its operations since its inception. In this regard, the Company incurred a net operating loss of $6.3 million and used net cash in its operations of $3.5 million during the three months ended March 31, 2025, and had an accumulated deficit of $209.4 million as of March 31, 2025.
•In order to execute its emerging growth strategy, the Company has been heavily dependent on financing from lenders and capital from private and public investors (collectively “outside capital”) since its inception and expects to remain heavily dependent on outside capital for the foreseeable future until such time that the Company’s operations reach a scale of profitability that allows it to fund its obligations primarily with cash inflows from operations. However, management can provide no assurance the Company will ever be able to generate sufficient cash inflows to reduce or eliminate its reliance on outside capital.
•The Company’s available liquidity to fund its operations over the next twelve months beyond the issuance date was limited to approximately $0.5 million of unrestricted cash and cash equivalents. However, based on the Company’s anticipated liquidity needs, the foregoing available liquidity will not be sufficient to fund the Company’s obligations as they become over the next year beyond the issuance date due absent management’s ability to secure additional outside capital.
•While the Company is actively seeking to secure additional outside capital (and has historically been able to successfully secure such capital), no additional outside capital has been secured or was deemed probable of being secured as of the issuance date. In addition, management can provide no assurance the Company will be able to secure additional outside capital or on acceptable terms.
•Included in the Company’s anticipated liquidity needs is a substantial amount of outstanding debt that is scheduled to mature over the next twelve months beyond the issuance date. As of disclosed in Notes 11 and 21, the Company had total outstanding debt, including convertible notes, of approximately $10.9 million as of the issuance date, of which approximately $9.0 million is scheduled to mature over the next twelve months beyond the issuance date, for which the Company does not have sufficient liquidity to repay if a cash settlement is required. In the event the Company is unable to refinance its outstanding debt, settle some or all of the debt with shares of the Company’s common or preferred stock, secure additional outside capital, and/or secure amendments or waivers from its lenders to defer or modify the repayment terms, management will be required to seek other strategic alternatives to settle this indebtedness, which may include, among others, a significant curtailment of the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors, and/or allowing the Company to become insolvent by filing for bankruptcy protection under the provisions of the U.S. Bankruptcy Code.
•In the past, the Company has been unable to remain in compliance with certain qualifications required by the Nasdaq Capital Markets in order for the Company’s common stock to remain listed on the Nasdaq. These requirements include a minimum stockholders’ equity balance of $2.5 million, a minimum of 500,000 publicly held shares, and a minimum trading price of $1.00 per share for a sustained period of time (collectively the “Rules”). The Company received two notices from the Listing Qualifications staff of the Nasdaq (the “Staff”) with respect to the Company’s noncompliance with these requirements, as follows:
•The first notice dated August 22, 2023, notified the Company that it did not comply with the minimum $2.5 million stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b)(1) (the “Rule 1”) but was granted a period of time to regain compliance. On November 25, 2024, the Company received a letter from the Staff stating that the Company has demonstrated compliance with Rule 1. The letter also stated that the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with the requirements of Nasdaq Listing Rule 5815(d)(4)(B). If, within that one-year monitoring period, the Staff finds that the Company failed to remain in compliance with Rule 1, the Company will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency, the Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, and the Company will not be afforded an applicable cure or compliance period. Instead, the Staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing with the Panel. While the Company will have the opportunity to present to the Panel, no assurance can be provided that the Staff will grant the Company a compliance plan and allow the Company’s securities to remain listed on the Nasdaq.
•The second notice dated November 13, 2024 notified the Company that it did not comply with the minimum 500,000 publicly held shares requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(4) (“Rule 2”) but was granted a period of time to regain compliance. On December 23, 2024, the Company received a letter from the Staff confirming that the Company has demonstrated compliance with Rule 2. The letter also stated that the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with the requirements of Nasdaq Listing Rule 5815(d)(4)(B). If, within that one-year monitoring period, the Staff finds that the Company failed to remain in compliance with Rule 2, the Company will not be permitted to provide the Staff with a plan of compliance with respect to that deficiency, the Staff will not be permitted to grant additional time for the Company to regain compliance with respect to that deficiency, and the Company will not be afforded an applicable cure or compliance period. Instead, the Staff will issue a Delist Determination Letter and the Company will have an opportunity to request a new hearing with the Panel. While the Company will have the opportunity to present to the Panel, no assurance can be provided that the Staff will grant the Company a compliance plan and allow the Company’s securities to remain listed on the Nasdaq.
•As of March 31, 2025 and through the issuance date, the Company was in compliance with the Rules. However, management can provide no assurance that the Company will be able to remain in compliance with the Rules over the next twelve months beyond the issuance date and, if compliance is not maintained, the Staff will not require the Company’s securities to be delisted from the Nasdaq. If a delisting occurs, the Company will be faced with a number of material adverse consequences, including limited availability of market quotations for its common stock; limited news and analyst coverage; decreased ability to obtain additional financing; limited liquidity for the Company’s stockholders due to thin trading; and a potential loss of confidence by investors, employees and other third parties who do business with the Company.
These uncertainties raise substantial doubt about our ability to continue as a going concern. The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable
future. Accordingly, the accompanying condensed consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties.
Cash Flows
Comparison of the three months ended March 31, 2025 and 2024
|
|
|
|
|
|
|
|
|
(in thousands) |
|
2025 |
|
|
2024 |
|
Net cash used in operating activities |
|
$ |
(3,545 |
) |
|
$ |
(2,959 |
) |
Net cash used in investing activities |
|
|
(2,191 |
) |
|
|
(1,710 |
) |
Net cash provided by financing activities |
|
|
7,771 |
|
|
|
4,615 |
|
Effect of exchange rate on cash |
|
|
34 |
|
|
|
54 |
|
Net Change In Cash and Cash Equivalents |
|
$ |
2,069 |
|
|
$ |
— |
|
Operating Activities
Net cash used in operating activities of $3.5 million for the three months ended March 31, 2025, was primarily due to a net loss of $6.6 million, gain on extinguishment of debt and accounts payable of $3.0 million, decrease in operating assets and liabilities of $0.7 million, interest income on loan receivable of $0.2 million, and change in the fair value of warrants of $0.4 million offset by depreciation and amortization of $0.9 million, stock-based compensation of $2.1 million, amortization of debt discount and non cash interest of $1.7 million, change in fair value of derivatives of $1.5 million, loss on settlement of accounts payable of $0.6 million and change in fair value of convertible notes of $0.6 million.
Net cash used in operating activities of $2.9 million for the three months ended March 31, 2024, was primarily due to a net loss of $11.4 million, change in fair value of warrants of $1.8 million, offset by depreciation and amortization of $1.9 million, stock-based compensation of $3.4 million, partially offset by loss on debt extinguishment of $1.1 million, amortization of debt discount of $1.3 million, interest of $0.7 million, $0.3 million of warrants issued to service providers, $0.3 million common stock issued to lender, $0.3 million change in fair value of convertible notes, and an increase in operating assets and liabilities of $0.9 million due to a increase in accrued and other current liabilities.
Investing Activities
Net cash used in investing activities of $2.2 million for the three months ended March 31, 2025 related to acquisition of software and content of $0.2 million and loan agreement entered into with Sportstech of $2.0 million.
Net cash used in investing activities of $1.7 million for the three months ended March 31, 2024 related to acquisition of software and content offset by the acquisition of CLMBR, Inc. net of cash acquired.
Financing Activities
Net cash provided by financing activities of $7.8 million for the three months ended March 31, 2025 was primarily from the issuance of convertible notes of $6.2 million and At the Market Offering proceeds of $1.6 million.
Net cash provided by financing activities of $4.6 million for the three months ended March 31, 2024 was primarily from the issuance of convertible notes of $4.8 million offset by the payment of related party loans of $0.2 million.
Contractual Obligations and Other Commitments
Off-Balance Sheet Arrangements
In accordance with ASC 718, when a nonrecourse note is used to fund the exercise of a stock option, the stock option is not considered “exercised” for accounting purposes until the employee repays the loan. Prior to repayment of a nonrecourse loan, the outstanding shares received in exchange for the loan are excluded from the denominator of basic earnings per share. Additionally, the nonrecourse loan itself is not recorded on the Company’s condensed consolidated balance sheet since the arrangement is, in substance, a stock option.
In 2022, the sale of the shares of common stock to several employees was completed in the form of issuances of Secured Partial Recourse Promissory Notes (the “Note(s)”) by the respective employee to the Company.
The Notes were in the aggregate amount of $154,875 and 24 shares as of March 31, 2025 and December 31, 2024. The Notes are secured by a pledge of collateral, representing the shares of stock sold. Interest is charged at the mid-term Applicable Federal Rate as of the date of the Note and compounded annually. Per the terms of the Notes, 51% of the initial amounts of the outstanding principal balances plus any accrued and unpaid interest, represent a full recourse note, and 49% of the initial amounts represent a nonrecourse note. The
Company analyzed the terms of the Notes and concluded that the recourse portion of the notes are nonrecourse in nature as the Company does not have intention to seek repayment beyond the shares issued despite the recourse legal terms, and thus will be treated the same as the nonrecourse portion of the Notes. All Notes are outstanding as of March 31, 2025, and are not recorded on the condensed consolidated balance sheet.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. In preparing the condensed consolidated financial statements, we make estimates and judgments that affect the reported amounts of assets, liabilities, stockholders’ equity/deficit, revenue, expenses, and related disclosures. We re-evaluate our estimates on an on-going basis. Our estimates are based on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Because of the uncertainty inherent in these matters, actual results may differ from these estimates and could differ based upon other assumptions or conditions. The critical accounting policies that reflect our more significant judgments and estimates used in the preparation of our condensed consolidated financial statements include those noted below.
Our critical accounting policies are described under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in our Form 10-K and in Note 2. to our consolidated financial statements included in our Form 10-K. As disclosed in Note 2. to our consolidated financial statements included in our Form 10-K, the preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ significantly from those estimates. During the period covered by this Quarterly Report, there were no material changes to our critical accounting policies from those discussed in our Form 10-K other than those disclosed in Note 2. of this Quarterly Report.
Emerging Growth Company and Smaller Reporting Company Status
Under Section 107(b) of the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, an “emerging growth company” can delay the adoption of new or revised accounting standards until such time as those standards would apply to private companies. We have elected this exemption to delay adopting new or revised accounting standards until such time as those standards apply to private companies. Where allowable we have early adopted certain standards as described in Note 2. of our condensed financial statements included elsewhere in this report. As a result, our condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. We will continue to remain an “emerging growth company” until the earliest of the following: (i) the last day of the fiscal year following the fifth anniversary of the date of the completion of our initial public offering; (ii) the last day of the fiscal year in which our total annual gross revenue is equal to or more than $1.235 billion; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under the rules of the SEC. We are also a “smaller reporting company,” meaning that the market value of our stock held by non-affiliates is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250.0 million or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.
Item 3. Quantitative and Qualitative Disclosure About Market Risk
Foreign Currency Risk
To date, all of our inventory purchases have been denominated in U.S. dollars. A portion of our operating expenses are incurred outside the United States and are denominated in foreign currencies, which are also subject to fluctuations due to changes in foreign currency exchange rates. In addition, our suppliers incur many costs, including labor and supply costs, in other currencies. While we are not currently contractually obligated to pay increased costs due to changes in exchange rates, to the extent that exchange rates move unfavorably for our suppliers, they may seek to pass these additional costs on to us, which could have a material impact on our gross margins. Our operating results and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. However, we believe that the exposure to foreign currency fluctuation from operating expenses is relatively small at this time as the related costs do not constitute a significant portion of our total expenses. To date, we have not entered into derivatives or hedging transactions, as our exposure to foreign currency exchange rates has historically been partially hedged as our foreign currency denominated inflows have covered our foreign currency denominated expenses. However, we may enter into derivative or hedging transactions in the future if our exposure to foreign currency should become more significant.
Inflation Risk
We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition, and operating results.
Tariff Risk
One of the Company's manufacturing partners used in the manufacture of our products is located in China and we face risks associated with geopolitical conditions including new tariffs on imports. To date, the tariffs have not had a material effect on our business, financial condition or results of operations. The tariffs could increase the cost to us of finished goods we import and we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition, and operating results.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Under the supervision, and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in connection with the period ending March 31, 2025. Based on that evaluation, management has concluded that as of the respective period, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting described below.
Notwithstanding the material weaknesses in our internal control over financial reporting, management has concluded that the condensed consolidated financial statements included in this Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with accounting principles generally accepted in the United States of America.
Management’s Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act for the Company. Management assessed the effectiveness of internal control over financial reporting as of the three months ended March 31, 2025. In making this assessment, our management used the criteria set forth in the Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “COSO Framework”). Based on this evaluation, our management concluded that our internal control over financial reporting was not effective as of March 31, 2025, because of the material weaknesses described below.
This annual report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm, as allowed by the SEC.
Material Weaknesses
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that a reasonable possibility exists that a material misstatement of our annual or interim consolidated financial statements would not be prevented or detected on a timely basis.
Management concluded that material weaknesses existed as of the three months ended March 31, 2025. Specifically, management identified deficiencies in the principles associated with the control environment, risk assessment, control activities, information and communication and monitoring components of internal control, based on the criteria established by the COSO Framework, that constitute material weaknesses, either individually or in the aggregate.
•Control Environment: The Company lacked appropriate policies and resources to develop and operate effective internal control over financial reporting, which contributed to the Company’s inability to properly analyze, record and disclose accounting matters accurately and timely. This was further impacted by the lack of sufficient complement of qualified technical accounting and financial reporting personnel. This material weakness contributed to additional material weaknesses further described below.
•Risk Assessment: The Company did not have a formal process to identify, update, and assess risks, including risks around the accounting for complex transactions, that could significantly impact the design and operation of the Company’s control activities.
•Control Activities: The Company did not design and implement effective control activities and identified the following material weaknesses:
oThe lack of a sufficient number of trained professional with the expertise to design, implement, and execute a formal risk assessment process and formal accounting policies, procedures, and control over accounting and financial reporting to ensure the timely and accurate recording of financial transactions while maintaining a segregation of duties. This, coupled with management’s accounting software system has certain system limitations that do not allow for an effective control environment and the absence of sufficient other mitigating controls, created segregation of duties deficiencies.
oThe lack of a sufficient number of trained professionals with the appropriate U.S. GAAP technical expertise to identify, evaluate, and account for complex transactions and review valuation reports prepared by external specialists.
oThe Company failed to design and implement adequate internal controls over the recording of stock-based compensation expense including a precise review and procedures to ensure the proper accounting for stock based compensation expenses, and the recording of those expenses completely and accurately in the appropriate period.
•Information and Communication: The Company did not have adequate processes and controls for communicating information among the relevant parties.
•Monitoring Activities: The Company did not appropriately select, develop, and perform ongoing evaluations to ascertain whether the components of internal controls are present and functioning. The Company did not evaluate and communicate internal control deficiencies in a timely manner to those parties responsible for taking corrective action, including senior management and the board of directors.
These material weaknesses could result in a misstatement of the account balances or disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or timely detected.
Inherent Limitations on Effectiveness of Controls
Our management, including our principal executive officer and principal financial officer, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with
policies or procedures may deteriorate. Due to inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Remediation Plan and Status
We are committed to remediating the control deficiencies that constituted the above material weakness by implementing changes to our internal control over financial reporting. We are in the process of implementing measures designed to improve our internal control over financial reporting to remediate these material weaknesses, including formalizing our processes and internal control documentation and strengthening supervisory reviews by our financial management; hiring additional qualified accounting and finance personnel and engaging financial consultants to enable the implementation of internal control over financial reporting and segregating duties amongst accounting and finance personnel. In addition, we are planning on implementing an accounting software system with the design and functionality to segregate incompatible accounting duties, which we currently expect will be fully implemented in our 2025 fiscal year.
While we are implementing these measures, we cannot assure you that these efforts will remediate our material weaknesses and significant deficiencies in a timely manner, or at all, or prevent restatements of our financial statements in the future. In particular, our material weakness related to our accounting software was not fully remediated for the three months ended March 31, 2025 or the three months ended March 31, 2024, as we expect to implement new software in 2025. If we are unable to successfully remediate our material weaknesses, or identify any future significant deficiencies or material weaknesses, the accuracy and timing of our financial reporting may be adversely affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports, and the market price of our common stock may decline as a result.
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting during the period ended March 31, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Attestation Report of the Independent Registered Public Accounting Firm
This Quarterly Report on Form 10-Q does not include a report of management’s assessment regarding our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) or an attestation report of our independent registered accounting firm due to a transition period established by rules of the SEC for newly public companies. Additionally, our independent registered accounting firm will not be required to opine on the effectiveness of our internal control over financial reporting pursuant to Section 404 until we are no longer an “emerging growth company” as defined in the JOBS Act.
Part II - Other Information
Item 1. Legal Proceedings.
For information regarding legal proceedings please refer to Note 15. - Commitments and Contingencies in Part I, Item 1, "Financial Statements" of this Quarterly Report on Form 10-Q. From time to time, we are involved in legal proceedings and subject to claims arising in the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, we believe that the resolution of current matters will not have a material adverse effect on our business, financial condition, or results of operations. Even if any particular litigation or claim is not resolved in a manner that is adverse to our interests, such litigation can have a negative impact on us because of defense and settlement costs, diversion of management resources from our business, and other factors.
Item 1A. Risk Factors.
Our business, financial condition, results of operations, and cash flows may be impacted by a number of factors, many of which are beyond our control, including those set forth in our most recent Annual Report on Form 10-K and in our other filings with the SEC, the occurrence of any one of which could have a material adverse effect on our actual results. Except as set forth below, there have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K. The Company is supplementing the risk factors previously disclosed in our Annual Report on Form 10-K with the following risk factor.
Significant developments or changes in national laws or policies to protect or promote domestic interests and/or address foreign competition can have an adverse effect on our business and financial statements.
Significant developments or changes in national laws or policies to protect or promote domestic interests and/or address foreign competition, including laws and policies in areas such as trade, manufacturing, government purchasing, healthcare, intellectual property, regulatory enforcement and investment/development, can adversely affect our business and financial statements. The U.S. has announced and/or implemented significant new tariffs on imports from a wide range of countries, which has prompted retaliatory tariffs by a number of countries and a cycle of retaliatory tariffs by both the U.S. and other countries. In early April 2025, actions were taken by the U.S. and certain other countries to delay the effective date of certain of these tariffs, but as of the date of this report a number of new tariffs remain in effect, including significant tariffs between the U.S. and China. Collectively, these tariffs increase the cost to us of finished goods we import, which can increase the cost to our customers of certain of our finished goods, which can adversely impact demand for our products and our competitive positioning; could adversely impact the availability to us of certain products in certain countries and disrupt our supply chains, with related impacts to our operations; and could exacerbate inflation, diminish investment and result in broader negative impacts, economic instability and capital markets dislocation that may adversely impact demand for our products. In addition, whenever we are unable to fully recover higher costs, or whenever there is a time delay between the increase in costs and our ability to recover these costs, our margins and profitability can decline. The U.S. may implement additional tariffs and other measures, further retaliatory tariffs and other retaliatory actions may follow and the risks and adverse effects noted above may increase. Please see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of the impact of these tariffs. The full impact of these tariffs and other actions on the Company and on our business partners remains highly uncertain and subject to rapid change.
All of the risks identified in this risk factor can adversely affect our business and financial statements.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
On January 23, 2025, we issued 112,334 shares of Series A Preferred Stock in the aggregate as a dividend on the shares of Series A Preferred Stock.
On January 23, 2025, we issued 496,246 shares of Series C Preferred Stock pursuant to a Loan Restoration Agreement and issued 126,515 shares of Series C Preferred Stock as a dividend on the shares of Series C Preferred Stock.
On January 28, 2025, we entered into a securities purchase agreement with an accredited investor, pursuant to which we agreed to issue to the investor for approximately $2.9 million, (a) a senior secured convertible note issued by the Company in the aggregate principal amount of $3.3 million, which is convertible into shares of Common Stock, (b) warrants to purchase up to an aggregate of 674,274 shares of Common Stock, (c) Class A incremental warrants to purchase senior secured convertible notes in the aggregate principal amount of $13.0 million and warrants to purchase up to an aggregate of 2,697,097 shares of Common Stock and (d) Class B incremental warrants to purchase senior secured convertible notes in the aggregate principal amount of $20.0 million and warrants to purchase up to an aggregate of 4,149,380 shares of Common Stock. On March 11, 2025, the investor exercised Class A Incremental Warrants to purchase the Class A Incremental Notes for an aggregate principal amount of $4.0 million and, as a result, was issued the Class A Incremental Common Warrants to purchase an aggregate of 829,876 shares of Common Stock (207,469 shares for each of the four (4)
warrants). The exercise price of the Class A Incremental Common Warrants was $3.06 per share. The gross proceeds to the Company from the Warrant Exercise were approximately $3.6 million, before deducting legal fees and other estimated expenses.
On February 4, 2025, the Company issued five new secured promissory notes in exchange for existing promissory notes in the aggregate principal amount of $5.4 million.
On March 4, 2025, we issued 471,750 shares of common stock in exchange for the reduction of a principal amount of a note by $1.2 million.
On March 3, 2025, a holder of shares of Series A Preferred Stock converted 100,000 shares of Series A Preferred Stock into 63,898 shares of Common Stock.
From February 14, 2025 to March 12, 2025, a holder of Series C Preferred Stock converted 2,801,250 shares of Series C Preferred Stock into 1,723,846 shares of Common Stock.
On March 31, 2025 we issued 1,188,571 shares of Series C Preferred Stock pursuant to a Loan Restoration Agreement.
The offers, sales and issuances of the securities described above were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act and Rule 506 promulgated under Regulation D promulgated thereunder as transactions by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was an accredited investor or institutional accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act and had adequate access, through employment, business or other relationships, to information about the Registrant. No underwriter was involved in these transactions.
Item 5. Other Information
Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended March 31, 2025, no such plans or arrangements were adopted or terminated, including by modification.
Item 6. Exhibit
|
|
|
Exhibit No. |
|
Description |
|
|
2.1 |
|
Agreement for the Sale and Purchase of the Entire Issued Share Capital and Loan Notes of Wattbike (Holdings) Limited, dated as of April 8, 2025, by and among Interactive Strength Inc., the Shareholders and the Loan Note Holders (incorporated by reference from Exhibit 2.1 to the registrant’s Current Report on Form 8-K filed April 11, 2025). |
|
|
3.1 |
|
Certificate of Amendment to the Certificate of Designation of Series C Convertible Preferred Stock of Interactive Strength Inc. (incorporated by reference from Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed January 21, 2025). |
|
|
4.1 |
|
Form of Senior Secured Convertible Note (incorporated by reference from Exhibit 4.1 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
4.2 |
|
Form of Common Warrant (incorporated by reference from Exhibit 4.2 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
|
4.3 |
|
Form of Class A Incremental Note Purchase Warrant (incorporated by reference from Exhibit 4.3 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
|
4.4 |
|
Form of Class B Incremental Note Purchase Warrant (incorporated by reference from Exhibit 4.4 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
|
4.5 |
|
Form of Secured Convertible Note (incorporated by reference from Exhibit 4.1 to the registrant’s Current Report on Form 8-K filed February 5, 2025). |
|
|
|
4.6 |
|
Form of Common Warrant(incorporated by reference from Exhibit 4.1 to the registrant’s Current Report on Form 8-K filed March 7, 2025). |
|
|
|
4.7 |
|
Promissory Note (incorporated by reference from Exhibit 4.1 to the registrant’s Current Report on Form 8-K filed March 7, 2025). |
|
|
|
10.1 |
|
Letter Agreement, dated January 14, 2025, by and among Interactive Strength Inc. and CLMBR Holdings LLC and Woodway USA, Inc. (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed January 21, 2025). |
|
|
|
10.2 |
|
Settlement Agreement, dated January 23, 2025, by and between Interactive Strength Inc. and Vertical Investors, LLC (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed January 29, 2025). |
|
|
|
10.3 |
|
Form of Securities Purchase Agreement (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
|
10.4 |
|
Form of Registration Rights Agreement (incorporated by reference from Exhibit 10.2 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
|
10.5 |
|
Form of Guaranty (incorporated by reference from Exhibit 10.3 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
|
10.6 |
|
Form of Security and Pledge Agreement (incorporated by reference from Exhibit 10.4 to the registrant’s Current Report on Form 8-K filed February 3, 2025). |
|
|
|
10.7 |
|
Loan Agreement, by and between Sportstech Brands Holdings GmbH and Interactive Strength Inc., dated as of January 27, 2025 (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed February 4, 2025). |
|
|
|
10.8 |
|
Share Pledge Agreement, by and among Ali Ahmad, Sportstech Brands Holdings GmbH and Interactive Strength Inc., dated as of January 27, 2025 (incorporated by reference from Exhibit 10.2 to the registrant’s Current Report on Form 8-K filed February 4, 2025). |
|
|
|
10.9 |
|
Exchange Agreement, by and between Interactive Strength Inc. and TR Opportunities II LLC, dated as of February 4, 2025 (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed February 5, 2025). |
|
|
|
|
|
|
10.10 |
|
Binding Transaction Agreement, by and between Interactive Strength Inc., Ali Ahmad and Sportstech Brands Holding GmbH, dated as of February 10, 2025 (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed February 14, 2025). |
|
|
|
10.11 |
|
Letter Agreement, dated March 3, 2025, by and among Interactive Strength Inc. and CLMBR Holdings LLC and Woodway USA, Inc. (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed March 3, 2025). |
|
|
|
10.12 |
|
Settlement Agreement, dated March 5, 2025, by and between Interactive Strength Inc. and Pillsbury Winthrop Shaw Pittman LLP (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed March 7, 2025). |
|
|
|
10.13 |
|
March 2025 Settlement Agreement, dated as of March 31, 2025, by and between Interactive Strength Inc. and Vertical Investors, LLC (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed April 4, 2025). |
|
|
|
10.14 |
|
Letter Agreement, dated April 18, 2025, by and among Interactive Strength Inc., CLMBR Holdings LLC, and TR Opportunities II LLC (incorporated by reference from Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed April 18, 2025). |
|
|
|
31.1 |
|
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2 |
|
Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1* |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.2* |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
|
101.INS |
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
|
|
|
101.SCH |
|
Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents. |
|
|
|
104 |
|
Cover Page Formatted as Inline XBRL and Contained in Exhibit 101. |
|
|
|
* In accordance with Item 601(b)(32)(ii) of Regulation S K and SEC Release No. 34-47986, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933 except to the extent that the registrant specifically incorporates it by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
INTERACTIVE STRENGTH INC. |
|
|
|
|
Date: May 19, 2025 |
|
By: |
/s/ Trent A. Ward |
|
|
|
Trent A. Ward |
|
|
|
Chief Executive Officer |
|
|
|
(Principal Executive Officer and Duly Authorized Officer) |
|
|
|
|
Date: May 19, 2025 |
|
By: |
/s/ Michael J. Madigan |
|
|
|
Michael J. Madigan |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial Officer and Principal Accounting Officer) |